2025-09-11 12:23:19 [INFO] Fetching initial data...
2025-09-11 12:23:22 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home
2025-09-11 12:23:23 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/Data
2025-09-11 12:23:23 [INFO] Extracted Documents:
2025-09-11 12:23:23 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products
2025-09-11 12:23:23 [INFO] Extracted Documents:
2025-09-11 12:23:23 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about
2025-09-11 12:23:23 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/2025-06-05-focus-on-green
2025-09-11 12:23:23 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/2025-07-09-lupin
2025-09-11 12:23:23 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/2025-06-30-zentiva-calls
2025-09-11 12:23:23 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products/Data
2025-09-11 12:23:24 [INFO] Extracted Documents:
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products/catalog
2025-09-11 12:23:24 [INFO] Extracted Documents:
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products/generics-faq
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/Data
2025-09-11 12:23:24 [INFO] Extracted Documents:
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values
2025-09-11 12:23:24 [INFO] Extracted Documents:
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/management
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/2025-Zentiva acquires natural-based CHC heritage brands from Aboca
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/2025-07-11-zentiva-climates
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/find-out-more-2
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products/generics-faq/Data
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/100milion-people
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/2650-products
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products/catalog/Data
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/30-countries
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products/catalog/en
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/2650-products
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/1-58-bn
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/30-foodprint
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/main-message
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/management/Data
2025-09-11 12:23:24 [INFO] Extracted Documents:
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/management/steffen-saltofte
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/Rich Text 1
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/Rich Text 2
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/contract-manufacturing
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/generics-faq/Data/Promo Banner 1
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/generic-medicines
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/high-quality-pharmaceutical-production
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/generics-faq/Data/faq
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/generics-faq/Data/related-news
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/catalog/Data/Rich Text 1
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/image-card-set-about
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/contract-manufacturing
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/5000-employees
2025-09-11 12:23:24 [INFO] Extracted Documents:
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products/catalog/en/product-1
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/Data/test-1
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data/Authenticity
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data/Accountability
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data/Collaboration
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/Data/Rich Text 4
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/Data/Rich Text 1
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/Data/Rich Text 3
2025-09-11 12:23:24 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/management/steffen-saltofte/Data
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/pharmacovigilance
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/podcast-value-added-medicines
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/generics-faq/Data/Rich Text 1
2025-09-11 12:23:24 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/please-note
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/join-our-team
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/our-products
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/manufacturing-sites
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data/Courage
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data/Join our team
2025-09-11 12:23:25 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/products/catalog/en/product-1/Data
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/Data/Rich Text 5
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data/Rich Text 1
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/steffen-saltofte/Data/download-list-steffen-saltofte
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/steffen-saltofte/Data/career-steffen-saltofte
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/steffen-saltofte/Data/image-steffen-saltofte
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/Data/quality
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/Data/partner-with-us
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data/Trust
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/purpose-and-values/Data/Rich Text 2
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/catalog/en/product-1/Data/Promo Banner 1
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/catalog/en/product-1/Data/Image 1
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/steffen-saltofte/Data/related-news-steffen-saltofte
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/products/catalog/en/product-1/Data/Rich Text 1
2025-09-11 12:23:25 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/management/steffen-saltofte/Data/Rich Text 1
2025-09-11 12:23:25 [INFO] Extracted Documents:
2025-09-11 12:23:25 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies
2025-09-11 12:23:25 [INFO] Extracted Documents:
2025-09-11 12:23:25 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/quality
2025-09-11 12:23:25 [INFO] Extracted Documents:
2025-09-11 12:23:25 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/memberships
2025-09-11 12:23:26 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data
2025-09-11 12:23:26 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/memberships/Data
2025-09-11 12:23:26 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/quality/Data
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/download-list-code-of-ethics
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/button-explore-more
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/accordion
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/memberships/Data/memberschips-text-bellow
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/memberships/Data/memberships
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/memberships/Data/memberships-text-bellow2
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/quality/Data/join-our-team
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/quality/Data/read-quality-
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/quality/Data/partner-with-us
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/download-list-due-diligence
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/memberships/Data/Rich Text 2
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/download-list-environmental-social-and-governance
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/memberships/Data/Rich Text 1
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/download-list-gdpr
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/quality/Data/Rich Text 1
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/quality/Data/Rich Text 2
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/download-list-recruitment-privacy-notice
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/download-list-procurement
2025-09-11 12:23:26 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/download-list-reporting-of-concerns
2025-09-11 12:23:27 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/governance-and-policies/Data/download-list-websites-and-digital
2025-09-11 12:23:27 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/commercial-organizations
2025-09-11 12:23:27 [INFO] Extracted Documents:
2025-09-11 12:23:27 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/history
2025-09-11 12:23:27 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/history/Data
2025-09-11 12:23:27 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/about/commercial-organizations/Data
2025-09-11 12:23:28 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/commercial-organizations/Data/products
2025-09-11 12:23:28 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/commercial-organizations/Data/quality
2025-09-11 12:23:28 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/history/Data/2018-news-sanofi
2025-09-11 12:23:28 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/history/Data/history
2025-09-11 12:23:28 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/commercial-organizations/Data/contract-manufacturing
2025-09-11 12:23:28 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/history/Data/Rich Text 1
2025-09-11 12:23:28 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/commercial-organizations/Data/Rich Text 1
2025-09-11 12:23:28 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/about/history/Data/Rich Text 2
2025-09-11 12:23:28 [INFO] Extracted Documents:
2025-09-11 12:23:28 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/partnering
2025-09-11 12:23:28 [INFO] Extracted Documents:
2025-09-11 12:23:28 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/our-impact
2025-09-11 12:23:28 [INFO] Extracted Documents:
2025-09-11 12:23:28 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/partnering/Data
2025-09-11 12:23:29 [INFO] Extracted Documents:
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation
2025-09-11 12:23:29 [INFO] Extracted Documents:
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/Data
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/media-library
2025-09-11 12:23:29 [INFO] Extracted Documents:
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/our-impact/sustainability-report
2025-09-11 12:23:29 [INFO] Extracted Documents:
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/100-renewable-
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/Data/image-card-set-discover-more-about
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/Data/icon-card-set-discover-more
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/20-reduction
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/Data/open-innovations-button
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/100000-trees
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/100milion-people
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/5000employees
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/30markets
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation/Data
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/media-library/Data
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/our-impact/sustainability-report/Data
2025-09-11 12:23:29 [INFO] Extracted Documents:
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/media-library/logo
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/2m-bees
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/Data/Rich Text 1
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/Data/Rich Text 2
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/7-top-ranked
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/94-6-suppliers
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/Even more information
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/explore-our-platforms
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/euro1-58bn
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/Data/promo-banner-partner-with-us
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-albania
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation/Data/image-card-set-find-out-more
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/accordion-statements-for-countries
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation/Data/open-innovation-form
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-albania-2021
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation/Data/accordion-submit-your-idea
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/media-library/Data/Rich Text 2
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/media-library/Data/Rich Text 3
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/sustainability-report/Data/reports-archive
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/media-library/Data/Rich Text 1
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/sustainability-report/Data/read-sustainability-report-2024
2025-09-11 12:23:29 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/sustainability-report/Data/related-news
2025-09-11 12:23:29 [INFO] Extracted Documents:
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/media-library/logo/zentivas-logo
2025-09-11 12:23:29 [INFO] Extracted Documents:
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-15-carbon-neutral-in-2030
2025-09-11 12:23:29 [INFO] Extracted Documents:
2025-09-11 12:23:29 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-2-14-Day-of-Women-and-Girls-in-Science
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/find-out-more
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/imageCardSet
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/european-green-deal
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/imageCardSetNews
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/goal-1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/goal-10
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/Data/video-open-innovation
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-17-global-recycling-day
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-1-24-sustainability-podcast-about-fashion
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-11-26-zentiva-secures-apontis-pharma-voting-rights
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-06-16-zentiva-acquires-brands-from-Aboca
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-21-zentiva-and-euractiv-bring-policymakers-together
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-30-focus-on-green-chemistry
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-10-sustainability-podcast
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-albania-2022
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation/Data/text-banner-please-note
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-albania-2023
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-bosnia-2021
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation/Data/promo-banner-you-can-share
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/sustainability-report/Data/sustainability-podcast
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/sustainability-report/Data/steffen-saltofte
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/sustainability-report/Data/test-jp-iframe
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-15-carbon-neutral-in-2030/Data
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/Data/goal-11
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-2-14-Day-of-Women-and-Girls-in-Science/Data
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/Data/imagecardsetNoImages
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-17-global-recycling-day/Data
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-1-24-sustainability-podcast-about-fashion/Data
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-bosnia-2022
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-bosnia-2024
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-bosnia-2023
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-21-zentiva-and-euractiv-bring-policymakers-together/Data
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-06-16-zentiva-acquires-brands-from-Aboca/Data
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-11-26-zentiva-secures-apontis-pharma-voting-rights/Data
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/partnering/open-innovation/Data/timeline-how-does-the-submission
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-10-sustainability-podcast/Data
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-30-focus-on-green-chemistry/Data
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-15-carbon-neutral-in-2030/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-2-14-Day-of-Women-and-Girls-in-Science/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-17-global-recycling-day/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-1-24-sustainability-podcast-about-fashion/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/our-impact/transparency/Data/download-list-croatia-2020
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-21-zentiva-and-euractiv-bring-policymakers-together/Data/About-Zentiva
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-21-zentiva-and-euractiv-bring-policymakers-together/Data/Rich Text 2
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-21-zentiva-and-euractiv-bring-policymakers-together/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-06-16-zentiva-acquires-brands-from-Aboca/Data/About-Zentiva
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-06-16-zentiva-acquires-brands-from-Aboca/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-11-26-zentiva-secures-apontis-pharma-voting-rights/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-10-sustainability-podcast/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-06-16-zentiva-acquires-brands-from-Aboca/Data/Rich Text 2
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-30-focus-on-green-chemistry/Data/Rich Text 2
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-30-focus-on-green-chemistry/Data/Rich Text 1
2025-09-11 12:23:30 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-30-focus-on-green-chemistry/Data/podcast-13
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-12-18-steffen-saltofte-elected-as-a-member-of-executive-committee-medicines-for-europe
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-12-14-energy-efficiency-approach
2025-09-11 12:23:30 [INFO] Extracted Documents:
2025-09-11 12:23:30 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-21-Zentiva-commits-to-plant-1-million-trees-by-2030
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-21-zentiva-and-euractiv-bring-policymakers-together/Data/Steffen-Saltofte-quote
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-21-zentiva-and-euractiv-bring-policymakers-together/Data/Marie-claire-Rees
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-06-16-zentiva-acquires-brands-from-Aboca/Data/Steffen-Saltofte-quote
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-06-16-zentiva-acquires-brands-from-Aboca/Data/Rich Text 3
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-30-sustainability-report-2023
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-05-13-biotechnology-segment
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-25-critical-medicines-alliance
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-12-14-energy-efficiency-approach/Data
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-12-18-steffen-saltofte-elected-as-a-member-of-executive-committee-medicines-for-europe/Data
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-21-Zentiva-commits-to-plant-1-million-trees-by-2030/Data
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-15-zentiva-at-eas-congress-2025
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-30-sustainability-report-2023/Data
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-05-13-biotechnology-segment/Data
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-25-critical-medicines-alliance/Data
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-12-14-energy-efficiency-approach/Data/Rich Text 1
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-03-21-Zentiva-commits-to-plant-1-million-trees-by-2030/Data/Rich Text 1
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-15-zentiva-at-eas-congress-2025/Data
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-12-18-steffen-saltofte-elected-as-a-member-of-executive-committee-medicines-for-europe/Data/Rich Text 1
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare/Data
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-30-sustainability-report-2023/Data/Rich Text 1
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-05-13-biotechnology-segment/Data/Rich Text 1
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-04-25-critical-medicines-alliance/Data/Rich Text 1
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-04-21-welcome-to-zentiva-sustainability-podcast
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-04-18-Steffen-Saltofte
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-07-19-diversity-equity-inclusion-bulgaria
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/About-Zentiva
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-15-zentiva-at-eas-congress-2025/Data/Rich Text 1
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/download-sustainability-report
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/iframe-sustainability-report
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare/Data/Rich Text 1
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-06-07-time-interview
2025-09-11 12:23:31 [INFO] Extracted Documents:
2025-09-11 12:23:31 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-1-19-top-employer
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare/Data/Rich Text 2
2025-09-11 12:23:31 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare/Data/About-Zentiva
2025-09-11 12:23:32 [INFO] Extracted Documents:
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-05-20-sustainability-podcast
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/Rich Text 1
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/Rich Text 3
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/Rich Text 2
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare/Data/Marie-claire-Rees
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare/Data/Steffen-Saltofte-quote
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-04-18-Steffen-Saltofte/Data
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-04-21-welcome-to-zentiva-sustainability-podcast/Data
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-07-19-diversity-equity-inclusion-bulgaria/Data
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-1-19-top-employer/Data
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-06-07-time-interview/Data
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-05-20-sustainability-podcast/Data
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/sustainability-report
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/Ines-Windisch-quote
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/Rich Text 4
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-04-21-welcome-to-zentiva-sustainability-podcast/Data/Rich Text 1
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-07-19-diversity-equity-inclusion-bulgaria/Data/Rich Text 1
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-04-18-Steffen-Saltofte/Data/Rich Text 1
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-06-07-time-interview/Data/Rich Text 1
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-1-19-top-employer/Data/Rich Text 1
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-05-20-sustainability-podcast/Data/Rich Text 1
2025-09-11 12:23:32 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-04-09-sustainability-report-2024/Data/Steffen-Saltofte-quote
2025-09-11 12:23:32 [INFO] Extracted Documents:
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-07-13-zentiva-poland-great-place-to-work
2025-09-11 12:23:32 [INFO] Extracted Documents:
2025-09-11 12:23:32 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-08-22-sustainability-podcast-benefits-of-vegetarianism
2025-09-11 12:23:33 [INFO] Extracted Documents:
2025-09-11 12:23:33 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive
2025-09-11 12:23:33 [INFO] Extracted Documents:
2025-09-11 12:23:33 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-27-sustainable-architecture-in-the-spotlight
2025-09-11 12:23:33 [INFO] Extracted Documents:
2025-09-11 12:23:33 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-13-zentiva-supports-critical-medicines-act-as-welcome-step-forward
2025-09-11 12:23:33 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-07-13-zentiva-poland-great-place-to-work/Data
2025-09-11 12:23:33 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-08-22-sustainability-podcast-benefits-of-vegetarianism/Data
2025-09-11 12:23:33 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data
2025-09-11 12:23:33 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-13-zentiva-supports-critical-medicines-act-as-welcome-step-forward/Data
2025-09-11 12:23:33 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-27-sustainable-architecture-in-the-spotlight/Data
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2023/2023-07-13-zentiva-poland-great-place-to-work/Data/Rich Text 1
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2024/2024-08-22-sustainability-podcast-benefits-of-vegetarianism/Data/Rich Text 1
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data/presskit-download
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data/About-Zentiva
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data/Rich Text 1
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-13-zentiva-supports-critical-medicines-act-as-welcome-step-forward/Data/Rich Text 1
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-27-sustainable-architecture-in-the-spotlight/Data/Rich Text 2
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-27-sustainable-architecture-in-the-spotlight/Data/Rich Text 1
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-27-sustainable-architecture-in-the-spotlight/Data/podcast-12
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data/Rich Text 3
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data/Steffen-Saltofte-quote-2
2025-09-11 12:23:33 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data/Rich Text 2
2025-09-11 12:23:34 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data/teffen-Saltofte-quote-1
2025-09-11 12:23:34 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive/Data/Ines-Windisch
2025-09-11 12:23:34 [INFO] Extracted Documents:
2025-09-11 12:23:34 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-02-10-parc-awards
2025-09-11 12:23:34 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-02-10-parc-awards/Data
2025-09-11 12:23:35 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2025/2025-02-10-parc-awards/Data/Rich Text 1
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-25-Zentiva-celebrates-the-next-generation-of-scientists-with-The-Parc-Awards
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-25-First-Zentiva-Digital-Career-event
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-10-Sona-Porubska-joins-the-Zentiva-Executive-Committee
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/04-09-2021-EXPANSION-ONCOLOGY
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/05-28-21-Zent2u-announcement-successfull-development-completion-of-Metformin
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2020-02-18-Zentiva-scales-with-Microsoft-Azure
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-03-19-Coronavirus-Update
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-03-26-Zentiva-Sanitizer
2025-09-11 12:23:35 [INFO] Extracted Documents:
2025-09-11 12:23:35 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-01-27-celebrating-the-parc-impressive-2019-track-record
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-25-Zentiva-celebrates-the-next-generation-of-scientists-with-The-Parc-Awards/Data
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-25-First-Zentiva-Digital-Career-event/Data
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-10-Sona-Porubska-joins-the-Zentiva-Executive-Committee/Data
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/04-09-2021-EXPANSION-ONCOLOGY/Data
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2020-02-18-Zentiva-scales-with-Microsoft-Azure/Data
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-03-26-Zentiva-Sanitizer/Data
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/05-28-21-Zent2u-announcement-successfull-development-completion-of-Metformin/Data
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-03-19-Coronavirus-Update/Data
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-01-27-celebrating-the-parc-impressive-2019-track-record/Data
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-25-First-Zentiva-Digital-Career-event/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-25-Zentiva-celebrates-the-next-generation-of-scientists-with-The-Parc-Awards/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/04-09-2021-EXPANSION-ONCOLOGY/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-02-10-Sona-Porubska-joins-the-Zentiva-Executive-Committee/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2020-02-18-Zentiva-scales-with-Microsoft-Azure/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/05-28-21-Zent2u-announcement-successfull-development-completion-of-Metformin/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-03-26-Zentiva-Sanitizer/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-03-19-Coronavirus-Update/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-01-27-celebrating-the-parc-impressive-2019-track-record/Data/Rich Text 1
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-06-10-zentiva-bulgaria-initiative-to-help-ukraine
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2020-03-9-Zentiva-SUPERPOWERZ
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-03-06-Zentiva-Czech-Republic-underlines-its-commitment-to-Diversity-Inclusion
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-06-28-from-the-heart-an-interview-with-nick-haggar
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-02-26-ZENTIVA-ANNOUNCES-WINNERS-OF-AWARDS
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-02-15-Zentiva-top-employer-6th-time
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-04-09-zentiva-ikea-joining-forces-to-fight-covid-19
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-04-07-acquisition-from-Alvogen
2025-09-11 12:23:36 [INFO] Extracted Documents:
2025-09-11 12:23:36 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-06-01-Zentiva-expands-production-capacity
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-06-10-zentiva-bulgaria-initiative-to-help-ukraine/Data
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-03-06-Zentiva-Czech-Republic-underlines-its-commitment-to-Diversity-Inclusion/Data
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2020-03-9-Zentiva-SUPERPOWERZ/Data
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-02-26-ZENTIVA-ANNOUNCES-WINNERS-OF-AWARDS/Data
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-02-15-Zentiva-top-employer-6th-time/Data
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-06-28-from-the-heart-an-interview-with-nick-haggar/Data
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-04-07-acquisition-from-Alvogen/Data
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-06-01-Zentiva-expands-production-capacity/Data
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-04-09-zentiva-ikea-joining-forces-to-fight-covid-19/Data
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-06-10-zentiva-bulgaria-initiative-to-help-ukraine/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-03-06-Zentiva-Czech-Republic-underlines-its-commitment-to-Diversity-Inclusion/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2020-03-9-Zentiva-SUPERPOWERZ/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-02-26-ZENTIVA-ANNOUNCES-WINNERS-OF-AWARDS/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-06-28-from-the-heart-an-interview-with-nick-haggar/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-04-07-acquisition-from-Alvogen/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-02-15-Zentiva-top-employer-6th-time/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-06-01-Zentiva-expands-production-capacity/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-04-09-zentiva-ikea-joining-forces-to-fight-covid-19/Data/Rich Text 1
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-08-15-Zentiva-welcomed-representatives-of-the-Czech-Ministry-of-Industry-and-Trade
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-07-08-allergy-day
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-09-15-zentiva-uk-recognised-with-the-great-place-to-work-certificate
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-12-Zentiva-The-Parc-Incubator
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-25-production-record-prague-site
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-24-Zentiva-to-plant-27800-trees-madagascar
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-09-29 Zentiva Awards
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-09-29 World Heart Day 2020
2025-09-11 12:23:37 [INFO] Extracted Documents:
2025-09-11 12:23:37 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-07-29-Zentiva-made-1-5-milion-desinfectants
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-08-15-Zentiva-welcomed-representatives-of-the-Czech-Ministry-of-Industry-and-Trade/Data
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-07-08-allergy-day/Data
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-09-15-zentiva-uk-recognised-with-the-great-place-to-work-certificate/Data
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-12-Zentiva-The-Parc-Incubator/Data
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-25-production-record-prague-site/Data
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-24-Zentiva-to-plant-27800-trees-madagascar/Data
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-09-29 World Heart Day 2020/Data
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-09-29 Zentiva Awards/Data
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-07-29-Zentiva-made-1-5-milion-desinfectants/Data
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-08-15-Zentiva-welcomed-representatives-of-the-Czech-Ministry-of-Industry-and-Trade/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-09-15-zentiva-uk-recognised-with-the-great-place-to-work-certificate/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-25-production-record-prague-site/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-12-Zentiva-The-Parc-Incubator/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-07-08-allergy-day/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-24-Zentiva-to-plant-27800-trees-madagascar/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-09-29 World Heart Day 2020/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-09-29 Zentiva Awards/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-07-29-Zentiva-made-1-5-milion-desinfectants/Data/Rich Text 1
2025-09-11 12:23:38 [INFO] Extracted Documents:
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-10-1-birthday
2025-09-11 12:23:38 [INFO] Extracted Documents:
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-31-Sanicor-250000-packs-czech-food-banks
2025-09-11 12:23:38 [INFO] Extracted Documents:
2025-09-11 12:23:38 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-09-16-ORBIS-School
2025-09-11 12:23:39 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-31-Sanicor-250000-packs-czech-food-banks/Data
2025-09-11 12:23:39 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-10-1-birthday/Data
2025-09-11 12:23:39 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-09-16-ORBIS-School/Data
2025-09-11 12:23:39 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2020/2020-10-1-birthday/Data/Rich Text 1
2025-09-11 12:23:39 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2021/2021-03-31-Sanicor-250000-packs-czech-food-banks/Data/Rich Text 1
2025-09-11 12:23:39 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2022/2022-09-16-ORBIS-School/Data/Rich Text 1
2025-09-11 12:23:39 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/news
2025-09-11 12:23:39 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019
2025-09-11 12:23:39 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018
2025-09-11 12:23:40 [INFO] Extracted Documents:
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-09-11-zentiva-acquisition-site-production-ankleshwar-inde
2025-09-11 12:23:40 [INFO] Extracted Documents:
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-10-25-Alvogen-acquisition
2025-09-11 12:23:40 [INFO] Extracted Documents:
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-14-08-Horizon-2020
2025-09-11 12:23:40 [INFO] Extracted Documents:
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/Zentiva-independent-company
2025-09-11 12:23:40 [INFO] Extracted Documents:
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/sanofi-advent-finalize-negotiations
2025-09-11 12:23:40 [INFO] Extracted Documents:
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/2018-11-23_Zentiva_partnership-Phoenix
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-10-25-Alvogen-acquisition/Data
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-09-11-zentiva-acquisition-site-production-ankleshwar-inde/Data
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-14-08-Horizon-2020/Data
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/sanofi-advent-finalize-negotiations/Data
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/Zentiva-independent-company/Data
2025-09-11 12:23:40 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/2018-11-23_Zentiva_partnership-Phoenix/Data
2025-09-11 12:23:40 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-10-25-Alvogen-acquisition/Data/Rich Text 1
2025-09-11 12:23:40 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-14-08-Horizon-2020/Data/Rich Text 1
2025-09-11 12:23:40 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-09-11-zentiva-acquisition-site-production-ankleshwar-inde/Data/Rich Text 1
2025-09-11 12:23:40 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/Zentiva-independent-company/Data/Rich Text 1
2025-09-11 12:23:40 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/2018-11-23_Zentiva_partnership-Phoenix/Data/Rich Text 1
2025-09-11 12:23:40 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2018/sanofi-advent-finalize-negotiations/Data/Rich Text 1
2025-09-11 12:23:41 [INFO] Extracted Documents:
2025-09-11 12:23:41 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-13-zentiva-acquired-solacium
2025-09-11 12:23:41 [INFO] Extracted Documents:
2025-09-11 12:23:41 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-05-the-park-awards
2025-09-11 12:23:41 [INFO] Extracted Documents:
2025-09-11 12:23:41 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-05-31_PR_Solacium
2025-09-11 12:23:41 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-13-zentiva-acquired-solacium/Data
2025-09-11 12:23:41 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-05-31_PR_Solacium/Data
2025-09-11 12:23:41 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-05-the-park-awards/Data
2025-09-11 12:23:41 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-13-zentiva-acquired-solacium/Data/Rich Text 1
2025-09-11 12:23:41 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-05-the-park-awards/Data/Rich Text 1
2025-09-11 12:23:41 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-05-31_PR_Solacium/Data/Rich Text 1
2025-09-11 12:23:41 [INFO] Extracted Documents:
2025-09-11 12:23:41 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-01-the-parc
2025-09-11 12:23:41 [INFO] Extracted Documents:
2025-09-11 12:23:41 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-01-25_investment
2025-09-11 12:23:42 [INFO] Extracted Documents:
2025-09-11 12:23:42 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-02-06_top-zamestnavatel
2025-09-11 12:23:42 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-01-the-parc/Data
2025-09-11 12:23:42 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-01-25_investment/Data
2025-09-11 12:23:42 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-02-06_top-zamestnavatel/Data
2025-09-11 12:23:42 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-03-01-the-parc/Data/Rich Text 1
2025-09-11 12:23:42 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-01-25_investment/Data/Rich Text 1
2025-09-11 12:23:42 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-02-06_top-zamestnavatel/Data/Rich Text 1
2025-09-11 12:23:42 [INFO] Extracted Documents:
2025-09-11 12:23:42 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-01-15_Nick-Haggar-CEO-Zentiva
2025-09-11 12:23:43 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-01-15_Nick-Haggar-CEO-Zentiva/Data
2025-09-11 12:23:43 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/newsroom/2019/2019-01-15_Nick-Haggar-CEO-Zentiva/Data/Rich Text 1
2025-09-11 12:23:43 [INFO] Extracted Documents:
2025-09-11 12:23:43 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events
2025-09-11 12:23:44 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/Data
2025-09-11 12:23:44 [INFO] Extracted Documents:
2025-09-11 12:23:44 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/congress
2025-09-11 12:23:44 [INFO] Extracted Documents:
2025-09-11 12:23:44 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/conferences
2025-09-11 12:23:44 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/events/Data/Rich Text 1
2025-09-11 12:23:44 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/congress/2025
2025-09-11 12:23:44 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/conferences/2025
2025-09-11 12:23:44 [INFO] Extracted Documents:
2025-09-11 12:23:44 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/conferences/2025/global-community-advancing-human-health
2025-09-11 12:23:45 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/conferences/2025/global-community-advancing-human-health/Data
2025-09-11 12:23:45 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/events/conferences/2025/global-community-advancing-human-health/Data/Rich Text 1
2025-09-11 12:23:45 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/events/conferences/2025/global-community-advancing-human-health/Data/Speaker Set 1
2025-09-11 12:23:45 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/news/events/conferences/2025/global-community-advancing-human-health/Data/Speaker Set 2
2025-09-11 12:23:45 [INFO] Extracted Documents:
2025-09-11 12:23:45 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/webinar
2025-09-11 12:23:45 [INFO] Extracted Documents:
2025-09-11 12:23:45 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/fair-and-exhibition
2025-09-11 12:23:45 [INFO] Extracted Documents:
2025-09-11 12:23:45 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/news/events/other
2025-09-11 12:23:46 [INFO] Extracted Documents:
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/gdpr
2025-09-11 12:23:46 [INFO] Extracted Documents:
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/career
2025-09-11 12:23:46 [INFO] Extracted Documents:
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/contacts
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/career/Data
2025-09-11 12:23:46 [INFO] Extracted Documents:
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data
2025-09-11 12:23:46 [INFO] Extracted Documents:
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/career/benefits
2025-09-11 12:23:46 [INFO] Extracted Documents:
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/accordion-gdpr1
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/download-list-privacy-notice
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/download-list-privacy-notice-for-speakup
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/53-women
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/87-workforce
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/5000-employees
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/location-list-pharmacovigilance
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/locations
2025-09-11 12:23:46 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/czech-republic
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data
2025-09-11 12:23:46 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/download-list-privacy-notice-for-speakup-archive
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/recruitment-privacy-policy-locations
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/download-list-recruitment-privacy-notice
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/96-heartbeat
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/diversity-equity-inclusion-belonging
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/locations-in-asia
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/discover-more
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/locations-in-europe
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/medical-enquiry-form
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/1-7-invested-in-workforce
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/30-subsidiaries
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/drive-impact
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/information-for-partners
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/internal-reporting-channels
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/career-news
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/download-list-general-terms-of-delivery
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/compensation
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/flexibility
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/Rich Text 4
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/Rich Text 5
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/Rich Text 6
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/meet-manufacturing
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/meet-corporate-2
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/meet-corporate
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/reporting-of-concerns
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/hybrid-work-model
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/pharmacovigiliance-and-media-contact
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/open-innovation
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/explore-career-opportunities
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/key-areas-in-corporate-functions
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/report-to-us
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/Rich Text 2
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/Rich Text 3
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/health-wellbeing
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/personal-growth
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/rewards
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/gdpr/Data/Rich Text 7
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/Data/meet-research
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/Data/Rich Text 1
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/meet-our-employees-at-corporate-functions
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/manufacturing-for-real-impact
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/meet-our-employees-at-corporate-functions-2
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/Rich Text 4
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/Rich Text 6
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/contacts/information-for-our-partners-and-suppliers/Data/Rich Text 5
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/Rich Text 2
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/winning-culture
2025-09-11 12:23:47 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/benefits/Data/Rich Text 1
2025-09-11 12:23:48 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/career/careers-in-corporate-functions/Data/related-news
2025-09-11 12:23:48 [INFO] Extracted Documents:
2025-09-11 12:23:48 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns
2025-09-11 12:23:48 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/Data
2025-09-11 12:23:48 [INFO] Extracted Documents:
2025-09-11 12:23:48 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection
2025-09-11 12:23:48 [INFO] Extracted Documents:
2025-09-11 12:23:48 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/Data/Rich Text 1
2025-09-11 12:23:49 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data
2025-09-11 12:23:49 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/bulgaria
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/france
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/bosnia
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/bulgaria-zentiva
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/albania
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/croatia
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/kazakhstan
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/italia
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/hungary
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/denmark
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/moldova
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/germany
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/north-macedonia
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/montenegro
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/labormed-pharma-sa
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/netherlands
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/poland
2025-09-11 12:23:49 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/labormeda-pharma-trading
2025-09-11 12:23:50 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/speak-up/Data/Rich Text 1
2025-09-11 12:23:50 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblowers-protection/Data/Rich Text 1
2025-09-11 12:23:50 [INFO] Extracted Documents:
2025-09-11 12:23:50 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group
2025-09-11 12:23:50 [INFO] ğŸ” Crawling path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/faq
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/Petr-Rihova
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/faq-cs
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/reporting-channels-cs
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/Petr-Rihova-cs
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/reporting-channels
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/Rich Text 3
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/Rich Text 2
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/Rich Text 1
2025-09-11 12:23:51 [INFO] â›” Skipping path: /sitecore/content/Zentiva/zentiva/Home/reporting-of-concerns/whistleblower-protection-zentiva-group/Data/Rich Text 4
2025-09-11 12:23:51 [INFO] ğŸ“Š CelkovÃ½ poÄet extrahovanÃ½ch dokumentÅ¯: 111
2025-09-11 12:23:51 [INFO] ğŸ“„ Extracted documents:
2025-09-11 12:24:20 [INFO] [
  {
    "annotation": "",
    "type": "Content Page",
    "id": "4E37606D4FE94259B5966D5231E5E9BF-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "about",
    "subtitle": "At Zentiva, we contribute to public health across Europe and beyond by developing, manufacturing, and delivering high-quality, affordable medicines.Â ",
    "title": "About",
    "content_title": "About About",
    "content_text": "than 100 million people trust Zentivaâ€™s medicines. We continue to expand our portfolio in key therapeutic areas like cardiology and circulation, diabetes, oncology, respiratory, CNS (central nervous system) and consumer health. Zentivaâ€™s growth strategyEffective portfolio managementBusiness development &amp; strategic partnershipsSuccessful product launch execution across core portfolioSales &amp; Marketing excellence focused on customer valueRelentless pursuit of operational efficiencyTargeted mergers and acquisitions to strengthen market presenceCommitment to sustainable growth and responsible practices",
    "category": null,
    "url": "/about",
    "url_detail": [
      "about"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/about/_A6A5320.jpg?h=1333&iar=0&w=2000"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "1EB0312F6EA34EF5B79C831FC26B56F9-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "purpose-and-values",
    "subtitle": "",
    "title": "Purpose and values",
    "content_title": "Purpose and values",
    "content_text": "Our purpose is to provide health and wellbeing for all generations, guided by five core values.Our values guide our actions and reinforce our long-term commitment.  AccountabilityAuthenticityCollaborationCourageTrustTaking ownership for what we do. Being true to what makes us unique and living it every day.Working together to achieve great things.Growing when tackling new and difficult stuff.Doing whatâ€™s right every time with integrity.",
    "category": null,
    "url": "/about/purpose-and-values",
    "url_detail": [
      "about",
      "purpose-and-values"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/about/Purpose-and-values_1.jpg?h=430&iar=0&w=642"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "06528A91FC1E410584A28C5D810E4365-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "management",
    "subtitle": "",
    "title": "Management",
    "content_title": "Management",
    "content_text": "LEADERSHIP TEAM At Zentiva, we want to make sure that our company is managed by people who are properly selected based on their competency and skills. We believe that diversity in company's boards adds value to our management through differences in perspective and experience.  Executive Committee Leadership Team",
    "category": null,
    "url": "/about/management",
    "url_detail": [
      "about",
      "management"
    ]
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "8D2EC83B8B0D47FD93269001ADAD7F04-en",
    "tags": [],
    "publish_date": "2025-04-03T07:04:40Z",
    "language": "en",
    "name": "steffen-saltofte",
    "subtitle": "CEO",
    "title": "Steffen Saltofte",
    "content_title": "Steffen Saltofte",
    "content_text": "Bio summaryPassionate and focused, Steffen Saltofte is energized by creating a dynamic culture that strengthens purposeful companies, provides leadership, and drives strategic growth. Throughout his career, he has been grateful for the many opportunities to do just that.In his current role as CEO of Zentiva, Steffen leads a dedicated team of 4,800 associates across more than 30 countries. Together, they work to deliver high-quality, affordable medicines to those who depend on them every day. His mission is to guide the company on its growth journey to serve even more patients, further develop the #WinningTeam, and uphold Zentiva's strong sustainability commitment. ",
    "category": null,
    "url": "/about/management/steffen-saltofte",
    "url_detail": [
      "about",
      "management",
      "steffen-saltofte"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/headline/zentiva-at-night.jpeg?h=1667&iar=0&w=2500"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "A897E5DDA8FC42509799AFC83E01BFF9-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "quality",
    "subtitle": "At Zentiva, quality is at the heart of everything we do.",
    "title": "Quality",
    "content_title": "Quality",
    "content_text": "Quality is the foundation of our business success and a guiding principle across all our operations. We ensure the highest product standards through a robust Quality Management System (QMS) that supports full compliance with international and national regulations, including ICH guidelines. Every medicine we develop, manufacture, and distribute is made with a deep commitment to quality, safety, effectiveness, and regulatory compliance.Zentivaâ€™s commitment to quality is non-negotiable. Our strong track record of successful inspections by health authorities across our sites and affiliates reflects this dedication. We regularly host inspections from agencies such as the European Medicines Agency (EMA), MHRA (Medicines and Healthcare products Regulatory Agency), Swissmedic and the US FDA (U.S. Food and Drug Administration) and other national authorities to verify the quality of our development, manufacturing, and distribution practices.To drive continuous improvement and maintain high standards, Zentiva runs a risk-based quality audit program covering internal operations and external partners. Quality Audits are conducted by qualified auditors and result in clear action plans that are tracked through to completion ensuring continuous improvement.All our suppliers involved in GxP-relevant activities, including Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP), undergo a rigorous qualification and monitoring process. Responsibilities are clearly defined through contractual agreements, ensuring that all outsourced activities comply with regulatory and legislative requirements.Through these measures, strong internal systems, quality audits, regulatory collaboration, and responsible sourcing, we uphold our Quality Policy and deliver on our purpose to provide health and wellbeing for all generations.",
    "category": null,
    "url": "/about/quality",
    "url_detail": [
      "about",
      "quality"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/about/Zentiva-Visuals-1-10_Quality.jpg?h=1080&iar=0&w=1920"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "676AE030FF474F1CBCB86F443D06C2FB-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "governance-and-policies",
    "subtitle": "Our business is built on trust and responsibility with the patients and consumers at the heart of everything we do.",
    "title": "Governance & policies",
    "content_title": "Governance & policies",
    "content_text": "We put in place policies and added processes to ensure we fulfil these commitments. Those policies are publicly available and actively communicated internally and externally to our employees, our business partners and other relevant stakeholders.",
    "category": null,
    "url": "/about/governance-and-policies",
    "url_detail": [
      "about",
      "governance-and-policies"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/about/zen_fot_469.jpg?h=3333&iar=0&w=5000"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "F8AEE24C3E2D44E28A2752EE6EA1E1FF-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "memberships",
    "subtitle": "Partnering for progress in ethical and sustainable healthcare",
    "title": "Memberships",
    "content_title": "Memberships",
    "content_text": "As a proactive leader in the evolving healthcare and pharmaceutical landscape, Zentiva proudly partners with key associations to strengthen our commitment to ethical practices, regulatory compliance, and sustainable development. In many countries, our affiliates are also members of local generics associations, reflecting our proactive approach to political influence and public affairs. These partnerships are guided by a strict code of conduct that prioritizes transparency, competition, and ethical engagement. Zentiva does not contribute to political campaigns, political organizations, lobbyists, or any groups aimed at influencing political outcomes. Thus, Zentiva confirms, that we did not provide any contribution for political purposes (political contributions) in the fiscal year 2024.Our efforts are directed towards supporting policies that mitigate drug shortages, enhance healthcare resilience, and advance environmental responsibility within the pharmaceutical sector, in line with our overarching Sustainability objectives.Zentivaâ€™s sustainability initiatives emphasize environmental and social responsibility, with a strong focus on partnerships and collaboration. We extend our commitment beyond internal operations, working with suppliers, customers, and communities to foster a better future. By integrating sustainability into every aspect of our business, we ensure our partnerships align with our values and contribute to shared goals, creating lasting, positive impacts. For more details, explore Our Partnerships and Commitments to Sustainability.  ",
    "category": null,
    "url": "/about/memberships",
    "url_detail": [
      "about",
      "memberships"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/about/Memberships.png?h=610&iar=0&w=1017"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "EB4F4B14091C4C99965046687DBE5AC0-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "history",
    "subtitle": "Zentivaâ€™s roots reach back more than 500 years to a small pharmacy that still exists today in the heart of Prague, Czech Republic.",
    "title": "History",
    "content_title": "History",
    "content_text": "Back in 2009, Zentiva was acquired by Sanofi, and later in 2018, it was carved out by Advent International. From 2020 onwards, we have been expanding our business to new territories in Europe and complemented our portfolio in main therapeutical areas. And our exciting growth journey just began. Within four years we were successful in doubling the size of the company, expanding our geographical footprint to all of Europe, covering main therapeutical areas and standard treatments.By offering our products and services at a high-quality, and at the same time an affordable price, we make a huge contribution to public health. For more than 500 years, Zentiva has been a trusted partner in healthcare, and we have a responsibility to act today for a sustainable tomorrowâ€”ensuring Zentiva continues for at least another 500 years.",
    "category": null,
    "url": "/about/history",
    "url_detail": [
      "about",
      "history"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/about/History.jpg?h=1364&iar=0&w=2048"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "CF70AD4884F946FE8AFF4EBE54187D9A-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "products",
    "subtitle": "We offer a wide range of INN and branded generics, specialty products, and consumer healthcare solutions.",
    "title": "Products",
    "content_title": "Products",
    "content_text": "At Zentiva, we provide health and wellbeing for all generations by ensuring the supply of high-quality and affordable medicines in Europe and beyond.Over the years, we have successfully expanded our portfolio through strategic in-licensing and acquisitions, positioning ourselves for continued growth. We have also invested in strengthening our Consumer Healthcare portfolio, particularly in the Czech Republic, Romania, and Slovakia-helping even more people on their health journeys. In the past year alone, we launched over 140 new products, reaffirming Zentivaâ€™s role as a key platform for improving access to healthcare in Europe and beyond.By 2028, we aim to support 1 in 5 individuals across Europe.We collaborate closely with our partners to bring effective and innovative treatments to the markets we serve. Our world-class manufacturing capabilities and extensive network make Zentiva a trusted partner of choice for contract manufacturing and out-licensing within the pharmaceutical industry. Access to treatments for patients in Zentivaâ€™s marketsZentiva offers a diverse portfolio made of prescription (Rx) medicines and over-the-counter (OTC) products, as well as a wide range of food supplements. We provide originator brands which are protected by patents or data exclusivity, and branded generics that serve as equivalent and reliable alternatives to original products.Our product portfolio spans a broad range of therapeutic areas, supporting the health needs of patients across our markets. Value-added medicinesAt Zentiva, we actively manage the lifecycle of APIs, allowing us to launch new products immediately after loss of exclusivity. We focus on bioequivalent and value-added medicines, integrating green design solutions and advancing drug formulations.By leveraging new technologies and reinvesting in sustainable innovation, we aim to better understand and address patientsâ€™ unmet needs. Our goal is to improve quality of life and empower healthcare professionals to deliver high-quality care for everyone. Our supply chainAt Zentiva, our supply chain is the backbone of our purpose to deliver high-quality and affordable medicines to people across Europe and beyond. We manage the full value chain - from sourcing and product development to manufacturing, quality control, regulatory compliance, and timely delivery - ensuring reliable access to essential treatments.Our network comprises four state-of-the-art manufacturing sites, two of which are supported by modern R&amp;D centers and advanced testing facilities. These centers of excellence are equipped with cutting-edge technologies and specialized capabilities. As a company committed to sustainability, we view every part of our value chain as essential. We continuously innovate, invest in new technologies, and improve resource efficiency.We adhere to strict international quality and regulatory standards at every stage of production, ensuring that Zentiva medicines are reliably safe, effective, and accessible to patients and healthcare professionals. We are proud to be a member of the Pharmaceutical Supply Chain Initiative (PSCI), reinforcing our dedication to ethical practices, environmental sustainability, and social responsibility across our supply chain. Through continuous improvement and responsible sourcing, we aim to create long-term value for our partners and the communities we serve.",
    "category": null,
    "url": "/products",
    "url_detail": [
      "products"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/our-products.jpeg?h=1280&iar=0&w=853"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "847B5CA9EF2449E29C0F9D31C1FA58CF-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "catalog",
    "subtitle": "",
    "title": "Catalog",
    "content_title": "Catalog",
    "content_text": "Product 1 Link: link",
    "category": null,
    "url": "/products/catalog",
    "url_detail": [
      "products",
      "catalog"
    ]
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "30AE7F7B146140108E954C088A893FDD-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "product-1",
    "subtitle": "",
    "title": "Product 1",
    "content_title": "Product 1",
    "content_text": "",
    "category": null,
    "url": "/products/catalog/product-1",
    "url_detail": [
      "products",
      "catalog",
      "product-1"
    ]
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "C60717EE5AF54879A92D00348FE0B0A6-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "generics-faq",
    "subtitle": "At Zentiva, we bring value to patients and healthcare systems by supporting sustainable healthcare across Europe. We believe health for all should be a right, not a privilege.",
    "title": "Generics medicines",
    "content_title": "Generics medicines",
    "content_text": "Generic medicines, also known as â€œgenericsâ€, are affordable, high-quality pharmaceutical products that offer effective care to a broader population. They serve as alternatives to original, often more expensive, branded drugs â€” making treatment more accessible without compromising on safety or efficacy.Generics contain the same active ingredient as the original (reference) product and are produced in the same dosage form to treat the same medical conditions. Before approval, generics must demonstrate bioequivalence, confirming that they act in the same way in the human body as the reference medicine. This ensures they are interchangeable with the originator drug.Generic medicines are launched after the patent of the originator product expires and are held to the same strict regulatory standards as branded drugs. As a result, they match the original products in terms of safety, quality, and effectiveness.Typically offered at significantly lower prices, generics can also benefit from the brand recognition established by the originator companyâ€™s previous marketing efforts. This cost advantage translates into substantial savings for national healthcare systems, helping to reallocate funds to more advanced or innovative treatments.In general, generics medicines cost less than originator products. Over time, competition from generics will lead to the decrease of the price of the drug making it affordable for a larger number of patients. Therefore, generics can help increase access to medicines in developed countries struggling to contain rising healthcare costs and in developing countries that are often unable to afford branded medicines. In addition, these savings can make resources available for funding new innovative medicines.",
    "category": null,
    "url": "/products/generics-faq",
    "url_detail": [
      "products",
      "generics-faq"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/about/Generics.png?h=1080&iar=0&w=1920"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "B040266FB7254769A036635861694C66-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "partnering",
    "subtitle": "At Zentiva, we partner with organizations that share our commitment to expanding access to high-quality, affordable healthcare. Together, we create meaningful impact across Europe and beyond.",
    "title": "Partnering",
    "content_title": "Partnering",
    "content_text": "Today, more than 100 million people rely on Zentivaâ€™s products and services. By 2028, our goal is to reach 1 in 5 people across Europe. We are committed to improving access to healthcare by ensuring a reliable supply of high-quality, affordable medicines for those who depend on them every day. To achieve this, we are building strong partnerships with those who share our values and our sense of responsibility.At the core of our growth strategy is Zent2U, our dedicated business-to-business (B2B) platform. Zent2U offers a comprehensive range of services, including active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) solutions, and the licensing of our proprietary know-how. We bring deep expertise in key therapeutic areas such as cardiology, urology, oncology, neurology, and hormone-related treatments. Additionally, Prague Scientific delivers end-to-end development and scientific services, supporting every stage of the pharmaceutical lifecycle - from concept to compliant product maintenance. Its expertise spans three core pillars: API and formulation R&amp;D, manufacturing at Zentivaâ€™s state-of-the-art, sustainable production facilities, and scientific affairs, encompassing regulatory affairs and pharmacovigilance across a broad portfolio of products. Prague Scientific also fosters innovation through its academic partnership with the PARC â€“ the Pharmaceutical Applied Research Centre.  Open Innovation ProgrammeOur experts continue to explore new ways to improve current pharmaceutical products, simplify administration, increase patient compliance and keep healthcare accessible to everybody.Innovation means collaboration and we would like to join forces with those who are having the same commitment and asking the same questions than we do.  With our Open Innovation Programme we can make the difference together. ",
    "category": null,
    "url": "/partnering",
    "url_detail": [
      "partnering"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/partnering/zen_fot_633.jpg?h=3333&iar=0&w=5000"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "CC84CB241F564801BE363A5B4BD02A0A-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "open-innovation",
    "subtitle": "We can make the difference together.",
    "title": "Open Innovation Zentiva",
    "content_title": "Open Innovation Zentiva",
    "content_text": "With a direct link for submission of the innovative proposals we are widening the pool from where our future value-added medicines can be selected.Are you thinking how to improve current medicines? Do you see any unmet patient need? Do you see a possibility to simplify administration pathways and increase patient compliance? There are so many areas where we can work together to create medicines with added values for our patients. ",
    "category": null,
    "url": "/partnering/open-innovation",
    "url_detail": [
      "partnering",
      "open-innovation"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/partnering/Zentiva-Visuals-1-11_RD.jpg?h=1080&iar=0&w=1920"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "8EA06F256C9549FE813F7E9063F68AFE-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "our-impact",
    "subtitle": "At Zentiva we care for people, partners and our planet.",
    "title": "Our Impact",
    "content_title": "Our Impact",
    "content_text": "Our impact is rooted in our purpose: to provide high-quality, affordable medicines to more than 100 million people across Europe and beyond. But our responsibility doesnâ€™t stop there. We are committed to building a healthier, more sustainable future - for people, for our partners, and for the planet.Learn more about us and our ambitions for tomorrow. We focus on small steps that contribute to big changes, as we strongly believe that every small step counts.We act with integrity, transparency, and purpose. From responsible sourcing and ethical governance to community engagement and biodiversity restoration, our commitment is embedded in everything we do.",
    "category": null,
    "url": "/our-impact",
    "url_detail": [
      "our-impact"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/our-impact/Our_impact.jpeg?h=706&iar=0&w=1060"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "AF7A9E979D134E3D8564F317211C51EC-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "transparency",
    "subtitle": "At Zentiva, we are deeply committed to transparency in our collaboration with doctors, patient organizations, and other healthcare sector partners.",
    "title": "Transparency",
    "content_title": "Transparency",
    "content_text": "As a member of Medicines for Europe, Zentiva adheres to its Code of Practice. In line with this commitment, any transfers of value to healthcare organizations, patient associations, or healthcare professionals are reported in accordance with the relevant national requirements.Zentiva Transfer of Value reports and statements for countries:",
    "category": null,
    "url": "/our-impact/transparency",
    "url_detail": [
      "our-impact",
      "transparency"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/our-impact/Zentiva-Visuals-1-9_transparency1.jpg?h=603&iar=0&w=1124"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "A50451243BBA4A489076BFF71DFCEF4B-en",
    "tags": [],
    "publish_date": "2025-04-03T12:26:16Z",
    "language": "en",
    "name": "sustainability-report",
    "subtitle": "At Zentiva, our annual Sustainability Report provides a transparent view of our progress, challenges, and ambitions across environmental, social, and governance (ESG) topics.",
    "title": "Sustainability Report",
    "content_title": "Sustainability Report",
    "content_text": "",
    "category": null,
    "url": "/our-impact/sustainability-report",
    "url_detail": [
      "our-impact",
      "sustainability-report"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/our-impact/sustainability-report.png?h=200&iar=0&w=400"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "01E64807DA9D46489D085C5AE0526CF6-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "news",
    "subtitle": "Explore the latest news from Zentiva and stay up-to-date with our upcoming events.",
    "title": "News",
    "content_title": "News",
    "content_text": "",
    "category": null,
    "url": "/news",
    "url_detail": [
      "news"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/News1.png?h=1080&iar=0&w=1920"
  },
  {
    "annotation": "",
    "type": "News Search Page",
    "id": "7EB0B131AF674C17A6AAFEDB71003D5D-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "newsroom",
    "subtitle": "",
    "title": "Newsroom",
    "content_title": "Newsroom",
    "content_text": "",
    "category": null,
    "url": "/news/newsroom",
    "url_detail": [
      "news",
      "newsroom"
    ]
  },
  {
    "annotation": "Propol2 EMF, Ruscoven, Serenil, Fisiodepur and Finocarbo will become part of Zentiva&rsquo;s portfolio.",
    "type": "News Article",
    "id": "90AD8BAF22404C1AB7344F793AE76231-en",
    "tags": [
      "M&A",
      "Product Portfolio",
      "CEO"
    ],
    "publish_date": "2025-06-16T22:00:00Z",
    "language": "en",
    "name": "2025-06-16-zentiva-acquires-brands-from-Aboca",
    "subtitle": "",
    "title": "Zentiva acquires heritage brands from Aboca to expand natural-based Consumer Healthcare solutions across Europe",
    "content_title": "Zentiva acquires heritage brands from Aboca to expand natural-based Consumer Healthcare solutions across Europe",
    "content_text": "Propol2 EMF, Ruscoven, Serenil, Fisiodepur and Finocarbo will become part of Zentivaâ€™s portfolioPrague, 16 June 2025 â€“ Zentiva today announced the acquisition of five heritage brands from Aboca that will widen access to well-known natural treatments across Europe; due to take effect on 30 June 2025.The acquisition reinforces Zentivaâ€™s ambition to become a leading Consumer Healthcare (CHC) player. While the deal has a particular emphasis on the markets in Italy, Spain and France, its scope also covers other countries including Portugal, Poland, Romania, and Greece.By integrating the newly acquired brands from the Aboca herbal portfolio, Zentiva will immediately strengthen its position in three key and fast-growing self-care categories: Respiratory, Circulatory, and Calm &amp; Sleep, aligning with market trends and fast-growing consumer demand for natural, sustainably sourced products. The combined expertise will accelerate Zentivaâ€™s growth in Western Europe and complement its established CHC leadership in Central-Eastern Europe. The agreement adds value to Zentivaâ€™s portfolio ensuring greater category leadership, with Aboca brands such as Propol2 EMF (Respiratory), Ruscoven (Circulatory) and Serenil (Calm &amp; Sleep)1, complementing Zentivaâ€™s existing CHC range. It also lays the foundation for long-term growth through future portfolio and geographic extensions. 1 Propol2 EMF, Ruscoven Plus Fluid, Ruscoven Plus Capsules and Serenil are food supplements, Ruscoven Biogel is cosmetic product. ",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-06-16-zentiva-acquires-brands-from-Aboca",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-06-16-zentiva-acquires-brands-from-Aboca"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/UWWTD-detail.jpg?h=333&iar=0&w=653"
  },
  {
    "annotation": "At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.",
    "type": "News Article",
    "id": "5F4F56D607AA4D9C86CA8C0FBC066AF9-en",
    "tags": [
      "Sustainability Podcast",
      "Impact"
    ],
    "publish_date": "2025-05-30T22:00:00Z",
    "language": "en",
    "name": "2025-05-30-focus-on-green-chemistry",
    "subtitle": "",
    "title": "Focus on Green Chemistry: the latest episode of our Sustainability podcast",
    "content_title": "Focus on Green Chemistry: the latest episode of our Sustainability podcast",
    "content_text": "At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do. We act today for a sustainable tomorrow, continuously reducing our environmental impact, and we are on our path to becoming carbon neutral by 2030.As part of our ecological pathway, we find it important to educate and empower our associates. We therefore warmly invite you to join us and follow our new initiative - the Zentiva Sustainability Podcast, featuring a series of episodes where experts explain different areas of environmental protection.Episode #13 Green ChemistryIn this new episode, we delve into the realm of Green Chemistry, examining its crucial role in sustainability and its support for the transition toward a circular economy from the inception of product design.We are honored to welcome Thomas Freese, a researcher and fervent advocate for start-ups in this domain. Together, we explore the following questions:What is Green Chemistry, and why is it significant for sustainability?How can everyday products, such as running shoes or food packaging, be designed to be more sustainable?What implications does Green Chemistry have for medicines, and how can we encourage innovation in this field?We invite you to listen to the complete interview to gain valuable insights from Thomas. Stay tuned for upcoming episodes. In the meantime, spread the word by sharing this video to educate and empower as many individuals as possible. Additionally, discover how you can join the movement towards sustainability with our Sustainability Podcast.",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-05-30-focus-on-green-chemistry",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-05-30-focus-on-green-chemistry"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/article-image-size.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.",
    "type": "News Article",
    "id": "1ED9BC6DA77841EEA6E36F5D8E7ACDC7-en",
    "tags": [
      "Events & Conferences",
      "CEO",
      "Corporate Affairs"
    ],
    "publish_date": "2025-05-21T22:00:00Z",
    "language": "en",
    "name": "2025-05-21-zentiva-and-euractiv-bring-policymakers-together",
    "subtitle": "",
    "title": "Zentiva and Euractiv Bring Policymakers Together for Health Policy Conference:  Ensuring Fair Access to Medicines for All",
    "content_title": "Zentiva and Euractiv Bring Policymakers Together for Health Policy Conference:  Ensuring Fair Access to Medicines for All",
    "content_text": "Prague/Brussels, 21 May 2025: Zentiva supported Euractivâ€™s Health Policy Conference in Brussels, where its CEO, Steffen Saltofte, joined senior EU policymakers in the opening panel titled â€œThe EU Pharmaceutical Legislation - Ensuring Fair Access to Medicines for All.â€Representing Europeâ€™s off-patent medicine sector, Steffen Saltofte called for a unified approach to reshape pharmaceutical policy with patients at the centre. He emphasised the need to bring together all healthcare stakeholders - from innovators to the off-patent industry, from regulators to policymakers - to fulfil the promise of health as a fundamental right for all. Key topics that Zentiva underlined during the discussion:Equal Access and Timely Competition Are Vital We advocate for pharmaceutical reform that guarantees early patient access through fair competition. Extending exclusivity periods could delay the entry of generics and biosimilars, impacting both affordability and availability.Resilience Starts with Economically Viable EU-Based Manufacturing Our manufacturing sites in Prague and Bucharest maintained continuous supply during recent crises. We call for predictable pricing, investment incentives, and smart procurement rules to secure local production of essential medicines - not just for a few substances, but across the portfolio, ensuring fair access for all who depend on medicines every day.Policy Alignment and Cross-Sector Cooperation Are Essential Industrial, pharmaceutical, and environmental policies must be aligned. Without coordination, new directives - such as the Urban Wastewater Treatment Directive - risk undermining medicine supply and innovation in greener technologies.Modern Framework for Sustainable Healthcare Is Needed We support reforms that accelerate the adoption of digital tools, such as digital leaflets, incentivize value-added medicines, and ensure pricing systems reflect real-world costs and sustainability goals.Moderated by EURACTIVâ€™s Anna Gumbau, the discussion featured Rainer Becker, Director for Medical Products and Innovation at DG SANTE in the European Commission; Stine Bosse, Member of the European Parliament and Vice-Chair of the SANT Committee; and OndÅ™ej Knotek, Member of the European Parliament and of the SANT Committee.Platforms like the one provided by Euractiv are vital â€” they bring us together to listen, collaborate, and drive progress. For the benefit of all people who rely on medicines every day. Because health is a right, not a privilege.",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-05-21-zentiva-and-euractiv-bring-policymakers-together",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-05-21-zentiva-and-euractiv-bring-policymakers-together"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/article-image-size--(10).png?h=300&iar=0&w=653"
  },
  {
    "annotation": "Zentiva proudly participated in the 93rd European Atherosclerosis Society (EAS) Congress, held in Glasgow from May 4-7, 2025.",
    "type": "News Article",
    "id": "C095FE6FF5954C7C94E40716A117BB04-en",
    "tags": [
      "Events & Conferences",
      "Partnerships"
    ],
    "publish_date": "2025-05-15T22:00:00Z",
    "language": "en",
    "name": "2025-05-15-zentiva-at-eas-congress-2025",
    "subtitle": "",
    "title": "Zentiva at EAS Congress 2025: Advancing Cardiovascular Health",
    "content_title": "Zentiva at EAS Congress 2025: Advancing Cardiovascular Health",
    "content_text": "Zentiva proudly participated in the 93rd European Atherosclerosis Society (EAS) Congress, held in Glasgow from May 4-7, 2025. This prestigious event brought together global experts to discuss the latest advancements in atherosclerosis and vascular disease research.\nWe firmly believe that close collaboration with scientific experts and clinicians is essential for proposing treatments with added value to the people who depend on them every day. That is why we have become an official partner of the EAS for the second consecutive year. Through our partnership with the European Atherosclerosis Society, we support scientific leadership via the publication of guidelines and consensus position papers, fostering discussions on new developments in the field of atherosclerosis. This collaboration helps us fulfill our purpose of providing health and wellbeing for all generations.\n\nFor more information about the EAS Congress 2025, please visit the official website here.",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-05-15-zentiva-at-eas-congress-2025",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-05-15-zentiva-at-eas-congress-2025"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/eas-2025-article-image.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "Zentiva supports the EU vision of leaving no one behind and the UN Sustainable Development Goal (SDG) 3 - Health &amp; Wellbeing, which is strongly linked to other SDGs.",
    "type": "News Article",
    "id": "85C847E46C704BDCAB74D712D0A24E8C-en",
    "tags": [
      "Corporate Affairs",
      "Impact"
    ],
    "publish_date": "2025-05-07T22:00:00Z",
    "language": "en",
    "name": "2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare",
    "subtitle": "",
    "title": "Zentiva Joins the Call to Action to Finalize Pharmaceutical Reform and Secure Sustainable Healthcare for People in Europe",
    "content_title": "Zentiva Joins the Call to Action to Finalize Pharmaceutical Reform and Secure Sustainable Healthcare for People in Europe",
    "content_text": "Brussels / Prague, May 7, 2025: Health is a right, not a privilege. Zentiva supports the EU vision of leaving no one behind and the UN Sustainable Development Goal (SDG) 3 - Health &amp; Wellbeing, which is strongly linked to other SDGs. As discussions on pharmaceutical legislation reform continue, Zentiva joins the united voice of Europe's off-patent medicines industry to ensure health is at the center of all political decisions. We urge EU Health Ministers to conclude the reform and take steps to secure sustainable healthcare in Europe, protecting the people who depend on affordable medicines every day.This is not just another technical EU policy. It is about ensuring that every European, wherever they live, can access the medicines they need. Itâ€™s about avoiding shortages, bringing production back to Europe, and making our health systems more resilient and fair. It is also about making the industry robust for the future, recognising investments in sustainability like reducing carbon emissions and increasing the use of renewable energy at our manufacturing sites.Zentiva is pleased that the off-patent medicines sector, represented by Medicines for Europe, had the opportunity to exchange views with European Health Commissioner OlivÃ©r VÃ¡rhelyi during a recent meeting. We call on EU decision-makers to translate these discussions into actions that strengthen access, affordability, and European production of essential medicines. Itâ€™s time for Europe to take responsibility, finalize the pharmaceutical reform, and safeguard patients. Zentiva is calling on decision-makers to:Act as a single market with harmonized principles to ensure faster access to medicines, reduce duplication in regulatory processes, and enable equal treatment for patients across the EU.Support affordable treatment by boosting competition on Day 1 once patents or regulatory exclusivity expire. Harmonization and clarification of the Bolar exemption are critical to achieving this.Prevent medicine shortages with better EU coordination and digital tools.Encourage smarter and affordable innovation on off-patent medicines that can change lives and address major health and environmental issues.Empower the Critical Medicines Act and broaden the principles to the whole sector, as people rely on access to other molecules beyond those defined as â€œcriticalâ€ to sustain their health and wellbeing.Address and repair the disproportionate environmental legislation of Urban Wastewater Treatment Directive (UWWTD).With 70% of prescription medicines being generics, 9 out of 10 critical medicines, and 40% of products having no therapeutic alternative other than generic medicines (IQVIA, 2024), it is essential to secure access and production for affordable medicines in Europe. There is no reason to delay reforms that serve Europeans who depend on our medicines every day.",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-05-07-zentiva-calls-to-finalize-pharmaceutical-reform-secure-sustainable-healthcare"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/UWWTD-detail.jpg?h=333&iar=0&w=653"
  },
  {
    "annotation": "For the fourth consecutive year, Zentiva is publishing its Sustainability Report, highlighting the key achievements delivered in 2024.",
    "type": "News Article",
    "id": "C4B10450D566411185C4A4CA68008874-en",
    "tags": [
      "Sustainability Report",
      "Impact"
    ],
    "publish_date": "2025-04-09T22:00:00Z",
    "language": "en",
    "name": "2025-04-09-sustainability-report-2024",
    "subtitle": "",
    "title": "Zentiva presents its Sustainability Report 2024: Acting today for a sustainable tomorrow",
    "content_title": "Zentiva presents its Sustainability Report 2024: Acting today for a sustainable tomorrow",
    "content_text": "Prague, April 9th, 2025: For the fourth consecutive year, Zentiva is publishing its Sustainability Report, highlighting the key achievements delivered in 2024. The company reports a reduction of more than 20% in GHG emissions in Scope 1 over the last three years. All European manufacturing sites are powered by 100% renewable electricity. Together with its partners, Zentiva drives the decarbonization of Scope 3 emissions forward to achieve its climate target, which is in line with Europe's ambition to become the first climate-neutral continent by 2050. Zentiva has operations in more than 30 countries and is recognized as a Top Employer in its main locations and certified as a Great Place to Work in several others. With a healthy gender balance of 53:47 in favor of women, a workforce consisting of more than 50 nationalities and 4 generations, Zentiva is an attractive employer.Zentivaâ€™s 2024 Sustainability Report discloses non-financial topics referencing GRI standards, showing the company's full commitment to further progress in all areas of ESG. The full report is accessible via www.zentiva.com.Click here to download Zentiva Sustainability Report 2024 (pdf)",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-04-09-sustainability-report-2024",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-04-09-sustainability-report-2024"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/article-sustainability-report-2024.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.",
    "type": "News Article",
    "id": "0852CA2EC70943F28C02350E69903F14-en",
    "tags": [
      "Sustainability Podcast",
      "Impact"
    ],
    "publish_date": "2025-03-27T23:00:00Z",
    "language": "en",
    "name": "2025-03-27-sustainable-architecture-in-the-spotlight",
    "subtitle": "",
    "title": "Sustainable architecture in the spotlight â€“ the latest episode of our podcast",
    "content_title": "Sustainable architecture in the spotlight â€“ the latest episode of our podcast",
    "content_text": "At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do. We act today for a sustainable tomorrow, continuously reducing our environmental impact, and we are on our path to becoming carbon neutral by 2030.As part of our ecological pathway, we find it important to educate and empower our associates. We therefore warmly invite you to join us and follow our new initiative - the Zentiva Sustainability Podcast, featuring a series of episodes where experts explain different areas of environmental protection.Episode #12 About ArchitectureIn this new episode, we focus on Sustainable Architecture, exploring how the built environment can be transformed to reduce our ecological footprint. With the construction sector contributing significantly to global carbon emissions, itâ€™s crucial to discuss innovative solutions for a greener future.We are honored to welcome Igor Bubenik, Communications Manager and Head of ESG at CORWIN SK a.s., a pioneering developer of sustainable architecture and design. CORWIN SK a.s. started in 2010 and has since grown into a large team of experts pushing the boundaries of sustainable and responsible development.In the podcast, Igor addresses questions such as: What are the key principles behind sustainable architecture and what is the impact on the environment?Which materials are being used and are they fit for the circular economy?We also highlight some iconic buildings that exemplify sustainability, and what can we learn from their designs.Join us in listening the complete interview to gain valuable insights from Igor. Stay tuned for more episodes. Until then, help us spread the word to educate and empower as many people as possible, and learn about how you can hop on the Green train with our Sustainability Podcast!Check out our Podcast series here.",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-03-27-sustainable-architecture-in-the-spotlight",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-03-27-sustainable-architecture-in-the-spotlight"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/article-podcast-12.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "Zentiva is delighted to announce its endorsement for the European Commission&rsquo;s Critical Medicines Act, a crucial initiative toward ensuring the availability of essential medicines and enhancing pharmaceutical manufacturing across Europe.",
    "type": "News Article",
    "id": "3CE7A0AC5E624117806CF6F3F5BF4B47-en",
    "tags": [
      "Corporate Affairs",
      "Impact"
    ],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "2025-03-13-zentiva-supports-critical-medicines-act-as-welcome-step-forward",
    "subtitle": "",
    "title": "Zentiva supports the Critical Medicines Act as a welcome step forward",
    "content_title": "Zentiva supports the Critical Medicines Act as a welcome step forward",
    "content_text": "Zentiva is delighted to announce its endorsement for the European Commission&rsquo;s Critical Medicines Act, a crucial initiative toward ensuring the availability of essential medicines and enhancing pharmaceutical manufacturing across Europe.\nFor decades, critical medicines have played a vital role in saving lives and improving the health of millions. However, their availability and supply stability face increasing challenges. The European Union&rsquo;s list of critically important medicines includes more than 270 active substances, with 90% being generics&mdash;a cornerstone of accessible healthcare.\nThe Critical Medicines Act introduces strategic investments, improved stockpiling measures, and optimized procurement regulations, laying the groundwork for a more resilient and sustainable supply chain.\nWhile this represents a significant milestone, it is imperative that we advance further. Concentrating only on today&rsquo;s critical medicines is insufficient, as millions of individuals rely on a broader range of medicines daily.\nTo establish a truly resilient system, it is crucial to: \n\n    Invest in European-based medicine production to reduce supply risks \n    Reform procurement rules to prioritize reliability and sustainability, not just the lowest price \n    Ensure financial and regulatory support for off-patent manufacturers of medicines \n    Strengthen supply chain resilience beyond the currently listed critical medicines\n\nZentiva is dedicated to collaborating with all stakeholders to realize this vision. It is imperative that we ensure continued access to essential medicines for the people of Europe. Decisive action is required today to ensure a sustainable future for all generations.",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-03-13-zentiva-supports-critical-medicines-act-as-welcome-step-forward",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-03-13-zentiva-supports-critical-medicines-act-as-welcome-step-forward"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/article_Critical_medicines_act.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "Zentiva has filed a legal case with the Court of Justice of the European Union challenging the Urban Wastewater Treatment Directive (UWWTD) to safeguard access to affordable medicines in Europe.",
    "type": "News Article",
    "id": "81A2AFA1570D4F44B99E5ACD6855DAA5-en",
    "tags": [
      "Corporate Affairs",
      "Impact",
      "CEO"
    ],
    "publish_date": "2025-03-10T23:00:00Z",
    "language": "en",
    "name": "2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive",
    "subtitle": "",
    "title": "Zentiva takes legal action and challenges Urban Wastewater Treatment Directive to protect access to affordable healthcare for millions of people in Europe",
    "content_title": "Zentiva takes legal action and challenges Urban Wastewater Treatment Directive to protect access to affordable healthcare for millions of people in Europe",
    "content_text": "Prague, March 10th, 2025: Zentiva has filed a legal case with the Court of Justice of the European Union challenging the Urban Wastewater Treatment Directive (UWWTD) to safeguard access to affordable medicines in Europe. The implementation of the Directive will lead to medicine shortages, leaving people behind who depend on those products every day.In late 2024, the European Union adopted a significant update to the UWWTD. This revision aims to align the Directive with the Green Deal, addressing contemporary issues such as micropollutants and introducing the Extended Producer Responsibility (EPR) scheme. The Directive enforces the polluter pays principle, specifically requiring the pharmaceutical and cosmetic industries to finance the new quaternary treatment processes at urban wastewater treatment plants to remove these micropollutants. 16 out of 27 Member States of the European Union raised concerns about the Directiveâ€™s impact on medicines. Zentiva is challenging the funding mechanism under the Directive, which imposes an unsustainable financial burden on the pharmaceutical industry, threatening the economic viability of needed medicines. Generics account for 70% of all medicines sold in Europe, representing only 19% of the market value, thus making a significant contribution to public health. The role of generics is to expand access to healthcare and secure health outcomes, while helping healthcare decision-makers finance sustainable healthcare.",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-03-10-Zentiva-takes-legal-action-Urban-Wastewater-Treatment-Directive"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/UWWTD-detail.jpg?h=333&iar=0&w=653"
  },
  {
    "annotation": "Initiated by Zentiva, The Parc (Pharmaceutical Applied Research Center ) provides world class academic education combined with practical hands-on industrial and business experience under the leadership of scientists, engineers, and managers both from academia and the pharmaceutical industry.",
    "type": "News Article",
    "id": "C215E86833F846929826EA332902C00E-en",
    "tags": [
      "Awards & Recognition",
      "Science",
      "Partnerships"
    ],
    "publish_date": "2025-02-21T23:00:00Z",
    "language": "en",
    "name": "2025-02-10-parc-awards",
    "subtitle": "",
    "title": "Zentiva celebrates the 2024 Parc Awards",
    "content_title": "Zentiva celebrates the 2024 Parc Awards",
    "content_text": "Initiated by Zentiva, The Parc (Pharmaceutical Applied Research Center ) provides world class academic education combined with practical hands-on industrial and business experience under the leadership of scientists, engineers, and managers both from academia and the pharmaceutical industry.\nEvery year, &ldquo;The Parc Awards&rdquo; are presented to researchers behind the best projects in applied research and pharmaceutical development. \nWe are delighted to congratulate the 2024 winners for their best projects in the field of applied research and drug development.\nIn the Student Choice Award category, Suada Djukaj won with the project \"Development of Artificial Mucus as a Predictive Model for Studying Drug Diffusion&rdquo;.\n\nIn the Expert Choice Award category, Filip Zavrgel succeeded with his research on \"Development of a Continuous Process for Drug Nanoformulation.\"\n\nThe Parc - Center for Applied Pharmaceutical Research was founded by Zentiva in collaboration with the University of Chemistry and Technology in Prague, Charles University in Prague, and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. Other members include the General University Hospital in Prague and Palacky University in Olomouc, which joined the center last year. It provides world-class postgraduate education with practical experience in industry and business under the guidance of experts from academia and the pharmaceutical industry.\nOur goal is to accelerate innovation in drug research and development. The results of student research are often directly implemented into real products brought to market and help real patients.\nThe Parc currently brings together 33 students and 26 supervisors, including 13 from academia and 23 experts from Zentiva. Over the past year, 11 students have successfully defended their PhDs, 9 have completed The Parc program, and 8 new members have joined. Since its inception, the Center has achieved over 30 patents, more than 110 scientific publications, and numerous prestigious awards.",
    "category": "Newsroom",
    "url": "/news/newsroom/2025/2025-02-10-parc-awards",
    "url_detail": [
      "news",
      "newsroom",
      "2025",
      "2025-02-10-parc-awards"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/article_Parc_awards_2024.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030.",
    "type": "News Article",
    "id": "7F57E357A851417288AD7B790FA559C1-en",
    "tags": [
      "Sustainability Podcast",
      "Impact"
    ],
    "publish_date": "2024-01-23T23:00:00Z",
    "language": "en",
    "name": "2024-1-24-sustainability-podcast-about-fashion",
    "subtitle": "",
    "title": "Meet the new Zentiva Sustainability Podcast!",
    "content_title": "Meet the new Zentiva Sustainability Podcast!",
    "content_text": "\nWelcome to Zentiva Sustainability Podcast!\nAt Zentiva, we believe that each and every one of us can contribute to taking care of our planet and do what we can to protect it so that future generations can enjoy life as much as we do. We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030. As part of our environmental pathway, we find it also important to educate and empower our associates and we warmly invite you to join us and follow our new initiative - the Zentiva Sustainability Podcast with a series of episodes where experts explain different areas of environmental protection!\nEpisode #7 About Fashion\nHave you found you need a big wardrobe clear-out coming into the new year? Our latest episode explores the topic of responsible fashion and the dangers of fast fashion for our planet. With the fashion industry accounting for 10% of global carbon emissions, thinking about alternative choices we can all make is a great way to enter 2024.\nWe are joined by Javier Saborido from the NGO ONGD Madre Coraje. Javier answers questions on:\n \nï¿½ï¿½ï¿½ï¿½ What practical steps can all of us as consumers take to help reduce fast fashion? \nï¿½ï¿½ï¿½ï¿½ How does the fashion industry need to transform for a sustainable future? \nï¿½ï¿½ï¿½ï¿½ What recent trends in fashion may hold the answers for a zero-waste industry in the future?\nThe answers to all this and more are covered in our insightful interview with Javier below. \n\nJoin us and discover ways to nurture our planet with Zentiva!\n \n \nEpisode #6 About Circular Economy\nEvery time we learn something new that can help our planet and how we can participate in it. Today in our Sustainability Podcast, we explore the Circular Economy, an approach for reducing waste and protecting the environment. With our guest Roman Gdovjak, Partner and Head of Consulting Operations at Cyrkl.com, you will learn: \nï¿½ï¿½ï¿½ï¿½ What exactly is the Circular Economy and how it benefits the environment. \nï¿½ï¿½ï¿½ï¿½ Circular Economy as a global trend that is reshaping industries.\nâ™»ï¸ Which items can be given a second life.\nï¿½ï¿½ï¿½ï¿½ How you, as an individual, can contribute to the Circular Economy and make a positive impact. \nJoin us and learn how to take care of our planet with Zentiva! \n \n \n \nEpisode #5 About Food Wasting \nThis time in our Sustainability Podcast, we will explore the topic of food wasting to contribute to the upcoming International Day of Food Loss and Waste which will be celebrated on September 29. In conversation with Anna Strejcov&aacute; from the non-profit organization ZachraÅˆ j&iacute;dlo (\"Save the Food\"), you will learn for example:\n\n    How food contributes to global CO2 emissions.\n    How much food goes to waste and how much money can a family save by adopting shopping habits.\n    How can you use new technologies to prevent food wasting.\n    Why is it important to pick up wonky, imperfect vegetable and fruits.\n\nLearn to treat the natural resources better with Zentiva!\n \n \n \nEpisode #4 About City Gardens \nThe #EarthOvershootDay means that from tomorrow on, the resources humanity uses will exceed what Earth can regenerate this year. At Zentiva, we do what we can to help to shift the date later in the year and reverse the trend of exhausting our planet, that is why we bring awareness to this day. Aside from concrete sustainability actions to achieve carbon neutrality by 2030, we believe in awareness and the need to educate ourselves and others about which small actions we can take as individuals to contribute.\nOur Sustainability Podcast is the result of that, and we bring you a new episode inspired by City Gardens projects. In this conversation with Luca Comino, Creative and Planning Director of I.E.S - Italian Enables of Sustainability we learn that these kinds of initiatives not only help to reduce the negative impact on the environment but also have a positive influence on well-being, reducing stress, improving mental health and enhancing the overall quality of life.\nWe invite you to join our Sustainability #podcast and learn about:\n\n    What is Biophilia and why is it important?\n    How we can help the environment in cities?\n    What is the social perspective of having nature in the cities?\n\nLearn to take care of the environment with Zentiva!\n \n \n \nEpisode #3 About Waste\nWe are inviting you once again to join us on our Sustainability #podcast. The new episode is inspired by today&acute;s #WorldRefillDay , which aims to reduce plastic waste. Zofia Maciejewicz, Head of Communication at Zentiva Poland talked with Julia Rokicka, co-founder and board member of the Polish Biorecycling Association, eco-educator, representative of Trash Hero WrocÅ‚aw, and initiator of waste-collecting actions. What can you find out from our podcast?\n\n    How you can lead by example.\n    What environmental problems are caused by cigarette butts.\n    How you can become a Trash hero.\n\n \n \n \nEpisode #2: About Bees\nWe learned many interesting facts that we would like to share with you in the new episode of our Zentiva Sustainability Podcast, where Veronika Ocasio, Communications Specialist at Zentiva Czech Republic talked to Alexandra Harmon-Threatt, Associate Professor in the Department of Entomology at the University of Illinois and is currently a Fulbright Scholar at Charles University in Prague. \nTomorrow the world celebrates World Bee Day and inspired by this podcast, we should think about how to help restore more natural habitats for the bees!\n\n \n\n\n \n\nEpisode #1: About Trees\n\n\nIn this first episode, we went to Romania where we began planting trees four years ago. Ioana Lucescu, Communication Manager at Zentiva Romania talked with Mihai Zotta - Conservation Director at Conservation Carpathia Foundation, about reforestation teaching us more about deforestation and its effect on biodiversity and the planet. \nStay with us and learn how can we protect, preserve and contribute to keeping this natural ecological force.\n\n \n \n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-1-24-sustainability-podcast-about-fashion",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-1-24-sustainability-podcast-about-fashion"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/zentiva_newspage_ppp_653x300.jpg?h=300&iar=0&w=653"
  },
  {
    "annotation": "In this episode, we welcome Sebastien Taillemite, President of Ecovamed, to discuss the topic of Green Product Design.",
    "type": "News Article",
    "id": "05195D56A07B49EBA1DF452F72431AEC-en",
    "tags": [
      "Sustainability Podcast",
      "Impact"
    ],
    "publish_date": "2024-04-09T22:00:00Z",
    "language": "en",
    "name": "2024-04-10-sustainability-podcast",
    "subtitle": "",
    "title": "Welcome to the April Zentiva Sustainability Podcast!",
    "content_title": "Welcome to the April Zentiva Sustainability Podcast!",
    "content_text": "Welcome to the April Zentiva Sustainability Podcast!\nAt Zentiva, we believe that each and every one of us can contribute to taking care of our planet and do what we can to protect it so that future generations can enjoy life as much as we do. We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030. As part of our environmental pathway, we find it also important to educate and empower our associates and we warmly invite you to join us and follow our new initiative - the Zentiva Sustainability Podcast with a series of episodes where experts explain different areas of environmental protection!\n\nEpisode #8 About Green Design\n\nIn this episode, we welcome Sebastien Taillemite, President of Ecovamed, to discuss the topic of Green Product Design. Ecovamed company offers innovative lifecycle solutions for health, biological and chemical products. Sebastien provides some insight into exactly what this involves. \n\nâœ…ï¿½ï¿½ï¿½ï¿½ What makes a product \"Green\"?\n\nï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½What is the methodology of a product lifecycle assessment? \n\nï¿½ï¿½ï¿½ï¿½â™»ï¸ How can companies take practical steps to greener products?\n\n\nThis and more is discussed in the episode. \n\n \nPlease help us educate and empower as many people as possible by sharing this episode. \n\nï¿½ï¿½ï¿½ï¿½ Check out our Podcast series here. \n\nStay tuned for more episodes to come.",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-04-10-sustainability-podcast",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-04-10-sustainability-podcast"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/april_sustain_podcast_newspage.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "E6D4ECEB00A140859D2ABA1CE2C79D7C-en",
    "tags": [
      "M&A",
      "CEO",
      "Growth"
    ],
    "publish_date": "2024-11-25T23:00:00Z",
    "language": "en",
    "name": "2024-11-26-zentiva-secures-apontis-pharma-voting-rights",
    "subtitle": "",
    "title": "Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer",
    "content_title": "Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer",
    "content_text": "Frankfurt am Main, 26 November 2024 &ndash; Zentiva AG, a wholly-owned subsidiary of Zentiva Pharma GmbH, headquartered in Frankfurt am Main, Germany, and part of Zentiva group (&ldquo;Zentiva&rdquo;), announced today that it has secured approx. 83.57% of the share capital and approx. 85.27% of voting rights in the context of its voluntary public purchase offer for APONTIS PHARMA AG (&ldquo;APONTIS PHARMA&rdquo;) following the end of the acceptance period on 21 November 2024.\nSteffen Saltofte, CEO of Zentiva, said: &ldquo;We are pleased with the success of our public purchase offer. This milestone marks a significant step forward in our journey to expand our reach and enhance our ability to deliver high-quality, affordable medicines to the people who depend on them every day. We look forward to combining our strengths and working together under a unified ownership structure to deliver on our long-term strategy.&rdquo;\nSettlement of the offer is still subject to foreign direct investment control clearance in Germany. Settlement is expected to occur in December 2024 or in Q1 2025.\nMedia contacts for Zentiva \nInes Windisch \nHead of Communications, Corporate Affairs &amp; Sustainability\nines.windisch@zentiva.com\nIsabel Henninger \nKekst CNC\n+49 174 940 9955\nisabel.henninger@kekstcnc.com  \n\n\nAbout Zentiva\nZentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology &amp; Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe.\nWe are a team of almost 5,000 unique talents bonded together by our purpose to provide health and wellbeing for all generations. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability. \nFor additional information about Zentiva, please visit www.zentiva.com or www.zentiva.de.\n\n\nAbout APONTIS PHARMA\nAPONTIS PHARMA is a leading pharmaceutical company specializing in Single Pill combinations in Germany. Single Pills combine two to three generic active ingredients in a single dosage form administered once a day. Single Pill therapies have been scientifically proven to significantly increase adherence and thus improve the treatment prognosis and quality of life of patients while reducing complications, mortality, and treatment costs. Consequently, Single Pill combinations are the preferred treatment option in numerous international treatment guidelines, including in the EU and Germany. APONTIS PHARMA has been developing, promoting, and distributing a broad portfolio of Single Pill combinations and other pharmaceutical products since 2013, with a special focus on cardiovascular diseases such as hypertension, hyperlipidemia, and secondary prevention. For additional information about APONTIS PHARMA, please visit www.apontis-pharma.de.\n\n\nImportant notice \nThis publication is neither an offer to purchase nor a solicitation of an offer to sell shares in APONTIS PHARMA or any other securities. The offer is only made by publication of the offer document published on 24 October 2024, as amended on 19 November 2024 (&ldquo;Amended Offer Document&rdquo;), and is exclusively subject to the terms and conditions set out in the Amended Offer Document (&ldquo;Offer&rdquo;). Investors and shareholders of APONTIS PHARMA are strongly advised to thoroughly read the Amended Offer Document and all other relevant documents regarding the Offer when they become available, as they will contain important information. The Amended Offer Document (in German and a non-binding English translation) with the detailed terms and conditions and other information on the Offer is published amongst other information on the internet at www.zentiva-offer.com.\n\n\n\n\n\n\n\nBack to zentiva.com\n\n\nYou are about to leave zentiva.com\n\n\nThe link you are about to open is a dedicated website organized by Zentiva.\n\n\n    \n    Back to zentiva.com\n    \n    \n    PROCEED TO EXTERNAL LINK\n    \n\n\n\nThis publication may contain statements about Zentiva, and/or APONTIS PHARMA and/or either of its affiliates that are or may be \"forward-looking statements\", i.e., statements about processes that take place in the future, not in the past. Forward-looking statements include, without limitation, statements that typically contain words such as \"seek\", \"estimate\", \"intend\", \"plan\", \"believe\", \"continue\", \"will\", \"may\", \"should\", \"would\", \"could\", or other words of similar meaning. By their nature, forward-looking statements are based on current expectations, assumptions, estimates and projections and involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and many of which are outside the control of Zentiva, APONTIS PHARMA and/or any of its affiliates. Zentiva and APONTIS PHARMA caution you that forward-looking statements are not guarantees of the occurrence of such future events or of future performance. Any forward-looking statement speaks only as at the date of this announcement. Except as required by applicable law, Zentiva does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.\nSince the APONTIS PHARMA shares are not admitted to trading on an organized market within the meaning of Section 1 (1) of the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und &Uuml;bernahmegesetz, \"Wp&Uuml;G\"), the Offer is not subject to the Wp&Uuml;G. The Offer is not subject to review or registration proceedings of any securities regulator neither in nor outside the Federal Republic of Germany, and has not been approved or recommended by any such securities regulator including the German Federal Financial Supervisory Authority (Bundesanstalt f&uuml;r Finanzdienstleistungsaufsicht).\nThe Offer will be implemented solely in accordance with German law and certain applicable securities law provisions of the United States of America. Any agreement that is entered into as a result of accepting the Offer will be governed by the laws of the Federal Republic of Germany and is to be interpreted in accordance with such laws.\nThe Bidder reserves the right to acquire further APONTIS PHARMA shares in a manner other than in the context of this Offer on or off the stock exchange and/or enter into corresponding acquisition agreements during the acceptance period. The Bidder is not obliged to publish information about such acquisitions or to adjust the offer price as a result of such acquisitions.",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-11-26-zentiva-secures-apontis-pharma-voting-rights",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-11-26-zentiva-secures-apontis-pharma-voting-rights"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2025/article_image_size.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "Zentiva is a leading manufacturer and supplier of high-quality and affordable medicines to more than 100 million people in Europe and beyond.",
    "type": "News Article",
    "id": "A2FD92F65CFC46328A677EC2C903BBD0-en",
    "tags": [
      "Sustainability Report",
      "Impact"
    ],
    "publish_date": "2024-04-29T22:00:00Z",
    "language": "en",
    "name": "2024-04-30-sustainability-report-2023",
    "subtitle": "",
    "title": "Acting today for a sustainable future. Discover Zentivaâ€™s Sustainability Report 2023",
    "content_title": "Acting today for a sustainable future. Discover Zentivaâ€™s Sustainability Report 2023",
    "content_text": "Zentiva is a leading manufacturer and supplier of high-quality and affordable medicines to more than 100 million people in Europe and beyond. With sustainability embedded into its business strategy, the company fulfilled its 2023 sustainability goals and implemented actions in 3 pillars: People, Partners and Planet.\nSteffen Saltofte, CEO Zentiva: &ldquo;Sustainability remains well-established in our operations with encouraging progress demonstrated in 2023. Our Sustainability Strategy is anchored in our commitment to limit the global temperature increase to 1.5 degrees Celsius by 2050, in alignment with the Paris agreement. To this end, we have committed to achieve Carbon Neutrality in Scopes 1 and 2 by 2030 and are progressing well on our journey, contributing with significant reductions of our carbon emissions in 2023.\"\n\n\nClick here to download Zentiva Sustainability Report 2023 (pdf)\nInes Windisch, Head of Communications, Corporate Affairs &amp; Sustainability: &ldquo;It is for a reason that the &ldquo;e&rdquo; in Zentiva is green. We are looking back at a history of more than 500 years where Zentiva served people and communities with better healthcare. We are acting today for a sustainable tomorrow to make sure that future generations can enjoy life as much as we do. This is why we are committed to provide health and wellbeing for all generations.&rdquo;\n \nZentiva&rsquo;s 2023 Sustainability Report discloses the non-financial topics referencing GRI standards. The company presents an ambitious outlook for 2024, showing full commitment to further progress in all areas of ESG. \n\n    .u-max-width-content {max-width: none !important;}\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-04-30-sustainability-report-2023",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-04-30-sustainability-report-2023"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/Baner_People_Partners_Planet.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "Prague.bio is a professional group whose main goals include the development of the biotechnology segment in the Czech Republic. Now Zentiva, has entered the Prague.bio biotechnology cluster as the first representative of the industry.",
    "type": "News Article",
    "id": "A24EA888C4D14A4CBC2A801E84856F71-en",
    "tags": [
      "Science",
      "Partnerships",
      "Innovation"
    ],
    "publish_date": "2024-05-12T22:00:00Z",
    "language": "en",
    "name": "2024-05-13-biotechnology-segment",
    "subtitle": "",
    "title": "Zentiva joins Prague.bio as first industry partner",
    "content_title": "Zentiva joins Prague.bio as first industry partner",
    "content_text": "Prague, May 13, 2024 &ndash; Prague.bio is a professional group whose main goals include the development of the biotechnology segment in the Czech Republic and increase its visibility internationally. Until now, it has brought together institutions that represent highly professional research centers with a strong influence on the development of new drugs, diagnostic methods and other medical technologies. Now Zentiva, has entered the Prague.bio biotechnology cluster as the first representative of the industry.\n\nThe biotechnological cluster Prague.bio was founded in the fall of last year and has so far consisted of six institutions from the academic environment: Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic, biotechnology incubator i&amp;i Prague, Biotechnology Institute of the Academy of Sciences of the Czech Republic, Institute of Microbiology of the Academy of Sciences of the Czech Republic, Institute of Molecular Genetics of the Academy of Sciences of the Czech Republic Czech Republic and the University of Chemistry and Technology in Prague.\n\"The accession of Zentiva is a turning point for Prague.bio, as it is an important step towards fulfilling the basic mission of the association. This is the linking of science, industry and business. At the same time, we are very happy that the first non-academic representative in our association is Zentiva, a successful international company with its roots in the Czech Republic, which, in addition to production, also has a global research and development center here, and is among the top 10 investors in research and development in the Czech Republic,\" says Petra Kinzlov&aacute;, CEO of the Prague.bio association.\n\n\nSharing and cooperation for the development of innovation potential\nZentiva's accession to the association follows on from cooperation during the first year of the aforementioned Prague.bio conference, in which Zentiva representatives actively participated. \"The pharmaceutical industry has a long tradition in the Czech Republic. At Zentiva, we care that it stays here, grows and brings innovation and access to affordable treatment to those who need it. For a long time, we have participated in the development of Czech pharmaceutical science through the education of experts for industry and close cooperation with universities, for example within the Center for Applied Research, The PARC. Joining Prague.bio is the next logical step for us in building the domestic pharmaceutical potential, and we are pleased to have found another partner who shares the same vision,\" says Martin Albert, Chief Scientific Officer at Zentiva.\nAbout Zentiva\nZentiva is a pan-European platform that develops, manufactures and delivers high-quality, affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing plants and a wide network of external manufacturing partners. It offers solutions in key therapeutic areas such as cardiology and circulatory diseases, diabetes, oncology, respiratory diseases and neurology, and is focused on expanding its portfolio in the field of Consumer Healthcare Products. The company is owned by an investment fund and delivers sustainable double-digit growth with an ambitious five-year plan for further strong growth across Europe.\nZentiva consists of a team of 5,000 unique talents bonded together by delivering high-quality, affordable medicines to the people who depend on them every day. Zentiva is a great place to work where everyone feels welcome and valued, and where they can be their true selves and contribute to their best ability. We deliver on our purpose to provide health and wellbeing to all generations. \n\nAbout Prague.bio\nThe Prague.bio association was founded in the autumn of last year. It is a platform that aims to connect innovators, academic institutions, industry representatives, investors and other important actors in the field of biotechnology. The association is the organizer of the Prague.bio conference, the second year of which will take place on September 24 in the Slovansk&yacute; dÅ¯m in Prague. It also represents its members at important international conferences, most recently at Bio-Europe Spring, which took place this year in Barcelona, Spain.\n\n\n\nMedia Contact:\nInes Windisch, \nHead of Communications, Corporate Affairs &amp; Sustainability\nines.windisch@zentiva.com\n\n\n \n",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-05-13-biotechnology-segment",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-05-13-biotechnology-segment"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/653x300xnews-Zentiva-Visuals-1-9.jpg?h=300&iar=0&w=653"
  },
  {
    "annotation": "Zentiva, a Pan-European pharmaceutical company, joined the inaugural launch of the EUâ€™s Critical Medicines Alliance, held on April 24-25 in Brussels.",
    "type": "News Article",
    "id": "2CE3493C9E0A47538FA2550D3CA10098-en",
    "tags": [
      "Corporate Affairs",
      "Events & Conferences",
      "CEO"
    ],
    "publish_date": "2024-04-24T22:00:00Z",
    "language": "en",
    "name": "2024-04-25-critical-medicines-alliance",
    "subtitle": "",
    "title": "Zentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply",
    "content_title": "Zentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply",
    "content_text": "Brussels/Prague, April 25, 2024 &ndash; Zentiva, a Pan-European pharmaceutical company, joined the inaugural launch of the EU&rsquo;s Critical Medicines Alliance, held on April 24-25 in Brussels. This significant event, organized by DG HERA and the Belgian Presidency, convened leaders from across the healthcare industry to address the challenges of medicine supply resilience in the European Union.\n\nZentiva&rsquo;s CEO, Steffen Saltofte, and representatives from the pharmaceutical industry and Medicines for Europe, the Generics association, engaged with EU Health Ministers and discussed actionable strategies to enhance the availability and accessibility of critical medicines throughout Europe.\n\nSteffen Saltofte: \"Our participation in the Alliance underscores our commitment. Together, we need to ensure that essential medicines are accessible to all people who depend on them. As generic medicines represent 70% of treatment volume in Europe and constitute 9 out of 10 products on the critical medicines list, our role is crucial in maintaining the continuity of healthcare services across the continent.\"\n\nDG HERA presented a Vulnerability Assessment performed on a tranche of 11 chosen critical medicines, selected from a broader list of over 200 critical medicines. Zentiva has seriously engaged in this assessment and believes it will be instrumental in addressing future medicine shortages. The discussion highlighted the need for increased manufacturing resilience.\n\nSteffen Saltofte: \"We believe that this assessment and our diligent efforts will lead to comprehensive solutions for shortages, support the European production of medicines, and ensure that the focus remains on substantive outcomes rather than merely increasing administrative burdens and regulations.\"\n\nDiscussions also covered strategies for preventing medicine shortages, enhancing EU manufacturing competitiveness, and ensuring equitable access across member states.\n\nZentiva shared insights from its extensive experience in producing high-quality and affordable medicines at its manufacturing sites in the Czech Republic and in Romania that are marketed in more than 30 countries. The team of 5.000 people is devoted to supporting the EU&rsquo;s vision of building a robust and sustainable healthcare system, that ensures high-quality, accessible pharmaceutical solutions to all people who depend on them.  \nAbout Zentiva\n\nZentiva is a Pan-European Company developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology &amp; Circulation, Diabetes, Oncology, Respiratory, CNS, and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong growth across Europe. \nWe are a team of 5.000 unique talents bonded together by our responsibility to ensure the supply of high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated, and can be their authentic selves contributing to the best of their ability. We provide health and wellbeing to all generations. \n\n\nMedia Contact:\nInes Windisch, \nHead of Communications, Corporate Affairs &amp; Sustainability\nines.windisch@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-04-25-critical-medicines-alliance",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-04-25-critical-medicines-alliance"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/zentiva_newspage_crit_med_alli_653x300.jpg?h=300&iar=0&w=653"
  },
  {
    "annotation": "In this episode, we welcome Vlastimil KarlÃ­k, expert from Arnika, a Czech non-profit organization. Their mission is to protect nature and a healthy environment for future generations, both at home and around the world.",
    "type": "News Article",
    "id": "1EF8FED4546A4B2EAA0571658BD18BA1-en",
    "tags": [
      "Sustainability Podcast",
      "Impact"
    ],
    "publish_date": "2024-05-19T22:00:00Z",
    "language": "en",
    "name": "2024-05-20-sustainability-podcast",
    "subtitle": "",
    "title": "Discover Biodiversity on Zentivaâ€™s Sustainability Podcast!",
    "content_title": "Discover Biodiversity on Zentivaâ€™s Sustainability Podcast!",
    "content_text": "Discover Biodiversity on Zentiva&rsquo;s Sustainability Podcast!\n\nAt Zentiva, we believe that each and every one of us can contribute to taking care of our planet and do what we can to protect it so that future generations can enjoy life as much as we do. We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030. As part of our environmental pathway, we find it also important to educate and empower our associates and we warmly invite you to join us and follow our new initiative - the Zentiva Sustainability Podcast with a series of episodes where experts explain different areas of environmental protection!\nEpisode #9 About Biodiversity\n\nBy sharing experiences and best practices from our partners, we aim to inspire you. This latest edition focuses on biodiversity.\nIn this episode, we welcome Vlastimil Karl&iacute;k, expert from Arnika, a Czech non-profit organization. Their mission is to protect nature and a healthy environment for future generations, both at home and around the world.\n\nï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ Why is biodiversity important? \nï¿½ï¿½ï¿½ï¿½â™»ï¸ What is the methodology of a product lifecycle assessment? \nï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ How can companies take practical steps to greener products?\n\nThis and more is discussed in the episode. \n\n \nPlease help us educate and empower as many people as possible by sharing this episode.\n\nï¿½ï¿½ï¿½ï¿½ Check out our Podcast series here. \n\nStay tuned for more episodes to come.",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-05-20-sustainability-podcast",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-05-20-sustainability-podcast"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/may-podcast-newspage.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "Steffen Saltofte, CEO of Zentiva, told TIME that whatever the future holds, Zentiva has been an active leader in the pharmaceutical sector for 500 years, and it will carry on for at least the next 500.",
    "type": "News Article",
    "id": "0A717234E852433FBF63B7F83A857546-en",
    "tags": [
      "CEO"
    ],
    "publish_date": "2024-06-06T22:00:00Z",
    "language": "en",
    "name": "2024-06-07-time-interview",
    "subtitle": "",
    "title": "Steffen Saltofte, CEO of Zentiva: We are here to provide health and wellbeing for all generations",
    "content_title": "Steffen Saltofte, CEO of Zentiva: We are here to provide health and wellbeing for all generations",
    "content_text": "Steffen Saltofte, CEO of Zentiva, told TIME that whatever the future holds, Zentiva has been an active leader in the pharmaceutical sector for 500 years, and it will carry on for at least the next 500.\nZENTIVA -Accessible Medicines\nThe annual revenue generated by the Czech Republic's pharmaceutical industry accounts for 4% of the country's total GDP, making its contribution to the national purse proportionately larger than in any of its European counterparts except Poland. It is also a regular and growing magnet for foreign investment\nZentiva is a prime example of the sector&rsquo;s ability to attract foreign direct investment, and the company has become something of an ambassador for both the industry and the country. &ldquo;A great platform full of talented people who we can invest behind to build a new, independent European generics leader,&rdquo; is how U.S. private equity investor Advent International described Zentiva in 2018, after finalizing the company&rsquo;s $2 billion acquisition from another multinational, France&rsquo;s Sanofi.\n \nHow right that description has proved to be. Since changing hands, Zentiva has doubled in size and currently operates in more than 30 countries through a network of 32 subsidiaries and 6 branches, By the end of 2022 it had finalized its expansion into the Netherlands and started operations in Austria.\n&ldquo;We are a European-based company and focus our activities there for the foreseeable future. We are here to provide health and wellbeing for all generations,\" says Zentiva CEO Steffen Saltofte, who was appointed to the role last year and brings with him a wealth of strategic and operational experience from a long and illustrious career at several large multinationals and fast-growing companies.\n \n&ldquo;We reacted to COVID by looking to source our raw materials more locally and moving our production facilities closer to home. Now we look forward to deepening our presence in the region, especially within Central Europe.\" \n \nZentiva's Central European pedigree is beyond question, with the company dating its involvement in the pharmaceutical industry back to the 15th century and the Black Eagle pharmacy, which is still open for business in Prague's Old Town. These roots are, however, just one of the qualities that caught Advent International's eye (and earlier that of Sanofi) and which Saltofte intends to harness to drive the company forward.\n \nZentiva's core strength lies in its commitment to providing high-quality generic medications.\nWith its portfolio, the company contributes to sustainable public health in Europe. These \"off-patent\" drugs offer the same therapeutic benefits as brand-name counterparts, but at a significantly lower cost. This translates to increased access for patients who might otherwise struggle to afford their medications. By focusing on a broad portfolio of essential medicines, Zentiva helps ensure individuals receive the treatment they need, regardless of their financial situation.\n \nWhile a big portion of Zentiva's portfolio is in the off-patent sector, the team's focus on research follows the Czech tradition of searching for innovative solutions. The teams at its R&amp;D centers in Prague and Ankleshwar in India actively manage the life cycle of its products and bring value for the people who depend on the medicines every day. Zentiva drives innovation in drug product formulation and brings bioequivalent medicines to European regulators for review and approval.\nThe company also provides pharmacovigilance and regulatory consulting services to partners via Prague Scientific.\n \nSince 2022, Value-Added Medicines have become the focus. These are the new generation of customized drugs that help address unmet patient needs by moving from a one-size-fits-all approach to a much more tailored and patient specific one. Two years ago, Zentiva took its first public step into this world with the launch of the drug Dasatinib, which is registered in the UK and EU and is a life-saving oncology treatment for people with chronic myeloid and acute lymphoblastic leukaemia. In the same year, Zentiva also launched 152 molecules and combinations of well-established treatments, all designed to provide more patients with affordable access to high-quality medicines.\n \nSuccessful R&amp;D is only half the battle, with production, logistics, marketing, and sales equally important. \"It can take up to 7 to 10 years to get a concept to market, and we have about 200 people working in R&amp;D,\" says Saltofte. \"But around another 2,500 staff work in our Product Supply division, and it is their job to ensure the drugs get produced and delivered.\" They in turn are supported by a network of 1,900 account handlers and medical representatives who are in regular contact with physicians, pharmacists, and healthcare decision-makers in each of its markets. The loyalty and dedication Zentiva inspires across disciplines has earned it Top Employer awards in Bulgaria and Romania, as well as at home in the Czech Republic.\n \nThe pandemic compelled Zentiva to shorten its supply chain, but it also prompted the company to accelerate its digitalization process.\n \n\"I think COVID forced us to use different sources of communications and to continue to accelerate the way we communicate with each other,\" says Saltofte. \"In time, this will help us speed up some of our processes. Whatever the future holds, we've been active leaders in this sector for 500 years, and we will carry on for at least the next 500.\"\n \nLink to original article by TIME\n\nTo open the interview from TIME as a file, click HERE",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-06-07-time-interview",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-06-07-time-interview"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/Zentiva_banner_653x300px_v7.jpg?h=300&iar=0&w=653"
  },
  {
    "annotation": "The Top Employer certification is one of the worldâ€™s most prestigious in the field of human resources management and measures each sub-activity in relation to the best industry experience.",
    "type": "News Article",
    "id": "9C5E159A54DD45139A27731569B95DAB-en",
    "tags": [
      "Awards & Recognition",
      "People & Culture",
      "Career"
    ],
    "publish_date": "2024-01-18T23:00:00Z",
    "language": "en",
    "name": "2024-1-19-top-employer",
    "subtitle": "",
    "title": "Top Employer 2024: Zentiva receives three certifications",
    "content_title": "Top Employer 2024: Zentiva receives three certifications",
    "content_text": "Zentiva proudly announces its recognition as a Top Employer in the Czech Republic and Romania for the third consecutive year, and for the first time, in Bulgaria, by the well-respected Top Employers Institute.\n\nThe Top Employer certification is one of the world&rsquo;s most prestigious in the field of human resources management and measures each sub-activity in relation to the best industry experience. Therefore, this achievement not only highlights Zentiva's commitment to its employees but also positions the company as an employer of choice in the pharmaceutical industry.\n\n&ldquo;We care about our people, and we want Zentiva to be a great place to work. Only thanks to satisfied and motivated employees can we fulfil our mission and successfully ensure the supply of high-quality and affordable medicines to people in Europe and beyond,\" comments Bridget Olde Olthof, Head of People &amp; Organization at Zentiva, on the award.\n\nThe Top Employer Institute assesses organisations via a rigorous analysis of their people practices based on six domains: Steer, Shape, Attract, Develop, Engage, Unite consisting of 20 different topics, across the business and employee lifecycle. These include: People Strategy, Work Environment, Talent Acquisition, Learning, Wellbeing, Diversity, Equity &amp; Inclusion, and Sustainability.\n\nIn 2024, the Top Employers Institute certified more than 2,300 organizations in 119 countries, positively impacting the lives of over 12 million employees worldwide.",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-1-19-top-employer",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-1-19-top-employer"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/zentiva_hero_topemployees_653x300.jpg?h=300&iar=0&w=653"
  },
  {
    "annotation": "In this episode of our Sustainability Podcast series, you will learn about the importance of vegetarian food for our health, and the environment.",
    "type": "News Article",
    "id": "26540B425C244CEDBFAD6D823EEE79BA-en",
    "tags": [
      "Sustainability Podcast",
      "Impact"
    ],
    "publish_date": "2024-08-21T22:00:00Z",
    "language": "en",
    "name": "2024-08-22-sustainability-podcast-benefits-of-vegetarianism",
    "subtitle": "",
    "title": "Why is vegetarianism healthy for our planet?",
    "content_title": "Why is vegetarianism healthy for our planet?",
    "content_text": "Tune in to the August Zentiva Sustainability Podcast!\n\nAt Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do. We act today for a sustainable tomorrow, continuously reducing our environmental impact, and we are on our path to becoming carbon neutral by 2030. \n\nAs part of our ecological pathway, we find it important to educate and empower our associates. We therefore warmly invite you to join us and follow our new initiative - the Zentiva Sustainability Podcast, featuring a series of episodes where experts explain different areas of environmental protection.\nEpisode #10 About Vegetarian Diet\n\nIn this episode, we have Dr Vijay Thakore, a renowned vascular and endovascular surgeon and a leading expert on sustainable living with 25 years of experience. Starting with the food choices we make, through the health benefits of a plant-based diet, to its impact on reducing our environmental footprint, Dr Thakore provides insight into the importance of vegetarian food for our health, as well as the environment. Practical tips included. Watch the video and find out the following and much more: \n  \n\nï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ Why is vegetarian diet healthy for us and the planet? \nï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ï¿½ Why is eating green embedded in Indian culture?\nï¿½ï¿½ï¿½ï¿½ï¸âœ… Why should we keep food waste and local food in mind?\n\n\n \n Stay tuned for more episodes. Until then, help us spread the word to educate and empower as many people as possible, and learn about how you can hop on the Green train with our Sustainability Podcast!\n\nï¿½ï¿½ï¿½ï¿½ Check out our Podcast series here.",
    "category": "Newsroom",
    "url": "/news/newsroom/2024/2024-08-22-sustainability-podcast-benefits-of-vegetarianism",
    "url_detail": [
      "news",
      "newsroom",
      "2024",
      "2024-08-22-sustainability-podcast-benefits-of-vegetarianism"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2024/website-hero-image_vegetarianism_sustainability_podcast.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "8D0670A8DB32435EA64FD40D755FCBFE-en",
    "tags": [
      "People & Culture",
      "Awareness Days",
      "Career"
    ],
    "publish_date": "2023-02-13T23:00:00Z",
    "language": "en",
    "name": "2023-2-14-Day-of-Women-and-Girls-in-Science",
    "subtitle": "",
    "title": "International Day of Women and Girls in Science",
    "content_title": "International Day of Women and Girls in Science",
    "content_text": "Meet Shaida Panbachi who is a PhD candidate at the University of Basel. Two months ago she joined us at Zentiva ÄŒesk&aacute; republika to complete her studies with 18 months of practical education in the industrial environment. Under the supervision of our colleague Josef Ber&aacute;nek from Zentiva&acute;s R&amp;D centre, she works on her university research project. The exchange is possible within the EU&acute;s InPharma program which focuses on creating international and interdisciplinary connections between academia and industry.\nWhat does she say about the experience? &bdquo;I really appreciate that I can see the bigger picture. At Zentiva, I can see all the processes, departments, and functions that participate in translating a research project into reality. I was surprised by how supportive the company is, providing good guidance, trust and materials for my PhD project.&ldquo;\n\nShaida hopes to one day bring a new solution for patients in drug delivery. We applaud all such ambitions and we celebrate her and all the other women on today&acute;s International Day of Women and Girls in Science.\n\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-2-14-Day-of-Women-and-Girls-in-Science",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-2-14-Day-of-Women-and-Girls-in-Science"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/Zentiva_women_day.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "B939692BFD084DD09B42DD57AAF560AE-en",
    "tags": [
      "Impact",
      "Sustainability",
      "Climate"
    ],
    "publish_date": "2023-03-14T23:00:00Z",
    "language": "en",
    "name": "2023-03-15-carbon-neutral-in-2030",
    "subtitle": "",
    "title": "Carbon Neutral in 2030,  a commitment to the future has already started",
    "content_title": "Carbon Neutral in 2030,  a commitment to the future has already started",
    "content_text": "At Zentiva, we are aware of our responsibility towards People, our Partners and our Planet. As a producer of high-quality and affordable medicine, we are producing carbon emissions, and we are aware of our impact on the environment. \nThat is why we committed to a strong sustainability roadmap and becoming carbon neutral in 2030 for Scope 1 and 2 emissions. We must invest further and review our production process and ways of working to achieve that. On top, we care about our energy, water efficiency and waste management, investing in reforestation and biodiversity. \nThanks to the engagement of our teams, we will contribute to a healthier planet today and in the future so that future generations can enjoy their lives as much as we do. Discover our Sustainability program by following us, especially during the next two weeks and learn more about how we at Zentiva act already today for a sustainable tomorrow!",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-03-15-carbon-neutral-in-2030",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-03-15-carbon-neutral-in-2030"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/zentiva-carbon-neutral-2030.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "A9060BEA1DC74183A3368CCCC4C47968-en",
    "tags": [
      "Awareness Days",
      "Impact",
      "Climate"
    ],
    "publish_date": "2023-03-16T23:00:00Z",
    "language": "en",
    "name": "2023-03-17-global-recycling-day",
    "subtitle": "",
    "title": "Global Recycling Day - Acting today for a sustainable tomorrow",
    "content_title": "Global Recycling Day - Acting today for a sustainable tomorrow",
    "content_text": "Acting today for a sustainable tomorrow\nToday&rsquo;s Global Recycling Day is a great reminder that recycling is a key component of reducing waste generation and cutting carbon emissions. That is why it is one of the focus areas of Zentiva&rsquo;s strategy on waste management, based on our Reduce &ndash; Recycle &ndash; Prevent approach.\nWith a comprehensive waste management plan we are proud that in 2022 we have achieved a reduction of 12% of waste per Standard Manufacturing Unit (from 7,6 g in 2021 to 6,7 g). Industrial recycling projects are happening across the company and are playing an important role, like the partnership we have with CYRCL, a public waste management marketplace in Prague. Our Sustainability motto is &ldquo;Acting today for a sustainable tomorrow&rdquo; and we are sure that each of us can make a difference and be a #RecyclingHero by following basic rules in our professional and private lives. It is about proper waste sorting, using reusable refill cups and bottles, using cloth bags, avoiding disposable food and drink containers, trying to avoid buying non-recyclable materials that can&rsquo;t be separated &ndash; every small action counts!\nThe vision of Zero waste can be achievable - with the right mindset, expertise, education and processes. With each green step, we are delivering on our environmental roadmap to become a carbon neutral company in Scope 1 and Scope 2 in 2030!\nAct today for a sustainable tomorrow so that future generations can enjoy our planet as much as we do.\n\nRead more about Zentiva&rsquo;s sustainability strategy: www.zentiva.com/sustainability          ",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-03-17-global-recycling-day",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-03-17-global-recycling-day"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/global-recycling-day-800px.jpg?h=533&iar=0&w=800"
  },
  {
    "annotation": "The General Assembly focused on critical issues such as EU pharmaceutical legislation that delivers on accessibility, affordability and availability of the medicines, removing any barriers and delays, and environmental impact.",
    "type": "News Article",
    "id": "7D235D7A57A844D78DAEDFC09C576717-en",
    "tags": [
      "Corporate Affairs",
      "Membership"
    ],
    "publish_date": "2023-12-17T23:00:00Z",
    "language": "en",
    "name": "2023-12-18-steffen-saltofte-elected-as-a-member-of-executive-committee-medicines-for-europe",
    "subtitle": "",
    "title": "Zentiva CEO, Steffen Saltofte elected as a member of Executive Committee Medicines for Europe",
    "content_title": "Zentiva CEO, Steffen Saltofte elected as a member of Executive Committee Medicines for Europe",
    "content_text": "We are pleased to announce the election of Steffen Saltofte as the new member of the Medicines for Europe Executive Committee during the recent General Assembly in Brussels.\n\nThe General Assembly focused on critical issues such as EU pharmaceutical legislation that delivers on accessibility, affordability and availability of the medicines, removing any barriers and delays, and environmental impact.\n\nMedicines for Europe is the official trade association for the European generic, biosimilar and value-added pharmaceutical industries across Europe. Its vision is to provide sustainable access to high quality medicines for Europe, based on 5 important pillars: patients, quality, value, sustainability and partnership.\n\nIn his new role, Steffen will collaborate closely with the members of the Medicines for Europe, its staff, and other stakeholders to promote sustainable innovation in the pan-European pharmaceutical platform and enhance patient access to value- added medicines.\n\n&ldquo;At Zentiva, we have been dedicated for a number of years in driving value-added medicines. I am delighted to share our exceptional skill and long standing experience as part of the Medicine for Europe membership community for the benefit of people who depend on our products every day. I believe that Zentiva's clear vision and straightforward mission can underpin sustainable healthcare in Europe and can ensure that as many people as possible get access to affordable medicines&rdquo;, said Steffen Saltofte.\n\nAdditionally, we are excited to announce that our Corporate Affairs Manager, Tomas Pala, has been appointed as Vice-Chair of the Generics Market Access Committee (GMAC) of the Medicines for Europe. Tomas is passionate about contributing our significant value and expertise to the generics market and increasing the sustainability of pan-European platform, further solidifying Zentiva&rsquo;s leadership and commitment in the pharmaceutical industry.",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-12-18-steffen-saltofte-elected-as-a-member-of-executive-committee-medicines-for-europe",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-12-18-steffen-saltofte-elected-as-a-member-of-executive-committee-medicines-for-europe"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/zentiva_hero_konference_653x300.jpg?h=300&iar=0&w=653"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "60800B3309204DCEAA36DD71035DCB23-en",
    "tags": [
      "Impact",
      "Sustainability",
      "Climate"
    ],
    "publish_date": "2023-03-20T23:00:00Z",
    "language": "en",
    "name": "2023-03-21-Zentiva-commits-to-plant-1-million-trees-by-2030",
    "subtitle": "",
    "title": "Zentiva commits to plant 1 million trees by 2030",
    "content_title": "Zentiva commits to plant 1 million trees by 2030",
    "content_text": "The company further strengthens its contribution to a healthier planet as part of their Sustainability strategy\nZentiva today celebrates the International Day of Forests by committing to plant 1 million trees by 2030. Being a producer of high-quality and affordable medicines, Zentiva is generating carbon emissions and is aware of its impact on the environment. That is why the company committed to a strong sustainability program as part of its business strategy.\nNick Haggar, CEO of Zentiva: &ldquo;At Zentiva, we ensure medicines supply and more than 100 million people in Europe and beyond trust in our products. We have defined a comprehensive Sustainability Strategy and we have formalized our commitment to become carbon neutral for scope 1 and scope 2 by 2030. On top, we are further investing in programs to improve our efficiency in energy, water and waste management. I am proud that actions are real and not just paper commitments.&ldquo;\nZentiva&rsquo;s Sustainability journey started back in 2019 by planting the first trees in Romania. Since then, the company has already planted more than 250.000 trees as part of its reforestation and offsetting program. The formalization of the 1-Million-Trees commitment is another milestone for the team.\nInes Windisch, Head of HR, Communications &amp; Sustainability: &ldquo;Everyone in our company is involved in the Sustainability agenda as we believe that every small step and every small contribution counts. We are focusing our efforts not only on efficiency programs but as well on Biodiversity, supporting nature to recover and restore local ecosystems. There is just one Planet, and we want that future generations will enjoy their lives on Earth as much as we do.&rdquo;\nZentiva has continued to significantly reduce its CO2 emissions during 2022 following on from a 16% reduction in 2021. It is important that all companies work to reduce their environmental impact and the Zentiva team is proud of the progress it is making. While the company&rsquo;s sustainability strategy is framed around 3 pillars: People, Partners and Planet, Zentiva will achieve the goal of carbon neutrality by focusing on reducing carbon emissions, sourcing from renewable energy, and increasing efficiency in energy, water and waste management.\nClick here to read more information about Sustainability at Zentiva.         ",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-03-21-Zentiva-commits-to-plant-1-million-trees-by-2030",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-03-21-Zentiva-commits-to-plant-1-million-trees-by-2030"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/banner-zentiva-1-million-trees-2030.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "As a leader in the pan-European pharmaceutical platform, Zentiva actively shares its experience and explores advancements in energy efficiency management through its participation in dedicated events.",
    "type": "News Article",
    "id": "61BCD65074C9492AB331CEA9A238386A-en",
    "tags": [
      "Events & Conferences",
      "Impact",
      "Sustainability"
    ],
    "publish_date": "2023-12-13T23:00:00Z",
    "language": "en",
    "name": "2023-12-14-energy-efficiency-approach",
    "subtitle": "",
    "title": "World Energy Conservation Day- Zentiva's commitment to sustainability",
    "content_title": "World Energy Conservation Day- Zentiva's commitment to sustainability",
    "content_text": "Today is World Energy Conservation Day, and we are highlighting our mission to improve energy conservation and our commitment to energy efficiency. \nAt Zentiva, our sustainability strategy is framed around 3 pillars: People, Partners and our Planet and is following the principles of ESG (Environmental, Social, Governance). We are proud that all our European manufacturing sites are sourced by 100% renewables.  \n \nAs a leader in the pan-European pharmaceutical platform, Zentiva actively shares its experience and explores advancements in energy efficiency management through its participation in dedicated events.  \n \nRecently, Dan Bandrabula, Energy &amp; Technical Facilities Manager at Zentiva, presented Zentiva&rsquo;s sustainable approach to our energy transition in front of a diverse audience of energy experts, scientists, public officials and business leaders brought together in frame of the &ldquo;Energy Efficiency for Energy Transition&rdquo; conference held in Bucharest. The conference aimed to share best practices in renewable energy sources projects and solutions for a better future by 2030. \n \n&ldquo;Advancing global sustainability efforts needs to be a collaborative mission across all industries. By adopting impactful sustainable practices, we are contributing to a better future for our planet, communities, and people. At Zentiva, each of us is dedicated to fostering a healthier future by ensuring a sustainable approach in everything we do &mdash; from the development to supply of high-quality and affordable medicines to those who depend on them every day&rdquo;, emphasized Dan.  \n \nZentiva&rsquo;s Engineering group constantly works in enhancing energy efficiency, achieving measurable progress in reducing carbon emissions. For example, in Romania since 2019, we have reduced the CO2 in more than 3 times: from 10,032  to 3,158 tons.   \n \nZentiva continues to allocate resources to its environmental initiatives, fostering active collaborations with partners, HCPs and specialized communities across Europe and beyond. \n \nWe believe that by raising awareness and fostering synergies in the way we work,  we can empower global commitment to building a future that prioritizes energy efficiency and environmental responsibility. By acting today we are actively contributing to a better tomorrow for our planet.",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-12-14-energy-efficiency-approach",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-12-14-energy-efficiency-approach"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/zentiva_hero_nean9919_653x300.jpg?h=300&iar=0&w=653"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "9FB02E88F0AF4DAAABB735F2C8BD88FE-en",
    "tags": [
      "CEO",
      "Career"
    ],
    "publish_date": "2023-04-17T22:00:00Z",
    "language": "en",
    "name": "2023-04-18-Steffen-Saltofte",
    "subtitle": "",
    "title": "STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA",
    "content_title": "STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA",
    "content_text": "STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA\nZentiva is pleased to announce the appointment of Steffen Saltofte to the role of Chief Executive Officer (CEO), succeeding Nick Haggar who moves to the Zentiva Advisory Committee as a non-executive member. Steffen joins as CEO with effect from 2nd May 2023.\nSteffen Saltofte joins from Acino, where he was CEO from 2018 until 2022. He brings a wealth of strategic and operational experience from large multinationals and fast growing companies, and will lead the further acceleration of Zentiva. Steffen will be based in Prague.\nSteffen Saltofte commented: &ldquo;I am excited to be joining Zentiva, a company with a strong track record in business growth and customer focus. Together we will continue this growth story, bringing high-quality affordable medicines to people across Europe and beyond. Health and access to medicines are more important than ever and I am fully committed to Zentiva&rsquo;s mission.&rdquo;\nThe Zentiva Advisory Committee, shareholders and employees wish to thank Nick Haggar for his leadership during the last four years as CEO. Nick&rsquo;s vision, inspiration and drive to create a high performing, inclusive and sustainable European pharmaceutical company has helped Zentiva double in size over the last four years. Nick will join the Zentiva Advisory Committee and is excited to support future development of the Company as a non-executive. \nMore than 100 million people trust Zentiva medicines to help them with their medical conditions and healthcare every year. ",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-04-18-Steffen-Saltofte",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-04-18-Steffen-Saltofte"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/Steffen-Saltofte-external-final.jpg?h=486&iar=0&w=1355"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "C90CE77A04E44A839D24344A67C19F1D-en",
    "tags": [
      "Membership",
      "People & Culture"
    ],
    "publish_date": "2023-07-18T22:00:00Z",
    "language": "en",
    "name": "2023-07-19-diversity-equity-inclusion-bulgaria",
    "subtitle": "",
    "title": "Zentiva Bulgaria underlines its commitment to Diversity, Equity and Inclusion",
    "content_title": "Zentiva Bulgaria underlines its commitment to Diversity, Equity and Inclusion",
    "content_text": "Sofia, July 19 - At Zentiva, diversity, equity and inclusion are one of our priority topics. We believe they are source of great energy and strength. Everyone should feel welcome in our company, be able to be their true selves and contribute to the best of their ability. We are thrilled to see the strengthening of the commitment in our countries. Zentiva Bulgaria has recently signed the Bulgarian Diversity Charter which is a local version of the European Diversity Charter. Thus, Bulgaria joined Czech Republic, Poland, Slovakia and Romania who are signatories of local initiatives as well.\nThe Bulgarian team has successfully proven the inclusive practices in the local workplace and the equal treatment for all employees. Signing the Charter also means underlining the commitment to further foster and develop the culture of diversity, equity and inclusion.\n&bdquo;Following the global Zentiva strategy, we are committed to encourage our people to fully reveal their knowledge, competences, talents and skills. The diversity certification will improve our local brand recognition, in addition to the social inclusion and it will helps us accommodate more talents in the organization,&rdquo; commented on the achievement Yulian Tsvetanov, Country Head of Bulgaria.\n\n    .u-max-width-content {max-width: none !important;}\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-07-19-diversity-equity-inclusion-bulgaria",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-07-19-diversity-equity-inclusion-bulgaria"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/Bulgaria-Diversity.jpg?h=3024&iar=0&w=4032"
  },
  {
    "annotation": "We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030.",
    "type": "News Article",
    "id": "DEDC1B8ABBFC43CD87311B162E6ABED5-en",
    "tags": [
      "Sustainability Podcast",
      "Impact"
    ],
    "publish_date": "2023-11-13T23:00:00Z",
    "language": "en",
    "name": "2023-04-21-welcome-to-zentiva-sustainability-podcast",
    "subtitle": "",
    "title": "Zentiva Sustainability Podcast!",
    "content_title": "Zentiva Sustainability Podcast!",
    "content_text": "\nWelcome to Zentiva Sustainability Podcast! \nAt Zentiva, we believe that each and every one of us can contribute to taking care of our planet and do what we can to protect it so that future generations can enjoy life as much as we do. We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030. As part of our environmental pathway, we find it also important to educate and empower our associates and we warmly invite you to join us and follow our new initiative - the Zentiva Sustainability Podcast with a series of episodes where experts explain different areas of environmental protection!\nEpisode #6 About Circular Economy\nEvery time we learn something new that can help our planet and how we can participate in it. Today in our Sustainability Podcast, we explore the Circular Economy, an approach for reducing waste and protecting the environment. With our guest Roman Gdovjak, Partner and Head of Consulting Operations at Cyrkl.com, you will learn: \nï¿½ï¿½ï¿½ï¿½ What exactly is the Circular Economy and how it benefits the environment. \nï¿½ï¿½ï¿½ï¿½ Circular Economy as a global trend that is reshaping industries.\nâ™»ï¸ Which items can be given a second life.\nï¿½ï¿½ï¿½ï¿½ How you, as an individual, can contribute to the Circular Economy and make a positive impact. \nJoin us and learn how to take care of our planet with Zentiva! \n \n \n \nEpisode #5 About Food Wasting \nThis time in our Sustainability Podcast, we will explore the topic of food wasting to contribute to the upcoming International Day of Food Loss and Waste which will be celebrated on September 29. In conversation with Anna Strejcov&aacute; from the non-profit organization ZachraÅˆ j&iacute;dlo (\"Save the Food\"), you will learn for example:\n\n    How food contributes to global CO2 emissions.\n    How much food goes to waste and how much money can a family save by adopting shopping habits.\n    How can you use new technologies to prevent food wasting.\n    Why is it important to pick up wonky, imperfect vegetable and fruits.\n\nLearn to treat the natural resources better with Zentiva!\n \n \n \nEpisode #4 About City Gardens \nThe #EarthOvershootDay means that from tomorrow on, the resources humanity uses will exceed what Earth can regenerate this year. At Zentiva, we do what we can to help to shift the date later in the year and reverse the trend of exhausting our planet, that is why we bring awareness to this day. Aside from concrete sustainability actions to achieve carbon neutrality by 2030, we believe in awareness and the need to educate ourselves and others about which small actions we can take as individuals to contribute.\nOur Sustainability Podcast is the result of that, and we bring you a new episode inspired by City Gardens projects. In this conversation with Luca Comino, Creative and Planning Director of I.E.S - Italian Enables of Sustainability we learn that these kinds of initiatives not only help to reduce the negative impact on the environment but also have a positive influence on well-being, reducing stress, improving mental health and enhancing the overall quality of life.\nWe invite you to join our Sustainability #podcast and learn about:\n\n    What is Biophilia and why is it important?\n    How we can help the environment in cities?\n    What is the social perspective of having nature in the cities?\n\nLearn to take care of the environment with Zentiva!\n \n \n \nEpisode #3 About Waste\nWe are inviting you once again to join us on our Sustainability #podcast. The new episode is inspired by today&acute;s #WorldRefillDay , which aims to reduce plastic waste. Zofia Maciejewicz, Head of Communication at Zentiva Poland talked with Julia Rokicka, co-founder and board member of the Polish Biorecycling Association, eco-educator, representative of Trash Hero WrocÅ‚aw, and initiator of waste-collecting actions. What can you find out from our podcast?\n\n    How you can lead by example.\n    What environmental problems are caused by cigarette butts.\n    How you can become a Trash hero.\n\n \n \n \nEpisode #2: About Bees\nWe learned many interesting facts that we would like to share with you in the new episode of our Zentiva Sustainability Podcast, where Veronika Ocasio, Communications Specialist at Zentiva Czech Republic talked to Alexandra Harmon-Threatt, Associate Professor in the Department of Entomology at the University of Illinois and is currently a Fulbright Scholar at Charles University in Prague. \nTomorrow the world celebrates World Bee Day and inspired by this podcast, we should think about how to help restore more natural habitats for the bees!\n\n \n\n\n \n\nEpisode #1: About Trees\n\n\nIn this first episode, we went to Romania where we began planting trees four years ago. Ioana Lucescu, Communication Manager at Zentiva Romania talked with Mihai Zotta - Conservation Director at Conservation Carpathia Foundation, about reforestation teaching us more about deforestation and its effect on biodiversity and the planet. \nStay with us and learn how can we protect, preserve and contribute to keeping this natural ecological force.\n\n \n \n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-04-21-welcome-to-zentiva-sustainability-podcast",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-04-21-welcome-to-zentiva-sustainability-podcast"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/zentiva_hero_ppp_653x300.jpg?h=300&iar=0&w=653"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "3A1623F7E97E45D0BE56C56FCDC3A181-en",
    "tags": [
      "Awards & Recognition",
      "People & Culture",
      "Career"
    ],
    "publish_date": "2023-07-12T22:00:00Z",
    "language": "en",
    "name": "2023-07-13-zentiva-poland-great-place-to-work",
    "subtitle": "",
    "title": "Zentiva Poland certified as Great Place To Work second year in a row",
    "content_title": "Zentiva Poland certified as Great Place To Work second year in a row",
    "content_text": "Warsaw, 13 July 2023 &ndash; Zentiva Poland has been received the prestigious Great Place To Work certificate for the second year in a row. The certification is awarded to companies on the basis of employee ratings expressed in an independent employee satisfaction survey.\nThe Great Place to Work International Institute, which awarded Zentiva Poland with the certificate, has been researching organizational culture in various market sectors for over 30 years, indicating employers who can be proud of the highest results in the employee opinion survey. Zentiva has been previously certified as &ldquo;Great Place to Work&rdquo; also in Italy, Serbia, Slovakia, the UK, and Croatia. Czech Republic and Romania are certified as Top Employer by the Top Employer Institute. The awards confirm that Zentiva is a trustworthy employer who cares about its people.\n&ldquo;The examination that precedes obtaining the certificate is one of the tools that allows us to verify how our activities are perceived and evaluated, analyze the needs and take further steps to strengthen and develop the company and the excellent employer brand. The distinction, which we received for the second year in a row, proves that our employees feel good and find themselves in the organization we create together,&rdquo; said Joanna Molga, HR Director at Zentiva Polska.\nIn its daily operations, Zentiva focuses on organizational culture based on respect for diversity, equity and inclusion, creating a working atmosphere where everyone can feel themselves. Since May 2023 Zentiva Poland, has been a signatory of the Diversity Charter in Poland and joined Czech Republic, Romania and Bulgaria who are signatories as well. \nZentiva supports the development of competences of its teams, offers opportunities for professional development and career paths as well as involvement in various business projects. It attaches the utmost importance to the quality and transparency of communication with the team and to the culture of feedback.\nThe overriding value in Zentiva is also care for the health and safety of employees &ndash; they are covered by the mission of pro-health education through well-being programs related to proper health prevention. Attractive salaries and a wide range of benefits are complemented by integration events, teambuilding and local pro-social initiatives, which further strengthen commitment and a positive atmosphere in the team.\n\nAbout Great Place to Work certification Great Place to Work\nThe certification is the most recognizable distinction for an employer of choice, based entirely on what employees say about their workplace experiences. The Great Place to Work certificate is recognized worldwide by both employees and employers. It serves as a global benchmark for identifying and valuing exceptional employee experiences. Every year, more than 10,60 companies in countries apply for the Great Place to Work certificate.\n \nAbout Zentiva\nZentiva is a manufacturer of high-quality, affordable medicines supplied to patients in Europe and beyond. The company employs 4,8 people and has a network of production facilities, including flagship factories in Prague, Bucharest and Ankleshwar. Zentiva aims to be a leader in branded and generic medicines in Europe to better meet patients' daily health needs.\nPeople, especially nowadays, need access to good quality medicines and healthcare at an affordable price. We work with doctors, pharmacists, wholesalers, regulators and authorities to create the best solutions to everyday problems.\n\n    .u-max-width-content {max-width: none !important;}\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2023/2023-07-13-zentiva-poland-great-place-to-work",
    "url_detail": [
      "news",
      "newsroom",
      "2023",
      "2023-07-13-zentiva-poland-great-place-to-work"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2023/Poland-again-Great-Place-To-Work.jpg?h=1070&iar=0&w=2048"
  },
  {
    "annotation": "SoÅˆa PorubskÃ¡â€™s New Role as the Global Head of Corporate Affairs",
    "type": "News Article",
    "id": "38372786EF4A403596678BEAC6850FD6-en",
    "tags": [
      "Corporate Affairs",
      "Career"
    ],
    "publish_date": "2022-02-09T23:00:00Z",
    "language": "en",
    "name": "2022-02-10-Sona-Porubska-joins-the-Zentiva-Executive-Committee",
    "subtitle": "",
    "title": "SoÅˆa PorubskÃ¡â€™s New Role as the Global Head of Corporate Affairs",
    "content_title": "SoÅˆa PorubskÃ¡â€™s New Role as the Global Head of Corporate Affairs",
    "content_text": "PRAGUE &ndash; February 10, 2022: After 10 years as General Manager Zentiva Czech Republic and Slovakia, SoÅˆa Porubsk&aacute; moves to a new position in the global executive team of Zentiva &ndash; she becomes the Head of Corporate Affairs and Strategic Franchises. She hands over the role of the General Manager to the next-generations talent Boris Sananes. \nSoÅˆa Porubsk&aacute; was the General Manager of the Czech Republic and Slovakia since 2011. Under her guidance, Zentiva has become the most important supplier of medicines to Czech citizens. With R&amp;D and a huge medicines manufacturing site in Prague, Zentiva makes a wonderful contribution to public health in Czechia and across the whole of Europe. In 2021, 17 new Zentiva medicine brands were launched,  including cardiovascular treatments, oncology treatments, asthma treatments, and diabetes treatments. The company also introduced a new innovative treatment for chronic wounds, Amnioderm. Zentiva continues to make an important contribution to the fight against the Covid-19 pandemic through its life-saving hospital medicines supply. Our company received an Award for an outstanding contribution to the fight against the Covid-19 pandemic by the Ministry of Industry and Trade.\nSoÅˆa Porubsk&aacute; is an accomplished leader and a role model. Her leadership is characterized by a strong focus on helping patients, supported by transparency and trust within the teams she has built. &ldquo;A good leader has to be open-minded and listen to his/her colleagues. One must be capable of developing the potential of others and making important but often tough decisions.&rdquo; SoÅˆa Porubsk&aacute; has been awarded numerously for her splendid work in the Czech Republic and Slovakia. Last time by the HospodaÅ™sk&eacute; noviny, who have included her among the TOP 20 female managers of the year in the Czech Republic for the fourth time, or the Forbes magazine, where she appeared in the prestigious list of the TOP 21 CEOs of 2021.\nIn her new global role as the Head of Corporate Affairs and Strategic Franchises, SoÅˆa will be responsible for growing the collaboration between Zentiva, the Czech Government, the Romanian Government, and Governments across Europe to help strengthen sustainable manufacturing, development, and supply of high-quality affordable medicines in Europe. Sona will also be returning to the board of the Czech Association of Pharmaceutical Companies (ÄŒAFF). In 2022, she will concentrate on the Presidency of the Czech Republic in the Council of the EU which will happen in the second half of the year. In her Strategic Franchises role, she will guide Zentiva&rsquo;s medicines portfolio commercialization strategy, allowing Zentiva to focus its energy and make the biggest difference possible to the patients in Europe.\n&ldquo;I am looking forward to the new challenges my new global role brings. Zentiva is in a phase of rapid growth and I am excited to help the company move forward and provide high-quality affordable medicine to even more patients in Europe and beyond. I will also stay passionately close to our teams, customers, and stakeholders in both Czechia and Slovakia,&rdquo; said SoÅˆa Porubsk&aacute; about her new position. \nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,700 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. \nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-02-10-Sona-Porubska-joins-the-Zentiva-Executive-Committee",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-02-10-Sona-Porubska-joins-the-Zentiva-Executive-Committee"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/Sona_Zentiva_cz.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "First Zentiva Digital Career event",
    "type": "News Article",
    "id": "718EBA8189C14C35A8C708DF714C143F-en",
    "tags": [
      "Events & Conferences",
      "Career"
    ],
    "publish_date": "2022-05-08T22:00:00Z",
    "language": "en",
    "name": "2022-02-25-First-Zentiva-Digital-Career-event",
    "subtitle": "",
    "title": "First Zentiva Digital Career event",
    "content_title": "First Zentiva Digital Career event",
    "content_text": "On April 28, Zentiva held its very first Digital Career Event. Check out the highlights of the day and see what the attendees got to learn about our #WinningTeam. \nBut you don&rsquo;t need to wait for the next event to join us and unleash your potential. Explore our job opportunities now: https://lnkd.in/gTNGa4pU\n\n\n\n\n    iframe {\n    position: relative;\n    width: 675px;\n    height: 415px;\n    }\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-02-25-First-Zentiva-Digital-Career-event",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-02-25-First-Zentiva-Digital-Career-event"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/thumb_article.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "Zentiva celebrates the next generation of scientists  with The Parc Awards",
    "type": "News Article",
    "id": "486EBEA3C3DF41E1B57C3FEC141E9DE9-en",
    "tags": [
      "Awards & Recognition",
      "Science",
      "Career",
      "Partnerships"
    ],
    "publish_date": "2022-02-24T23:00:00Z",
    "language": "en",
    "name": "2022-02-25-Zentiva-celebrates-the-next-generation-of-scientists-with-The-Parc-Awards",
    "subtitle": "",
    "title": "Zentiva celebrates the next generation of scientists  with The Parc Awards",
    "content_title": "Zentiva celebrates the next generation of scientists  with The Parc Awards",
    "content_text": "PRAGUE &ndash; 25th February 2022: The Centre for Applied Pharmaceutical Research (The Parc), which was founded by Zentiva in cooperation with leading Czech academic institutions, awarded its doctoral students with The Parc Awards for their outstanding academic work in applied drug research and development. In 2021, the Parc students achieved impressive results, including the completion of 17 scientific papers and 33 contributions to scientific conferences in total. \nThe Parc doctoral students were awarded The Parc Awards in two categories. VojtÄ›ch Klim&scaron;a won for the second time The Student Choice Award for his project on &ldquo;High-throughput screening of spray-dried formulations&rdquo;. The second Student award went to Dita Sp&aacute;lovsk&aacute; for &ldquo;Vibrational and chiroptical spectroscopy as an advanced tool for structure studies and identification of pharmaceutical and psychoactive substances&rdquo;, and the third Student prize was awarded to Nikita Marinko for his work on &ldquo;Combined in-silico and experimental approach for effective scaling-up processes in the pharmaceutical industry&rdquo;. The Expert Choice Award went to Erik Sonntag for his work &ldquo;Robotic compounding line for continuous manufacturing of personalised formulations&rdquo;.\n&bdquo;Every year I am impressed by the quality and ingenuity of students who work in The Parc &ndash; not just the winners but all our students. I am grateful to the industrial supervisors from Zentiva for giving the students a practical insight into pharmaceutical research, and to the academic supervisors for their expert guidance and continuing support. I wish to extend my congratulations to the winners, and I am looking forward to seeing them create the future of the pharmaceutical industry\" said Prof. Franti&scaron;ek &Scaron;tÄ›p&aacute;nek, The Parc&rsquo;s Scientific Director.\nIn 2021, The Parc continued its mission to provide young talented researchers with a world-class education and collaboration with professionals working to accelerate drug innovation and research in the Czech Republic. The international educational platform welcomed 7 new students into the program, extending the number of current participants to a record of 39 doctoral students. Zentiva strongly believes that supporting students by bridging the gap between theoretical science and what happens in real-life in pharma will have a valuable impact on the future careers of young people. \n&ldquo;The Parc awards are a great opportunity to celebrate the past year. The list of publications, conference contributions, and grant submissions shows that we have succeeded in creating an extraordinary pharmaceutical platform. These achievements stem from a perfect symbiosis between industry and academia based on the synergy of smart students, idea-rich academicians, and skilled industry experts. The Parc graduates are well prepared for their career, most of them have already found great job positions in almost all domestic pharmaceutical companies and also abroad,&rdquo; said OndÅ™ej Dammer, Operational Director of The Parc.\nSince its foundation, there have been more than 60 students, 43 professors, and academic and industrial leaders involved in The Parc. The PhDs who already graduated continue successfully in their careers either in the pharmaceutical industry or academic institutions. One-third of them started working at Zentiva, significantly helping the company on its growth journey.\nAbout The Parc\nInitiated by Zentiva, The Parc was created in association with three academic partners: the University of Chemistry and Technology Prague; the Faculty of Science of Charles University; and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. This highly successful initiative has brought rising talent together with leading pharmaceutical and academic experts, all working to accelerate innovation in drug research &amp; development.\nThe Parc provides world-class academic education combined with practical hands-on industrial and business experience under the leadership of scientists, engineers, and managers both from academia and the pharmaceutical industry. It enables students to gain graduate-level training in pharmaceutical sciences bridging chemistry, pharmaceutical technology, bio pharmacy, and clinical research. Results of the students&rsquo; research are frequently directly implemented in real-world products launched to the market to help patients. Collaborating with academic partners across Europe, The Parc also offers secondments for students and research experience exchanges supervised by top academic scientists. \nMore information about The Parc can be found on www.theparc.eu.\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,700 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Visit us at www.zentiva.com.\nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-02-25-Zentiva-celebrates-the-next-generation-of-scientists-with-The-Parc-Awards",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-02-25-Zentiva-celebrates-the-next-generation-of-scientists-with-The-Parc-Awards"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/the-parc-award-2-25.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "Zentiva Czech Republic underlines its commitment to  Diversity & Inclusion",
    "type": "News Article",
    "id": "976859508E9249AE8672558CB27B0BD7-en",
    "tags": [
      "Corporate Affairs",
      "Partnerships"
    ],
    "publish_date": "2022-06-01T22:00:00Z",
    "language": "en",
    "name": "2022-03-06-Zentiva-Czech-Republic-underlines-its-commitment-to-Diversity-Inclusion",
    "subtitle": "",
    "title": "Zentiva Czech Republic underlines its commitment to  Diversity & Inclusion",
    "content_title": "Zentiva Czech Republic underlines its commitment to  Diversity & Inclusion",
    "content_text": "The European Diversity Charter has been signed by Zentiva during the International Conference for European Diversity Day\nPRAGUE &ndash; June 2,  2022: Zentiva, a leading Czech producer of high-quality and affordable medicines has just signed the European Diversity Charter on Friday, 27th May during the International Conference for European Diversity Day. The conference was organized by the Business for Society alliance, the national coordinator of the European Diversity Charter. The event was held under the auspices of Mark&eacute;ta Adamov&aacute; Pekarov&aacute;, Chairwoman of the Chamber of Deputies of the Parliament of the Czech Republic. This high-profile event celebrated the addition of new businesses to the Diversity Charter, including Zentiva, during the charter accession ceremony. The European Diversity Charter aims to promote and implement diversity, flexibility and inclusion in the labor market in EU countries.\nAll new signatories formalizing their commitment  to   had their representatives received by Mark&eacute;ta Adamov&aacute; Pekarov&aacute;, Chairman of the Chamber of Deputies of the Parliament of the Czech Republic, who noted: \"I consider diversity to be a very important contribution and a very valuable source of inspiration in society, not a weakness and an obstacle to social development. That is why I try to support it in every way I can, and that is why I have also decided to give European diversity my patronage\". Zentiva was represented by Ines Windisch, Head of HR, Communications &amp; Sustainability and Tomas Pala, Corporate Affairs Manager. By joining, companies have voluntarily and publicly committed to developing the principles of openness, a fair working environment, anti-discrimination and, of course, diversity and inclusion in the work environment. As for Zentiva it is already its second affiliate which joined the Charter after Romanian site which joined already in November 2021.\nAdditionally, the conference theme revolved around Building bridges, and Ines Windisch was also a member of the &ldquo;European and transatlantic cooperation in the labor market and society&rdquo; panel representing Zentiva among other prominent business representatives and global ambassadors. &bdquo;We want to contribute to a world where everyone can be their true selves, no matter which nationality, gender, education or belief you have. This is what we do at Zentiva.&ldquo;\nZentiva is committed to diversity and has employees representing more than 50 nationalities in 30 countries with different ethnical and educational backgrounds, across four different generations, with various beliefs. The operations are headquartered in Prague, where the story of Zentiva began more than 530 years ago in a small pharmacy that served the people in Prague. Until today, Zentiva has kept this high customer focus and is building up operations for future generations as a great and healthy employer. In the Czech Republic, the company employs more than 1.500 people and seeks a balanced team in terms of gender. Being inclusive is at the heart of everything what Zentiva is doing. Diversity plays an important role in Zentiva&rsquo;s main mission and purpose, as the uniqueness of each talent that is working for Zentiva is strengthening the group as a team by bonding them together for a common mission: To help people live well through the development and supply of high-quality and affordable medicines that people rely on every day. \n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-03-06-Zentiva-Czech-Republic-underlines-its-commitment-to-Diversity-Inclusion",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-03-06-Zentiva-Czech-Republic-underlines-its-commitment-to-Diversity-Inclusion"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/news_diversity_inclusion.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "Zentiva to donate 100,000 packs of medicines to the Ukrainian Humanitarian Crisis",
    "type": "News Article",
    "id": "CAEE1A941957453E99CC1A88CA4487EA-en",
    "tags": [
      "Impact",
      "Charity"
    ],
    "publish_date": "2022-03-01T23:00:00Z",
    "language": "en",
    "name": "2022-06-10-zentiva-bulgaria-initiative-to-help-ukraine",
    "subtitle": "",
    "title": "Zentiva to donate 100,000 packs of medicines to the Ukrainian Humanitarian Crisis",
    "content_title": "Zentiva to donate 100,000 packs of medicines to the Ukrainian Humanitarian Crisis",
    "content_text": "PRAGUE &ndash; March 2nd, 2022: Zentiva is a major developer and producer of high-quality and affordable medicines in Europe. Zentiva will donate 100,000 packs of medicines to humanitarian aid programs targeted at helping the citizens of Ukraine.\n\nThe medicines will include life-saving hospital medicines, cardiovascular medicines, pain medication, and anti-infectives. The Company is working with governmental organisations and NGOs, as they respond to the urgent requests from the Ukrainian government and Ukrainian citizens as they cross the borders into the EU.\n\n&ldquo;There is an urgent need for medicines and requests are coming in very fast. Zentiva has large manufacturing operations in the Czech Republic (Prague) and Romania (Bucharest) so we can help by responding quickly to support the citizens of Ukraine and their need for medicines. We are in close contact with several governments to be ready to support and have pledged 100,000 packs of medicines&rdquo;, said Sona Porubska &ndash; Head of Zentiva Corporate Affairs.\n\nThe donation plan is part of a broader set of activities being undertaken by the Company to provide support to Ukrainian citizens, including the Zentiva Ukraine team, their families, and our partners in the country.\n\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,700 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Visit us at www.zentiva.com.\nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-06-10-zentiva-bulgaria-initiative-to-help-ukraine",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-06-10-zentiva-bulgaria-initiative-to-help-ukraine"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/Zentiva_banner_article.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "FBB40785A86C44F1B59D9FFDCD7621D2-en",
    "tags": [
      "CEO"
    ],
    "publish_date": "2022-07-03T22:00:00Z",
    "language": "en",
    "name": "2022-06-28-from-the-heart-an-interview-with-nick-haggar",
    "subtitle": "",
    "title": "From the heart: an interview with Nick Haggar",
    "content_title": "From the heart: an interview with Nick Haggar",
    "content_text": "At Zentiva, offering high-quality, affordable generics to deliver vital drugs is what drives us. Patients are at the heart of everything we do.\nThey should be able to enjoy their life to the fullest. That is why we follow the needs in the most-needed therapeutic areas very closely to cater to the needs of the majority.\nWe are focusing on bringing medicines for patients with cardiovascular, respiratory, urogenital system conditions, and oncology where we also develop our own value-added medicines. \n\nBecause in everyday life minor ailments happen, Zentiva also focuses on selfcare for people to get efficient, affordable fast-relief OTC products at the pharmacy.\nRead our CEO&rsquo;s, Nick Haggar, interview with the CEO Magazine on how the company is committed to answering these unmet patients&rsquo; needs.\n\nNick Haggar&rsquo;s father suffered from a heart condition that required him to take medication for his entire life. As a child, Nick saw how the disease made simple things difficult or impossible for his dad, and this inspired him to pursue a career where he could help people with similar issues. \n&ldquo;My father didn&rsquo;t enjoy a normal life,&rdquo; Nick says. &ldquo;At times, he was quite restricted in what he could do. So I wanted to be part of something that would be helpful &ndash; helpful to him and helpful to people like him.&rdquo;\n\nSo, at the age of 21, Nick entered the healthcare industry. Today he is CEO of Zentiva, a Prague-based pharmaceutical company that specialises in off-patent medicines and serves around 100 million people a year across 50 countries. The firm employs around 4,700 people, with four manufacturing sites in Prague, Bucharest and Ankleshwar, and also has a physical presence in 30 countries.  \n&ldquo;My purpose is to try to help as many people as possible have access to high-quality, affordable medicines, to live better lives and to live life to the full,&rdquo; Nick says. &ldquo;That motivates me every day.&rdquo;\n\nZentiva&rsquo;s role in the pharmaceuticals market is to offer lower cost drugs to a wider section of the market once the drugs&rsquo; patents have expired. While the company does not have its own drug discovery, it innovates to improve the patient experience &ndash; for example, by developing new combinations of drugs to better manage symptoms or offering a new way to deliver a drug. \n\n&ldquo;Companies like Zentiva enter the market and bring competition with our own bio-equivalent medicine,&rdquo; Nick explains. &ldquo;At that moment, the pricing of the medicine comes down and the number of patients receiving access to that gold-standard medicine goes up. Healthcare budgets don&rsquo;t increase, in fact these medicines can come in under budget, allowing the difference to be reinvested.&rdquo; \n\nZentiva&rsquo;s offerings in high-volume generic medicines are focused on several therapeutic areas, including cardiology &ndash; the branch of medicine so important to Nick&rsquo;s father &ndash; diabetes, respiratory conditions, oncology and cancer care, over-the-counter self-care medications and urology.\n\n\nOffering lower-cost generics and expanding the market in vital drugs is a model that Nick finds extremely motivating; the better Zentiva does as a business, the more people stand to benefit. \n&ldquo;As Zentiva grows, more patients get the medicines they need,&rdquo; he says. &ldquo;Every single year, as Zentiva grows, we reduce the cost of medicines across Europe. I love that. It&rsquo;s a great passion of mine. It drives me and we work hard as a company to connect everybody to that purpose.&rdquo;\n&ldquo;It&rsquo;s also a bit of a guiding light because it helps you make good decisions,&rdquo; he adds. &ldquo;It helps you keep a balanced view. We are here to grow the company and perform financially, but we have an incredible role to play in public health and in society. We have to make sure that we achieve both those objectives.&rdquo;\nDOUBLING SALES\n\n\nShortly after Nick became Zentiva&rsquo;s CEO in early 2019, the company set out on an ambitious plan to double the size of the business, from &euro;700 million to &euro;1.4 billion in sales, within five years.\n\n\n&ldquo;As of the end of 2021, we&rsquo;re about a &euro;1.2 billion sales company, so we&rsquo;re well on track to doubling the company in five years,&rdquo; Nick says. That growth has been achieved thanks to an insatiable desire among his team to seek out and deliver to underserved markets, which has been made possible thanks to the backing of Zentiva&rsquo;s private equity parent company, Advent International.\n\n\n&ldquo;Everyone in our company can put their fingerprints on differences that we are making every day, whether that&rsquo;s new combinations of medicines, better ways of helping patients or being able to respond when a country or a customer has no supply, and Zentiva is able to fill the gap and make sure there&rsquo;s a continuous flow of medicines,&rdquo; Nick says.\n&ldquo;I love the team that I&rsquo;m with because we are doing so much good, but there is so much opportunity to do more. Being a fast-growing company with a private equity backer, we have the ability to invest in our teams, invest in our technology, invest in our manufacturing sites and invest in helping patients,&rdquo; he adds.\n\n\n\n\n\nAs well as being a way to reach more patients, growth is what Nick calls &ldquo;the magic ingredient&rdquo; &ndash; it helps demonstrate to everyone within the company, and all the stakeholders outside of it, that the formula is working and that being on board with Zentiva is worthwhile.\n&ldquo;All partners involved in this see the benefit &ndash; patients get benefits, payers get benefits, the company grows, there&rsquo;s more opportunity in the company,&rdquo; he says. &ldquo;It&rsquo;s exciting. It&rsquo;s a dynamic environment and really supported by this growth mindset. It gets me going each day because every day there&rsquo;s something new, something more we can do, and it just keeps coming.&rdquo;\nTHE CORE FRAMEWORK\nWhile his inspiration for entering the industry comes from his father, the framework that Nick uses to guide him as a leader comes from his wife, Jacqui, who is, quite conveniently, an executive coach.\n\n\n&ldquo;She came up with a model a long time ago called CORE: courage, openness, resilience and energy. It&rsquo;s a framework that I keep going back to, whether I&rsquo;m confronted with a new situation or I&rsquo;m thinking about the business, but it also plays extremely well when your path ahead is uncertain,&rdquo; Nick says.\n\n\n\n\n\nThe CORE framework gives Nick a calm confidence in the face of challenges, he says, and helps him to maintain empathy towards those around him when things don&rsquo;t go the way he wants them to.\n \n&ldquo;People are suffering around you in different ways,&rdquo; he says. &ldquo;They&rsquo;re uncertain. In some cases, they&rsquo;re lost. Some of your business partners don&rsquo;t know where they&rsquo;re going, and that ability to empathise and connect and to show resilience, to really show the caring dimension, makes all the difference.&rdquo;\n\n\nNick always tries to bear in mind, whoever he&rsquo;s dealing with, that &ldquo;everybody is challenged, not just purely professionally but in a rather unique way, a profound way, privately and personally as well as professionally&rdquo;.\n\n\n\n\nHis empathetic approach is not just an individual leadership strategy; it also feeds into the fundamental values of the company, which prizes ethics and responsibility throughout its hierarchy and among its external partners.\n \nIt has been particularly valuable to have such values in the face of the COVID-19 pandemic, Nick says. &ldquo;I think in these moments, it reminds you how powerful it is to have a good centre, to be building a healthy company that you&rsquo;re proud of, because there are certain things that carry you through. One of those things in our company is our sense of responsibility, that we have to put other things aside and focus on what&rsquo;s going to make the biggest difference to the most people.&rdquo;\n\n\nWith any decision the company makes, Nick and his team always try to look ahead 10 years to imagine how that decision will be judged in the future, he says.\n\n\n&ldquo;Did we as a leadership team, as a company, do everything we could?&rdquo; he says. &ldquo;Did we imagine the possibilities and did we really try to do the maximum? With that kind of future standard looking back at you, I think that encourages you and gives you the courage to do more and the energy to do more.&rdquo; \nMIXING MEDS\nThe key areas where Zentiva is focusing its innovative efforts at the moment are cardiology and oncology. Despite the prevalence of numerous cancer and heart disease drugs, the company still sees many unmet needs. That does not mean Zentiva&rsquo;s researchers are on the hunt for new types of drugs, but rather new ways of combining existing drugs and new ways of delivering them.\n\n\n&ldquo;We are looking at new, unique and innovative combinations of medicines to help patients manage their symptoms better, what we call value-added medicines,&rdquo; Nick says. &ldquo;So we&rsquo;re looking at the medicine from the patient point of view and making it more flexible for the patient &ndash; easier for the patient to take and to tolerate.&rdquo;\n\n\nZentiva also uses its expertise to make work easier for medical professionals as well, for example, by making it easier for nurses to deliver certain drugs. The company keeps a close eye on emerging technologies and works to incorporate them into its offerings. \n&ldquo;We&rsquo;re deploying and exploring how to make existing medication work even better. For example, we&rsquo;re exploring nanotechnology films, rapid dissolving films and new technology platforms that are only just now coming into the mainstream,&rdquo; Nick says.\n\n\n\n\n\nWith a goal of reaching carbon neutrality by 2030, sustainability is another core priority. Zentiva&rsquo;s European manufacturing sites already run on 100 per cent renewable energy and, in the last year alone, strides have been taken to reduce water consumption (its Bucharest site decreased overall water usage by 35 per cent in the last year). The company has also planted over 40,000 trees.\n\nNick also explains that its research and development team is looking at ways to reduce the impact of its drugs on the environment as well. When someone takes medication, a large amount of it passes through their body and ends up in the water supply. So Zentiva is working on delivery systems that ensure the medicine stays in the patient. Sometimes, this means giving a lower dose that is taken up more efficiently by the body.\n\n\n&ldquo;That innovation stream looks pretty promising,&rdquo; Nick says. &ldquo;It&rsquo;s a complex path, for sure, but we believe if you look at the future standard, this is the work that should be done.&rdquo;\n\n\n\n\nFinding the answer to such problems may not be the easiest task for Zentiva, but Nick didn&rsquo;t join the industry for easy wins. He did it to make a difference.\n\nRead the original interview\n\n\n    .grid_article {display:grid;grid-template-columns: 1fr 1fr;gap: 30px;}\n    p {font-size: 18px;line-height: 28px;}\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-06-28-from-the-heart-an-interview-with-nick-haggar",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-06-28-from-the-heart-an-interview-with-nick-haggar"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/CEO_nick_banner.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "6187871F94D84954982C75B3AF8B4B7B-en",
    "tags": [
      "Awareness Days"
    ],
    "publish_date": "2022-07-07T22:00:00Z",
    "language": "en",
    "name": "2022-07-08-allergy-day",
    "subtitle": "",
    "title": "World Allergy Day",
    "content_title": "World Allergy Day",
    "content_text": "\n\n\n\n\n\n\n\n\n\n    .grid_article {display: grid ; grid-template-columns: auto;}\n    .grid_article p {margin-bottom:0px !important;margin-top:-6px !important;}\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-07-08-allergy-day",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-07-08-allergy-day"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/banner.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "706BDAF80552433291E10CD60CEE45CA-en",
    "tags": [
      "Corporate Affairs"
    ],
    "publish_date": "2022-08-14T22:00:00Z",
    "language": "en",
    "name": "2022-08-15-Zentiva-welcomed-representatives-of-the-Czech-Ministry-of-Industry-and-Trade",
    "subtitle": "",
    "title": "Zentiva welcomed representatives of the Czech Ministry of Industry and Trade",
    "content_title": "Zentiva welcomed representatives of the Czech Ministry of Industry and Trade",
    "content_text": "On August 11, Nick Haggar, CEO of Zentiva, Pavel &Scaron;ebek, Development Director, and SoÅˆa Porubsk&aacute;, Head of Corporate Affairs, welcomed the Deputy Minister of Industry and Trade of the Czech Republic doc. Ing. Marian Piecha, Ph.D. LLM and Eduard MuÅ™ick&yacute;. \nThey discussed many topics with them and during the meeting, Zentiva was presented as a major domestic pharmaceutical manufacturer and as a company focused on research and development in the field of value-added medicines. Furthermore, the discussion evolved around our contributions to the Czech economy, its sustainability, and responses to the energy and inflation crisis.\n\"Recent years have shown us how important a strong domestic pharmaceutical production is for the continuous supply of medicines to Czech citizens, whose health often depends on them. We are clearly aware of this importance and we have proven our ability to ensure the supply of medicines under all circumstances, especially in the last two pandemic years. It is this awareness that drives us forward in Zentiva. Currently, we deliver almost every fifth prescribed box of medicines to the Czech market,\" says SoÅˆa Porubsk&aacute;, Head of Corporate Affairs.\nIt was an honour to have them at our offices and discuss the Czech Pharmaceutical Industry. It has become an important topic especially due to the ongoing Czech Presidency of the Council of the European Union and the constant challenges it has faced over recent years such as the energy crisis.  \n\nDeputy Minister Doc. Ing. Marian Piecha, Ph.D. LLM underlined: \"The pharmaceutical industry is a strategic sector with high added value. We are very pleased that Zentiva is further developing its capacities for the production of pharmaceuticals in the Czech Republic, investing in research and development of value-added medicines, and fulfilling important EU documents &ndash; industrial and pharmaceutical strategy. The EU's self-sufficiency in key industrial sectors is currently our priority. \"\n \n\n\n\n\n\n\n\n\n    @media only screen and (min-width: 720px) {\n    .grid_article {display:grid; grid-template-columns: 1fr 1fr;gap:20px;}}\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-08-15-Zentiva-welcomed-representatives-of-the-Czech-Ministry-of-Industry-and-Trade",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-08-15-Zentiva-welcomed-representatives-of-the-Czech-Ministry-of-Industry-and-Trade"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/banner_Zentiva_Ministerstva.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "BEEE379CC61E42CD955631ACC66EE55E-en",
    "tags": [
      "Awards & Recognition",
      "People & Culture",
      "Career"
    ],
    "publish_date": "2022-09-14T22:00:00Z",
    "language": "en",
    "name": "2022-09-15-zentiva-uk-recognised-with-the-great-place-to-work-certificate",
    "subtitle": "",
    "title": "Zentiva UK recognised with the great place to work certificate",
    "content_title": "Zentiva UK recognised with the great place to work certificate",
    "content_text": "Our colleagues in the UK have come together to make Zentiva a Great Place to Work and highly value the culture of their workplace. \nEmployees expressed their recognition in an independent employee satisfaction survey and, based on their feedback, Zentiva UK has been accredited with the prestigious Great Place To Work certificate.  \nGreat Place to Work&reg; is the global authority on workplace culture and over the last 30 years has surveyed more than 100 million employees around the world, using deep insights to define what makes a great workplace trust:\n&ldquo;I am delighted that the UK has been accredited with the Great Place to Work accreditation - The work commitment, drive and passion from the entire team is outstanding and I am pleased that the work we are putting into driving improvements in the workplace is recognised and valued. Zentiva UK is a &lsquo;Great Place to Work&rsquo; but the hard work continues to ensure that we tackle the areas where our employees have told us improvements can still be made&rdquo;, Sophie Quin, Country Manager UK\n\n\nZentiva UK is committed to Equality and Diversity, with Inclusion being an integral part of the company culture and a source of great energy and strength. Zentiva is on an exciting growth journey, offering professional development opportunities that allow employees to discover their talents and unlock their potential. We focus on the importance of quality and transparent communication and incorporate a culture of feedback and continuous improvement into all daily activities.  \nZentiva UK is undoubtedly a winning team and their hard work and commitment to providing a great place to work for all have been rewarded with this amazing certification. \nMore information about our company and current vacancies can be found here.\n\n\n\n\n    @media screen and (min-width: 750px) {\n    .grid-article {display: grid; grid-template-columns : 1fr 300px; gap: 20px;}\n    }\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-09-15-zentiva-uk-recognised-with-the-great-place-to-work-certificate",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-09-15-zentiva-uk-recognised-with-the-great-place-to-work-certificate"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/carousel_team_UK_banner.jpg?h=408&iar=0&w=653"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "0F09DEEBEFA14CA38D2A4FBC8AA816F1-en",
    "tags": [
      "Science",
      "Partnerships",
      "Innovation"
    ],
    "publish_date": "2022-09-15T22:00:00Z",
    "language": "en",
    "name": "2022-09-16-ORBIS-School",
    "subtitle": "",
    "title": "The fourth ORBIS School enhancing international collaboration on pharmaceutical innovations was held in Prague",
    "content_title": "The fourth ORBIS School enhancing international collaboration on pharmaceutical innovations was held in Prague",
    "content_text": "PRAGUE &ndash; September 16, 2022 &ndash; Between 7th and 9th September, the fourth ORBIS School was held in Prague. The event was co-hosted by Zentiva in close collaboration with the German company Physiolution and the University of Chemistry and Technology in Prague. Many various lectures and workshops were held during these three days and the participants had a great opportunity to share their experiences and knowledge based on their own research. Part of the program was a visit to Zentiva&rsquo;s R&amp;D department in its Prague site.\nORBIS (Open Research Biopharmaceutical Internships Support) is an international project which is a part of the EU program HORIZON 2020, focused on research and development. ORBIS is a platform that unites universities, research institutes, and pharmaceutical companies from several European countries.\nSUPPORTING AN INTERNATIONAL NETWORK TO ENHANCE RESEARCH AND DEVELOPMENT \nParticipants from Ireland, France, Finland, Germany, Poland and Ukraine came to Prague for the ORBIS School. Lectures and workshops at the University of Chemistry and Technology and the Czech Technical University were focused on biopharmaceutical principles and novel techniques or modern bioanalytical methods. The goal of the ORBIS project is to strengthen the connection between academic and industry fields, exchange expert knowledge and create international partnerships across Europe, which can move pharmaceutical research ahead. &ldquo;Innovations are a crucial part of what we do. At Zentiva, almost 200 employees work in the R&amp;D department. We support young talents and work on strengthening the academia-pharma industry cooperation. Joining the ORBIS project was an ideal opportunity to develop this type of cooperation on an international level. We believe that this kind of partnership is the key to success,&rdquo; says Pavel &Scaron;ebek, Development Director of Zentiva. &ldquo;Meeting other experts with different backgrounds is very enriching. It is always interesting to hear about the experience of others and discover new original approaches to R&amp;D. These events are always a great motivation,&rdquo; says Nikita Marinko, a young and talented scientist from Zentiva who took part at this year&rsquo;s ORBIS School and was part of the organizational team that took care of all the participants.\nOut of all four ORBIS schools which have been held so far, two of them &ndash; the second one and this one (the fourth one) &ndash; have been co-organized by Zentiva. In September 2019, in collaboration with the University of Helsinki, Zentiva organized the school covering the design of pharmaceutical dosage forms and the manufacturing processes, whereas novel bio-relevant analytical approaches used in the characterization of dosage forms have been covered this September in Prague. Both schools were particularly based on academic findings combined with real-life examples, such applied scientific approaches being appreciated by all participants.\n\n\nThe high number of attendees confirmed the strength of the ORBIS scientific network and focus on innovative approaches to meet currently unmet patient needs.\n\nAbout ORBIS &ndash; Open Research Biopharmaceutical Internships Support (Maria SkÅ‚odowska-Curie Actions of Horizon 2020 Framework Programme, H2020-MSCA-RISE-2017)\n\nThe overarching objective of ORBIS is to form an international and inter-sectoral academic and industrial network. The action is aimed at improving the preclinical pathway of medicine development concentrating on processes and technologies. The goal is to integrate multidisciplinary research by involving the academia and the industry from EU (Poland, Ireland, Finland, Germany, and the Czech Republic), EU associated countries (Ukraine) and US. The coordinator of the project is Prof. Janina Lulek from Poznan University of Medical Sciences (Poland). Find out more at www.orbisproject.eu.  \nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,700 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs. At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Visit us at www.zentiva.com.\n\nMedia contact:\n\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU Kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nCell: (+420) 727 873 159 / E-mail: mounira.lemoui@zentiva.com\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2022/2022-09-16-ORBIS-School",
    "url_detail": [
      "news",
      "newsroom",
      "2022",
      "2022-09-16-ORBIS-School"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2022/ORBIS_banner.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "0F85A923A2894ABA9EFF601CD15E8B37-en",
    "tags": [
      "Product Portfolio",
      "CEO"
    ],
    "publish_date": "2021-04-08T22:00:00Z",
    "language": "en",
    "name": "04-09-2021-EXPANSION-ONCOLOGY",
    "subtitle": "",
    "title": "Zentiva continues its expansion in oncology with the launch of AlymsysÂ® (Bevacizumab) in 21 countries across Europe",
    "content_title": "Zentiva continues its expansion in oncology with the launch of AlymsysÂ® (Bevacizumab) in 21 countries across Europe",
    "content_text": "PRAGUE &ndash; April 9, 2021: Zentiva and mAbxience announce their collaboration for the launch of the ALYMSYS&reg; (bevacizumab) following its European Marketing Authorisation on March 26th. The EC approval is based on a comprehensive clinical and scientific package which demonstrated biosimilarity of ALYMSYS&reg; to the originator reference product.\nNick Haggar, Chief Executive Officer of Zentiva stated: &ldquo;We are very proud to take a further step in growing our Oncology medicines portfolio while realizing our ambition to increase the access to biologic medicines across Europe. Biologic medicines play a central role in the fight against cancer and our partnership with mAbxience marks an important milestone in the growth of Zentiva and the contribution we can make to public health across Europe.&rdquo;\nA biosimilar medicinal product is a biological medicine that is highly similar to the reference medicinal product with regard to quality, safety, and efficacy. Biosimilars can contribute to an increase in the number of patients gaining access to biological treatments while offering significant cost savings for healthcare systems.\nALYMSYS&reg; will be marketed by Zentiva in 21 countries across Europe.\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Learn more about Zentiva.com.\nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/04-09-2021-EXPANSION-ONCOLOGY",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "04-09-2021-EXPANSION-ONCOLOGY"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/Zentiva_banner_article.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "3EBB0179EB984E1A8B54BC17E49411DC-en",
    "tags": [
      "Product Portfolio",
      "Science",
      "R&D"
    ],
    "publish_date": "2021-05-27T22:00:00Z",
    "language": "en",
    "name": "05-28-21-Zent2u-announcement-successfull-development-completion-of-Metformin",
    "subtitle": "",
    "title": "Zent2U announces successful development completion of Metformin with controlled NDMA content",
    "content_title": "Zent2U announces successful development completion of Metformin with controlled NDMA content",
    "content_text": "May 28, 2021: is happy to announce its successful development of a Metformin finished drug product with significantly controlled NDMA content.\n\nZent2U&rsquo;s development of innovative manufacturing processes to control impurities, including N-nitrosodimethylamine (NDMA), is completed and the opportunity is now offered to you. Zentiva&lsquo;s improved processes have been successfully implemented into industrial use and Zentiva has related intellectual property rights. Application concerning worldwide patent rights is pending.\n\nSolving this complex task, which is closely observed by global regulators, allows Zentiva to offer complete EU dossiers to partners. We believe that having a Metformin finished drug product with controlled nitrosamine impurity content will bring significant advantages to millions of diabetes patients. Further, this innovation will advantage our potential business partners in overcoming nitrosamine impurity issues and allow the launch of the improved product quickly, with critical NMDA reduction and benefiting from Zentiva&rsquo;s proprietary technology. \n\n \n\n\nPartner up now and connect with our team today!\n \n\n\n\n\n\nTomas Pilarcik\nKey Account Manager\ntomas.pilarcik@zentiva.com\n\n\n\nThomas Koene\nHead of Growth Partnerships\nthomas.koene@zentiva.com\n\n\n\nMihai Stoian\nKey Account Manager\nmihai.stoian@zentiva.com\n\n\n\nRahul Padhye\nKey Account Manager\nrahul.padhye@zentiva.com\n\n \n \nClick here to discover Zent2U\n \nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com\n\n    .grid_z2 {display:grid; grid-template-columns:1fr 1fr;grid-gap:50px;}\n    @media screen and (max-width: 640px) { .grid_z2 {grid-template-columns:1fr;grid-gap:30px;}}\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/05-28-21-Zent2u-announcement-successfull-development-completion-of-Metformin",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "05-28-21-Zent2u-announcement-successfull-development-completion-of-Metformin"
    ]
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "8CAB2DD4CAF443B8A8C11E291297B718-en",
    "tags": [
      "IT"
    ],
    "publish_date": "2021-02-17T23:00:00Z",
    "language": "en",
    "name": "2020-02-18-Zentiva-scales-with-Microsoft-Azure",
    "subtitle": "",
    "title": "Global pharmaceutical manufacturer Zentiva scales ERP capabilities with SAP S/4HANA on Azure",
    "content_title": "Global pharmaceutical manufacturer Zentiva scales ERP capabilities with SAP S/4HANA on Azure",
    "content_text": "With a global reach that extends to more than 30 countries, Zentiva is a fast-growing pharmaceutical company. To keep delivering high-quality, affordable medicines and make them accessible to even more people, it needed a platform that could keep up with its continuous growth. So, the company decided to consolidate everything into the cloud. By deploying SAP on Azure, a large-scale project realized by the technology partner Atos, Zentiva now boasts a scalable and cost-effective enterprise resource planning (ERP) platform that offers unmatched agility and resilience.\n&ldquo;We now have a future-ready and flexible IT environment to help us optimize, scale and expand our footprint.&rdquo; Josef Matousek, Head of IS Zentiva\nHeadquartered in Prague and with manufacturing sites and R&amp;D centers spread across the globe, Zentiva employs more than 4,500 people. Yet, its fragmented, on-premises IT environment began to drain company time and resources, putting a wrench in its ambitious growth prospects and, more importantly, jeopardizing its mission to deliver high-quality, affordable branded generics and over-the-counter products.\n\n\"We needed a scalable, multi-country solution covering processes in areas spanning from production planning to finance and controlling,&rdquo; explains Josef Matousek, Head of IS at Zentiva. &ldquo;As Microsoft has been a strategic partner of Zentiva for over two decades, and they&rsquo;ve given us our cloud-first approach, Azure was naturally our number one choice for our SAP deployment,&rdquo; he adds. \n&ldquo;There are many design options when building an SAP S/4HANA environment in Azure, so we also needed experts who have knowledge of both Azure and SAP. Atos&rsquo; expertise proved critical in implementing SAP S/4HANA on Azure, providing innovative ideas and clear guidance on designing the solution that would best fit us,&rdquo; says Matousek.\nBringing down complexity and beefing up security \n&ldquo;Today, our SAP cluster solution is all within a single Azure region connected through a low-latency network. This helped us reduce complexity and optimize costs, as we can easily monitor and adjust our consumption to our needs and at any time through a pay-as-you-go model,&rdquo; explains Matousek. \nThe company&rsquo;s data privacy needs were addressed through Microsoft&rsquo;s comprehensive set of compliance offerings and strengthened with Azure Security Center. Zentiva also keeps track of its IT environment apps performance using Azure Monitor.  &ldquo;Thanks to a single sign-on with multi-factor authentication through Azure Active Directory, we&rsquo;ve also facilitated access for our IT officers while dramatically improving our security,&rdquo; highlights Matousek.\nA future-proof, partner-friendly technology\nWithin Azure, Zentiva enjoys access to innovative solutions such as big data capabilities and IoT platforms, enabling it to keep pace with the latest technological progress. &ldquo;All these new technologies are rolled out in a very short time which is crucial for us. We need to accelerate the pace, so do our supporting processes. We now have a future-ready and flexible IT environment to help us optimize, scale, and expand our footprint,&rdquo; Matousek enthuses.\nZentiva is poised for a new era of innovation. &ldquo;SAP S/4HANA on Azure offered us the ERP capabilities we wanted with the security, availability and resiliency we needed to develop our business, but it&rsquo;s also given us the speed and confidence to embrace the future with excitement,&rdquo; Matousek concludes.\n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/2020-02-18-Zentiva-scales-with-Microsoft-Azure",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "2020-02-18-Zentiva-scales-with-Microsoft-Azure"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/ZentivaMicrosoftAzure.jpeg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "6E96FB7E14CB49B598C6DF4D22ED7652-en",
    "tags": [
      "People & Culture",
      "Career"
    ],
    "publish_date": "2021-03-04T23:00:00Z",
    "language": "en",
    "name": "2020-03-9-Zentiva-SUPERPOWERZ",
    "subtitle": "",
    "title": "Discover our six SuperpowerZ from Zentiva",
    "content_title": "Discover our six SuperpowerZ from Zentiva",
    "content_text": "\n\n\n\n\n\n\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/2020-03-9-Zentiva-SUPERPOWERZ",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "2020-03-9-Zentiva-SUPERPOWERZ"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/MicrosoftTeams-image.png?h=496&iar=0&w=1081"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "32C3441F2B644EE885D25A23E8060F50-en",
    "tags": [
      "Awards & Recognition",
      "Career",
      "People & Culture"
    ],
    "publish_date": "2021-02-14T23:00:00Z",
    "language": "en",
    "name": "2021-02-15-Zentiva-top-employer-6th-time",
    "subtitle": "",
    "title": "Zentiva rewarded for the 6th time in a row as top employer in the Czech Republic",
    "content_title": "Zentiva rewarded for the 6th time in a row as top employer in the Czech Republic",
    "content_text": "PRAGUE &ndash; February 15, 2021: For the sixth time, Zentiva has been selected as the most prestigious employer in the pharmaceutical and healthcare industry in the Czech Republic, as part of a regular study TOP Employers. In addition, Zentiva ranked first place in the special category \"PHARMACIST &amp; DOCTOR\" for the fifth time in a row.\n\nThis year, the study celebrated its jubilee 10th year, which took place under the auspices of the Ministry of Industry and Trade, the Ministry of Labour and Social Affairs, the Ministry of Education and the GfK agency. The ranking of the most popular companies and institutions is compiled on the basis of voting by the Association of Students and Graduates among students of Czech universities, where the ranking in the category \"Pharmacy and Healthcare\" is determined on the basis of feedback from students of pharmaceutical and medical faculties. The awards in the special category are then chosen by the students with the best study results. The aim of the study is to identify those companies where young talented people want to start and develop their careers.\n\n\"We are very proud to have once again won these awards in the home-country of Zentiva that recognize our efforts to develop young talents. We believe that our commitment has a valuable impact on future careers of the Generation Z. Personally, I appreciate a lot working with young people as both sides can learn from each other. For us it is a prestigious award, as the feedback comes directly from the students themselves. At Zentiva we strive to be a great place to work and we are proud of every member of our Winning Team,&ldquo; comments Ines Windisch, Head of Corporate Affairs and Human Resources.\n\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. \nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/2021-02-15-Zentiva-top-employer-6th-time",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "2021-02-15-Zentiva-top-employer-6th-time"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/2021-02-15_Top_Employer.jpg?h=498&iar=0&w=1500"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "CA98D94B07A64CA39265BABB5342BAF6-en",
    "tags": [
      "Awards & Recognition",
      "Science",
      "Career",
      "Partnerships"
    ],
    "publish_date": "2021-02-25T23:00:00Z",
    "language": "en",
    "name": "2021-02-26-ZENTIVA-ANNOUNCES-WINNERS-OF-AWARDS",
    "subtitle": "",
    "title": "Zentiva announces the winners of  The Parc awards",
    "content_title": "Zentiva announces the winners of  The Parc awards",
    "content_text": "PRAGUE - February 26, 2021 - The Centre for Applied Pharmaceutical Research (The Parc), which was founded by Zentiva in cooperation with leading Czech academic institutions, is celebrating numerous successes again, summarizing its 2020 achievements and recognizing the participants with The Parc Awards for the third time\nIn 2020 The Parc continued its mission to provide young talented researchers with a world-class education and collaboration with professionals working to accelerate drug innovation and research. The international platform welcomed 11 new students into the program extending the number of participants to record 38 doctoral students. The participants achieved impressive results last year, including the completion of 12 professional publications and receiving a prestigious InPharma grant &ndash; an EU-funded MSCA (Marie Sklodowska Curie Actions) European Industrial Doctorate programme. Three students finalized their studies and one founded a technological start-up. The Parc also extended in 2020 the network of collaborating universities in Europe.\n&ldquo;Our achievements rocked science in 2020. I am proud of every student in The Parc and I would like to thank all the supervisors from Zentiva and the academia for the student&rsquo;s supervision and enthusiasm to solve current challenges in pharmaceutical science together. The Parc&acute;s research clearly addresses the key challenges the pharma industry is facing today and its results are directly applied in the new products development and manufacturing&rdquo; &ndash; said Ondrej Dammer, The Parc&rsquo;s Operational Director.\nFor the third time, The Parc doctoral students were awarded The Parc Awards in two categories. Tereza Boleslavsk&aacute; won The Student Choice Award for her project on &ldquo;Development of biorelevant in vitro dissolution method&rdquo; while the second Student award went to Jan Jir&aacute;t for &ldquo;Crystal design and crystallization process development&rdquo; and the third Student prize was awarded to Jakub PetÅ™&iacute;k for his work on &ldquo;Forced degradation study system development&rdquo;. The Expert Choice Award went to JiÅ™&iacute; Kol&aacute;Å™ for his work &ldquo;Mathematical modeling of unit operations in pharmaceutical formulation processes&rdquo;. \nProf. Franti&scaron;ek &Scaron;tÄ›p&aacute;nek, The Parc&rsquo;s Scientific Director commented: &ldquo;I would like to congratulate the winners and all the students for their 2020 research studies and results. At The Parc we continue to provide a bridge between excellent basic research in pharmaceutical sciences and its translation to real pharmaceutical products that can be clinically tested, registered, and manufactured. Through collaboration with the best academic institutions across the EU our platform provides its Ph.D. students with the opportunity to gain first-hand experience of both academic and industrial R&amp;D environment, thus broadening their future career prospects. It is great to acknowledge that The Parc alumni launch successful careers not only in the pharmaceutical industry and academic institutions across Europe, but this year also the first technological start-up company was founded by one of our graduates.&rdquo;\nZentiva strongly believes that supporting students by bridging the gap between theoretical science and what happens in the real-life in pharma will have a valuable impact on the future careers of young people, especially members of the Z generation in the Czech Republic. The high quality of the students&rsquo;  program and its practical benefits were also recognized by Prime Minister Andrej Babi&scaron; during his visit to The Parc last September.\n&ldquo;From the superb quality of research receiving this year&acute;s awards, it is clearly visible that the Parc is already fulfilling its mission to build a strong foundation for further growth of the pharmaceutical industry in the Czech Republic.  The unique combination of world-class academic education with practical hands-on industrial and business experience in The Parc clearly shows a functional and successful example of how to speed up the transfer of academic research into practical applications in the industry, boost the research and development activities in the companies and prepare the next generation of scientists and engineers to be ready at their graduation to tackle the industrial challenges of the future. The Parc shows one of the ways we can really deliver on the &ldquo;country for future&rdquo; strategy of the Czech Republic&rdquo; - summarized Pavel Sebek, Zentiva's Development Director and one of the founders of The Parc.\nAbout The Parc\nInitiated by Zentiva, The Parc was created in association with three academic partners: the University of Chemistry and Technology Prague; the Faculty of Science of Charles University; and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. This highly successful initiative has brought rising talent together with leading pharmaceutical and academic experts, all working to accelerate innovation in drug research &amp; development.\nThe Parc provides world-class academic education combined with practical hands-on industrial and business experience under the leadership of scientists, engineers, and managers both from academia and the pharmaceutical industry. It enables students to gain graduate-level training in pharmaceutical sciences bridging chemistry, pharmaceutical technology, bio pharmacy, and clinical research. Results of the students&rsquo; research are frequently directly implemented in real-world products launched to the market to help patients. Collaborating with academic partners across Europe, The Parc also offers secondments for students and research experience exchanges supervised by top academic scientists.\nMore information about The Parc can be found on www.theparc.eu.\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on.\nMedia contact:\nMounira Lemoui\nVedouc&iacute; komunikace\nZENTIVA GROUP, a.s.\nU Kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Praha 10\nTlf.+420 727 873 159\nE-mail: mounira.lemoui@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/2021-02-26-ZENTIVA-ANNOUNCES-WINNERS-OF-AWARDS",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "2021-02-26-ZENTIVA-ANNOUNCES-WINNERS-OF-AWARDS"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/The_Parc_Article.jpg?h=498&iar=0&w=1500"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "0F58B522C469413A9212E775D411FC5F-en",
    "tags": [
      "Partnerships",
      "Science"
    ],
    "publish_date": "2021-03-11T23:00:00Z",
    "language": "en",
    "name": "2021-03-12-Zentiva-The-Parc-Incubator",
    "subtitle": "",
    "title": "Discover The Parc | Pharmaceutical Applied Research Center",
    "content_title": "Discover The Parc | Pharmaceutical Applied Research Center",
    "content_text": "At Zentiva, we strongly believe that supporting students by bridging the gap between theoretical science and what happens in real-life in pharma has a valuable impact on their future careers.\nThat is why we are very proud to support The Parc, a talent incubator that provides young talented researchers with a world-class education and collaboration with professionals working to accelerate drug innovation and research in an inspiring environment.\nYou can get more insights on The Parc's mission in the video below : \n",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/2021-03-12-Zentiva-The-Parc-Incubator",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "2021-03-12-Zentiva-The-Parc-Incubator"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/The_Parc_Logo_Article.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "CD8994CEEFDF4E95A68DD1CCEE23E644-en",
    "tags": [
      "Impact",
      "Climate",
      "Sustainability"
    ],
    "publish_date": "2021-03-23T23:00:00Z",
    "language": "en",
    "name": "2021-03-24-Zentiva-to-plant-27800-trees-madagascar",
    "subtitle": "",
    "title": "Zentiva accelerates its carbon-neutral â€œPlanetZâ€ program by planting a further 27,800 trees in Madagascar and Romania",
    "content_title": "Zentiva accelerates its carbon-neutral â€œPlanetZâ€ program by planting a further 27,800 trees in Madagascar and Romania",
    "content_text": "PRAGUE &ndash; March 24, 2021: On the occasion of the International Day of Forests, Zentiva  approved the planting of 27,800 trees: 20,000 to be planted in Romania in April, and 7,800 in Madagascar. This new step is part of the PlanetZ program which aims to make a continuous and positive contribution to our environment. Zentiva is partnering with the NGOs Planet Urgence and Carpathia Conservation Foundation. The trees are planted in Itasy and Analamanga regions (Madagascar) and FÄƒgÄƒraÈ™ Mountains (Romania).\n\nIn addition to reducing carbon footprint, these two initiatives will also provide additional sources of income for local communities. In Madagascar, recovering wild silk trees protects biodiversity and enhances the local economy. In Romania, the project that is restoring the areas affected by deforestation is carried out with employees from neighboring localities. \n\nNick Haggar, Chief Executive Officer Zentiva commented: &ldquo;The Zentiva team of 4,500 associates is very engaged with our PlanetZ sustainability program. Our ambition is to plant 150,000 trees as part of our carbon-neutral program. We all share this beautiful planet and we all have the responsibility to take care of it. Zentiva has already switched its European manufacturing operations to renewable energy one year ago, and we continue to work on a wide range of environment, social care and governance projects.&rdquo;\n\nThe initiatives build on previous Zentiva PlanetZ collaborations in Romania with Forests Without Frontiers which saw 7,000 trees planted in 2019 and April 2020, and in Portugal with ANEFA which saw 4,500 trees planted.\n\n\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Learn more about Zentiva.com \nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/2021-03-24-Zentiva-to-plant-27800-trees-madagascar",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "2021-03-24-Zentiva-to-plant-27800-trees-madagascar"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/Zentiva-PlanetZ-program-planting-trees-Madagascar-Romania-news.jpeg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "FBD5F24FB87A4727948DCBF50CA505CF-en",
    "tags": [
      "Impact",
      "Manufacturing",
      "Product Portfolio"
    ],
    "publish_date": "2021-03-24T23:00:00Z",
    "language": "en",
    "name": "2021-03-25-production-record-prague-site",
    "subtitle": "",
    "title": "Production Record for Zentivaâ€™s Prague Site",
    "content_title": "Production Record for Zentivaâ€™s Prague Site",
    "content_text": "MAXIMISING THE SUPPLY OF MEDICINES IS MORE IMPORTANT THAN EVER, AS ZENTIVA RESPONDS TO PATIENT NEEDS ACROSS EUROPE\n \nPRAGUE &ndash; March 25, 2021: Zentiva, the largest manufacturer of medicines in the Czech Republic, produced 129 million  of medicines in 2020. This is an all-time-high since founding the site more than 90 years ago. \n\n&ldquo;We are united in our ambition to maximize our output and to ensure the supply of high-quality and affordable medicines to the people that rely on our products every day. We are conscious of the responsibility we have and we are joining forces with healthcare professionals, pharmacists, and health system decision-makers to fight against COVID-19 and navigate the crisis. As a company we acted fast and flexibly, adapted and increased our production activity, and created a safe environment for our people who have to come to our Zentiva campus to keep Development and Production activities ongoing&rdquo;, says Denis Paris, Head of Prague Site.\n\nZentiva&rsquo;s Prague Site produces tablets, hospital injectables medicines, ointments, hormones, eye drops, and suspensions. It is now the 3rd year in a row that Zentiva Prague increased its production capacity. 1 out of 5 prescribed products in the Czech Republic produced by Zentiva. The site is producing medicines used in intensive care units, life-saving medicines and a wide portfolio that help patients with chronic and acute conditions. During the first phase of the COVID-pandemic, SANICOR, a disinfection solution and spray was also added to the portfolio to help reduce virus transfer on the hands and surfaces. \n\nDenis Paris: &ldquo;We had to significantly change the way we operate. Thanks to the engagement and the trust of our people we could make it happen and today we are stronger than ever. There is a high commitment of the company to further invest into our home country, where we employ 1.500 people working in Development, our Manufacturing Site, our Commercial Organization and at our Headquarters.&rdquo;\n\nZentiva&rsquo;s roots reach back 530 years to the Black Eagle pharmacy, a small business that served the people of Prague. We are very proud that the heart of business is in the Czech Republic and have a strong investment programme underway allowing for further expansion and the creation of new employment opportunities.\n\n \n\n\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Learn more about Zentiva.com \nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/2021-03-25-production-record-prague-site",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "2021-03-25-production-record-prague-site"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/PR_Production-record-Prague-siote.jpeg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "B04257A464C74F7091FB5C3979FD3ABD-en",
    "tags": [
      "Impact",
      "Charity",
      "Partnerships"
    ],
    "publish_date": "2021-03-30T22:00:00Z",
    "language": "en",
    "name": "2021-03-31-Sanicor-250000-packs-czech-food-banks",
    "subtitle": "",
    "title": "Zentiva partners with Czech food banks to help at risk citizens. Supply of 250.000 packs of Sanicor disinfectant to ensure hygiene and personal disinfection",
    "content_title": "Zentiva partners with Czech food banks to help at risk citizens. Supply of 250.000 packs of Sanicor disinfectant to ensure hygiene and personal disinfection",
    "content_text": "Prague - March 31, 2021 &ndash; Zentiva passed over 250,000 packs of its Sanicor disinfectant to Czech Food banks for a symbolic price. Food banks will further distribute the Sanicor disinfectant to people in need and vulnerable groups, such as shelters, single mothers, and outreach clients.\nThe idea was supported by the Ministry of Labor and Social Affairs.\n\n\"Zentiva approached us with a request for recommendations on where to meaningfully direct its offer. We have been cooperating with Food banks for a long time and their support is more than appropriate in the current situation. Therefore, we decided to recommend this organization. The Food bank can get help to those most in need very quickly through his partners\" concludes Mgr. Martina &Scaron;tÄ›p&aacute;nkov&aacute;, MPA, Deputy Minister of Labour and Social Affairs.\n\nSanicor Disinfection will be supplied in two sizes, 50ml and 500ml intended for direct distribution to individuals, and larger packages can then be used in common areas of shelters, contact centers, etc. The symbolic price corresponds to 0.01 CZK smaller package and CZK 0.10 for larger.\n\n\"As part of our #WeHelpOthers Programme Zentiva wanted to help the most endangered groups in the Czech Republic within our capabilities in the current urgent epidemiological situation. Because we want to target where this need is the most urgent, we decided to contact the Ministry of Labor and Social Affairs for advice. We are very pleased that the Ministry has directed us, opening the door for further potential cooperation with Food bank, \"comments SoÅˆa Porubsk&aacute;, General Manager of Zentiva CZ&amp;SK.\n\nThe aim is to support all those who do not have access to disinfectants or hygiene products and protective equipment in the current situation. Together with Food banks, we managed to select specific institutions throughout the Czech Republic, through which personal disinfection of Sanicor will reach the most endangered clients. This will help them in their daily protection against viruses and bacteria.\n\n\"The number of people in need is constantly growing, our customer organizations work with them daily and try to help them as much as possible. They often lack the money to satisfy even the most basic human needs. Disinfection or special hygiene is not available for most of them. We appreciate that Zentiva is helping us. We will now get as quickly as possible to those who need it the most,\" adds Mgr. Veronika L&aacute;chov&aacute;, Director of the Czech Federation of Food Banks.\n\nThis activity will be further supported by a private carrier, the company PROfreight CZ, s.r.o., which will ship Sanicor Zentiva disinfection to food banks throughout the Czech Republic pro bono.\nMgr. Petra H&aacute;jkov&aacute; - Head of Communications of the Ministry of Labour and Social Affairs | Mgr. Martina &Scaron;tÄ›p&aacute;nkov&aacute;, - MPA Deputy Minister of Labour and Social Affairs | Mgr. Veronika L&aacute;chov&aacute; - Director of the Czech Federation of Food Banks | SoÅˆa Porubsk&aacute; -  General Manager Zentiva CZ&amp;SK | Zuzana Nov&aacute;kov&aacute; - OTC Lead at Zentiva CZ &amp; SK\n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2021/2021-03-31-Sanicor-250000-packs-czech-food-banks",
    "url_detail": [
      "news",
      "newsroom",
      "2021",
      "2021-03-31-Sanicor-250000-packs-czech-food-banks"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2021/2021-03-31-Sanicor-250000-packs-czech-food-banks-1080.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "Zentiva Acquires Central and Eastern European Business of Alvogen",
    "type": "News Article",
    "id": "E43FD10EBEAE4B52A122D6840A4DF768-en",
    "tags": [
      "Partnerships",
      "Awards & Recognition",
      "Career",
      "Science"
    ],
    "publish_date": "2020-01-26T23:00:00Z",
    "language": "en",
    "name": "2020-01-27-celebrating-the-parc-impressive-2019-track-record",
    "subtitle": "",
    "title": "Zentiva celebrates The Parcâ€™s impressive scientific track record in 2019",
    "content_title": "Zentiva celebrates The Parcâ€™s impressive scientific track record in 2019",
    "content_text": "PRAGUE &ndash; January 27, 2020: Zentiva welcomed The Pharmaceutical Applied Research Center (The Parc) to their Prague headquarters to celebrate the first anniversary of The Parc Awards. The Parc is a unique research platform designed to prepare future generations of pharmaceutical scientists and engineers. Twenty-nine students are currently included in the program and an outstanding track record has been achieved in 2019: 16 publications, one patent application, 30 conference presentations, six plenary and keynote lectures, eight research grants and five students finalized their studies.\n&ldquo;2019 was a hugely successful year. I&rsquo;d like to clearly emphasize the energy all our partners bring to the project. We now have 29 PhD students in the program and what is really important is the joint supervision students receive from both scientific/academic and industrial supervisors. This creates a unique combined industrial-academic environment which is the strength of The Parc for 2020 and the future,&rdquo; says Ondrej Dammer, The Parc&rsquo;s Operational Director. \nProf. Franti&scaron;ek &Scaron;tÄ›p&aacute;nek, The Parc&rsquo;s Scientific Director added, &ldquo;I feel very proud, especially of the students. I have had the opportunity to see them develop over several years from being young undergraduates joining The Parc to becoming Master&rsquo;s graduates and then joining the PhD program. It is really satisfying to see the progress that they have made, both as individuals, as professionals and, of course, as scientists.&rdquo;\nThis year, The Parc Awards went to two young talents. Denisa Lizonova was awarded the Student Choice Award 2019 for her project on &lsquo;Modified Liposomes for Drug Delivery&rsquo; and Vojtech Klimsa received the Expert Choice Award 2019 for his work on &lsquo;High Throughput Screening of Spray Dried Formulations&rsquo;. Both awards are sponsored by Zentiva.\nPavel Sebek, Zentiva's Development Director and one of the founders of The Parc recalled its history and growth from an idea born 5 years ago: &ldquo;We are so proud of what has been achieved to date. The combination of top-level science training combined with the development of industrial, business and leadership skills is not only unique but recognized across Europe. The future is in the hands of our young and creative cluster of students who have the ambition and skills to be at the top of pharmaceutical science and technology and are energized to make a difference in the pharma world. What makes me especially proud is that some of the students have decided to work for Zentiva after completing The Parc program and have become valuable members of our international development team.&rdquo;\nAbout The Parc\nInitiated by Zentiva, The Parc was created in association with three academic partners: the University of Chemistry and Technology Prague; the Faculty of Science of Charles University; and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. This highly successful initiative has brought rising talent together with leading pharmaceutical and academic experts, all working to accelerate innovation in drug research &amp; development.\nThe Parc provides world class academic education combined with practical hands-on industrial and business experience under the leadership of scientists, engineers and managers both from academia and the pharmaceutical industry. It enables students to gain graduate-level training in pharmaceutical sciences bridging chemistry, pharmaceutical technology, biopharmacy and clinical research. Results of the students&rsquo; research are frequently directly implemented in real world products launched to market to help patients. Collaborating with academic partners across Europe, The Parc also offers secondments for students and research experience exchanges supervised by top academic scientists.\nMore information about The Parc can be found on www.theparc.eu. \nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 3,000 people and a network of production sites - including flagship sites in Prague and Bucharest &ndash; Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.\nLearn more about Zentiva on www.zentiva.com.\nMedia Contact:\nInes Windisch\nHead of Corporate Affairs &amp; Human Resources \nTel: (+420) 601 341 444\nEmail: ines.windisch@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-01-27-celebrating-the-parc-impressive-2019-track-record",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-01-27-celebrating-the-parc-impressive-2019-track-record"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/2020-01-27_The_Parc_A.png?h=860&iar=0&w=1294"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "86B663FEA6D54AED8C1F4FCBF658B1C9-en",
    "tags": [
      "Impact"
    ],
    "publish_date": "2020-03-18T23:00:00Z",
    "language": "en",
    "name": "2020-03-19-Coronavirus-Update",
    "subtitle": "",
    "title": "Zentiva, acting responsibly during the Coronavirus (COVID-19) outbreak",
    "content_title": "Zentiva, acting responsibly during the Coronavirus (COVID-19) outbreak",
    "content_text": "During this pandemic crisis, Zentiva has two main responsibilities: continue to supply the medicines people depend on every day and protect and guarantee the safety of our employees.\nSince the new coronavirus (COVID-19) epidemic was announced, we have been taking every necessary action to prevent the spread of the disease within our offices and manufacturing sites. \n\nThe Zentiva network of manufacturing facilities, with flagship sites in Prague and Bucharest, works at full capacity. To meet the growing needs of healthcare systems during these particular times, we have adapted our production of paracetamol and ibuprofen (two molecules against fever to fight the disease's symptoms): \n\n\n    \n    our Prague site is producing a million more units of ibuprofen and paracetamol,\n    \n        in addition to the efforts of our Prague manufacturing team, our Bucharest site has also decided to adapt its plans by tripling its production of paracetamol.\n    \n\n\nWe are using digital tools to stay connected and remain in constant contact with our partners - wholesalers and pharmacy chains. \nPreventing the spread of the virus is everyone's responsibility. That is why we also have introduced additional safety measures and hygiene solutions and reinforced education on protection against infection within our employee population.\n \n \n\n\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-03-19-Coronavirus-Update",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-03-19-Coronavirus-Update"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/2020-03-19_Coronavirus-Update.jpg?h=498&iar=0&w=1500"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "250BCC2B6C454780B800ECAD770051B2-en",
    "tags": [
      "Impact",
      "Manufacturing",
      "Partnerships"
    ],
    "publish_date": "2020-03-25T23:00:00Z",
    "language": "en",
    "name": "2020-03-26-Zentiva-Sanitizer",
    "subtitle": "",
    "title": "Zentiva starts production of sanitizer to help the Czech Republic fight against coronavirus",
    "content_title": "Zentiva starts production of sanitizer to help the Czech Republic fight against coronavirus",
    "content_text": "Zentiva supports Czech Republic by producing sanitizer branded Anti-COVID to further help reducing the spread of Covid-19.\n\n\"Zentiva will supply the first batches of Anti-COVID to pharmacies in the Czech Republic within upcoming days,&ldquo; said Sona Porubska, Head of Zentiva Czech Republic &amp; Slovakia &ldquo;We will support our healthcare system where is needed. We hope that with this new product we can contribute to further protect all people,&rdquo; she added.\nDenis Paris, Prague Site Head, said: &ldquo;Thanks to our highly skilled pharmaceutical expertise we are glad to offer a more than 80% alcohol-based spray sanitizer.Its liquid formulation allows a usage not only for hand sanitization but as well all personal items and surface you can be exposed to (handrail, holder in public transport, door handles etc.)&rdquo; \nDenis added: &ldquo;Our Zentiva team in Prague is working hard 24 hours a day, 7 days a week to produce medicines for patients in the Czech Republic and across Europe. We are constantly adapting our production plan to meet the needs. I would like to take this opportunity and thank the whole development and production teams for their incredible efforts and speed in delivering this new product in a time of population need.&rdquo;\nPavel Sebek, Head of Development Center: \"It is our responsibility to help in the fight against the virus and we are working in close cooperation with the Czech government. As we are hosting Development, Manufacturing and Commercial Units in the Czech Republic we are able to join forces quickly and adapt if needed. \n&rdquo;Our development center in Prague is focused on development of generic and added value medicine and supports as well The PARC, a graduate level training and research center, preparing next generation of pharmaceutical scientists and engineers.\nOur Prague Production Site manufactures high quality and affordable products that people depend on every day for more than 90 years. We are producing more than 100 million packages per year.",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-03-26-Zentiva-Sanitizer",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-03-26-Zentiva-Sanitizer"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/2020-03-26_Zentiva_Sanitizer.jpg?h=498&iar=0&w=1500"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "6A3974A39B2148AEB9CE01D83895265B-en",
    "tags": [
      "M&A",
      "Growth",
      "Product Portfolio",
      "CEO"
    ],
    "publish_date": "2020-04-06T22:00:00Z",
    "language": "en",
    "name": "2020-04-07-acquisition-from-Alvogen",
    "subtitle": "",
    "title": "Zentiva extends commercial footprint by completing acquisition of CEE business from Alvogen",
    "content_title": "Zentiva extends commercial footprint by completing acquisition of CEE business from Alvogen",
    "content_text": "PRAGUE &ndash; April 7, 2020: Zentiva Group a.s. confirms the closing of its previously declared acquisition of Alvogen&rsquo;s Central and Eastern European (CEE) business. The deal adds to Zentiva&rsquo;s continuing organic growth, reinforcing Zentiva&rsquo;s commercial footprint in Poland, Romania and Bulgaria, and expanding its presence into additional new markets including Russia, Ukraine, Kazakhstan, Hungary, Croatia and West Balkans. As a result, Zentiva can now deliver an expanded product portfolio to millions more people across Europe and beyond.\n&ldquo;With this acquisition, we bring together two of the leading branded generic and OTC businesses in the CEE region,&rdquo; said Nick Haggar, Chief Executive Officer of Zentiva. &ldquo;Our strengths and product portfolios complement each other perfectly, in line with Zentiva&rsquo;s growth strategy. With our continued expansion into new markets and our winning team, we can deliver more high-quality and affordable medicines that people need every day.&rdquo;\nAlongside the recently announced acquisition of the manufacturing site in Ankleshwar, expected to be finalized in the coming weeks, this acquisition also expands Zentiva&rsquo;s production capacity with the Labormed Alvogen site in Bucharest, Romania.\nThis latest development builds on recent commercial acquisitions of Creo in the UK and Solacium in Romania and multi-million Euro investments in Zentiva&rsquo;s existing production facilities in Prague and Bucharest.\n&ldquo;Alvogen CEE markets over 200 branded generic and OTC products across multiple therapeutic areas, consisting of highly-recognized brands like Lactacyd&reg;, Persen&reg;, EuBiotic&reg; and many more with leading market positions in 14 key countries across CEE,&rdquo; said Hacho Hatchikian, newly appointed Head of Commercial CEE Region, Zentiva. &ldquo;To join Zentiva is a great opportunity to become part of one of the leading companies in Europe, expand our footprint, and advance operational excellence, all dedicated to meeting the healthcare needs of millions of people.&rdquo;\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,000 people and a network of production sites - including flagship sites in Prague and Bucharest - Zentiva strives to be the champion of branded and generic medicines and OTC products in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.\nLearn more about Zentiva on www.zentiva.com.\nMedia Contact:\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nCell: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-04-07-acquisition-from-Alvogen",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-04-07-acquisition-from-Alvogen"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/2020-04-07_Nick_Haggar.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "281071EE36CA436F8DCA829B51E5288E-en",
    "tags": [
      "Impact",
      "Partnerships"
    ],
    "publish_date": "2020-04-08T22:00:00Z",
    "language": "en",
    "name": "2020-04-09-zentiva-ikea-joining-forces-to-fight-covid-19",
    "subtitle": "",
    "title": "Zentiva and IKEA are joining forces to fight the COVID-19 pandemic",
    "content_title": "Zentiva and IKEA are joining forces to fight the COVID-19 pandemic",
    "content_text": "PRAGUE &ndash; April 9, 2020: Zentiva Group, a.s. announces the agreement with IKEA to cooperate during the COVID-19 crisis. As part of this collaboration, Zentiva Romania will temporarily employ 18 employees from IKEA Romania for 3 months to sustain the production of medicines supply following the increasing demand. \n\n\n&ldquo;At Zentiva we are doing everything in our power to help authorities fight COVID-19. Zentiva is working on several projects in Europe and beyond to ensure medicines supply and to protect people. That is why we welcome IKEA&rsquo;s initiative with open arms. They will be joining our current efforts in our mission to produce much-needed medicines for patients. We are confident that this type of cooperation can be replicated across the economy and help employees from fields that have restricted activity during this period&rdquo; said Margareta Tanase, Head of Bucharest Production site, Zentiva Romania. \n\n\n&ldquo;To support the measures to stop the spread of the pandemic, we have closed all of our stores and pick up points since March 20, 2020. Until life gets back to normal and we are again able to welcome our customers back to our stores, we have offered our co-workers a possibility to join, voluntarily, other companies that are manufacturing and distributing different supplies, essential to fight the ongoing pandemic crisis. We are happy to announce that the first group of 18 IKEA Romania workers joined Zentiva Romania. We are thankful to our co-workers for living up to the IKEA values of togetherness and care for people&rdquo;, stated Violeta Nenita, Market Manager, IKEA Romania\n\nCOVID-19 is a global pandemic that needs a consistent global response. That is why Zentiva and IKEA are looking at extending this partnership to other countries to support the fight against the virus.\n \nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,000 people and a network of production sites - including flagship sites in Prague and Bucharest - Zentiva strives to be the champion of branded generic medicines and OTC products in Europe to better support people&rsquo;s daily healthcare needs.\n\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on.\n\nLearn more about Zentiva on www.zentiva.com\nAbout IKEA\nINGKA Group is the world leader in home furnishing retail. We are a value-based company with a passion for life at home. Our vision is to create a better everyday life for the many people, by offering a wide range of good design, functional and sustainable home furnishings, at prices so low that most people can afford them. INGKA Group owns and operates 367 stores in 30 countries (31 August 2018). The IKEA Baneasa store was the 253rd opened on March 21st, 2007 in a local franchise. In March 2010, IKEA Romania became part of the INGKA Group, inside the South-East Europe organization also covering Croatia, Slovenia, and Serbia. In the financial year 2018 (September 1st, 2017 - August 31st, 2018), the IKEA store in Romania was visited by 3.2 million people and 18 million unique visitors visited the site www.IKEA.ro. On June 24, 2019, the company opened IKEA Pallady - the biggest store in South-East Europe and the 431st in the world.\nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nCell: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com\n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-04-09-zentiva-ikea-joining-forces-to-fight-covid-19",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-04-09-zentiva-ikea-joining-forces-to-fight-covid-19"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/ZentivIkea1084.jpg?h=498&iar=0&w=1085"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "3AA13BB7C3634FBF82865B37E3166304-en",
    "tags": [
      "M&A",
      "Manufacturing",
      "Growth",
      "CEO"
    ],
    "publish_date": "2020-05-31T22:00:00Z",
    "language": "en",
    "name": "2020-06-01-Zentiva-expands-production-capacity",
    "subtitle": "",
    "title": "Zentiva expands production capacity by completing acquisition of Ankleshwar manufacturing site",
    "content_title": "Zentiva expands production capacity by completing acquisition of Ankleshwar manufacturing site",
    "content_text": "PRAGUE &ndash; June 1, 2020: Zentiva Group announces the completion of its acquisition of a manufacturing site in Ankleshwar, India, from Sanofi. The finalization of the deal increases the number of wholly-owned Zentiva production sites worldwide and will enable Zentiva to serve more people who are in daily need of our high quality, affordable medicines.\n&ldquo;We are delighted to welcome the Ankleshwar team into our Zentiva family. We are continuing to deliver strong growth at Zentiva and the completion of this acquisition is an important milestone for our company,&rdquo; said Nick Haggar, Chief Executive Officer of Zentiva. &ldquo;The strength of our growing manufacturing network and additional capacity means we can keep pace with the accelerating demand for our medicines and increase our direct control over our supply chain to help ensure continuous supply and rapid response to patient needs.&rdquo;\nThe transaction continues the flow of decisive growth moves made by Zentiva, building on earlier acquisitions of Creo Pharma in the UK, Solacium in Romania and the Central and Eastern European operations of Alvogen completed in April 2020. This latest acquisition in India runs in parallel to the ongoing multiple multi-million Euro investments at Zentiva's flagship sites in Prague and Bucharest.\n&ldquo;I am so proud that our Ankleshwar team will be part of an even stronger Zentiva, integrated into the organization&rsquo;s long-term growth strategy,&rdquo; added Ashwani Sood, Head of the Ankleshwar site. &ldquo;We know demand for high quality and affordable medicines is increasing and we look forward to contributing to Zentiva&rsquo;s success on this journey.&rdquo;\nThe manufacturing site will be supported by a brand new Zentiva India affiliate office in Mumbai.\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,700 people and a network of production sites - including flagship sites in Prague, Bucharest and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on. \nAbout Zentiva&rsquo;s Ankleshwar site\nEstablished in 1987, the Ankleshwar manufacturing site has a chemistry and biotechnology development center, and manufactures both intermediates and pharmaceutical formulations. A large producer of tablets, the Ankleshwar site manufactures more than 6 billion tablets annually.\nMedia Contact:\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nCell: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-06-01-Zentiva-expands-production-capacity",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-06-01-Zentiva-expands-production-capacity"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/AKL-Site_Zentiva-2020.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "D1778931392848C6AC794782CCEB0B8A-en",
    "tags": [
      "Impact",
      "Manufacturing"
    ],
    "publish_date": "2020-07-28T22:00:00Z",
    "language": "en",
    "name": "2020-07-29-Zentiva-made-1-5-milion-desinfectants",
    "subtitle": "",
    "title": "Zentiva produces 1.5 million hand sanitizers in the Czech Republic to help fight COVID-19",
    "content_title": "Zentiva produces 1.5 million hand sanitizers in the Czech Republic to help fight COVID-19",
    "content_text": "Prague &ndash; July 29, 2020: One of the most effective ways to fight against COVID-19 is to regularly wash hands and disinfect. The Zentiva team in Prague wanted to do all they could to help protect the people of the Czech Republic, so they developed and produced a strong hand sanitizer and have just reached the 1.5-million-pack production milestone.  The hand sanitizer was developed, manufactured, and supplied to Czech citizens within 4 weeks of the first COVID protective measures being implemented. Zentiva has since donated over 250,000 hand sanitizers to hospitals, healthcare workers, key workers, and vulnerable citizens.   The hand sanitizers produced in Prague are now being used by people in 10 European Countries including Slovakia, Germany, and France.\nDenis Paris, Head of the Zentiva&rsquo;s manufacturing site in Prague: &ldquo;Zentiva is working every day to help protect the Czech people, and provide them with the medicines they need. I am proud of our exceptional team that worked throughout the first wave of COVID-19 infections to increase the supply of medicines while developing and launching a protective hand sanitizer in just four weeks.  I hope that the healthcare professionals and patients in Czech choose a Zentiva medicine whenever they can &ndash; as we are a Czech Manufacturing Company working day and night to support them.&rdquo;\nPrague produced 69 million packs of medicines in the first six months of 2020, it is a growth of 30% compared to 2019 and will invest over 300 million CZK in new technology and equipment to increase medicine supplies.\nSona Porubska, Head of Zentiva Czech Republic &amp; Slovakia: &ldquo;Our story started more than 500 years with a small pharmacy in Prague and we are proud of our roots and deep commitment to the Czech Republic. Today, we are the biggest supplier of generic medicines in the Czech Republic with a unique setup including an international R&amp;D center, huge manufacturing site, and a commercial team based in Prague. We are a Czech Company that serves the Czech people supplies the whole of Europe and beyond. We make a huge contribution to public health and that  begins with basic protection like being able to disinfect your hands&rdquo;.\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\n At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on.\nMedia Contact\nMounira Lemoui\nHead of Communications\nZENTIVA GROUP, a.s.\nU kabelovny 529/16, Doln&iacute; MÄ›cholupy, 102 00 Prague 10\nMobil: (+420) 727 873 159\nE-mail: mounira.lemoui@zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-07-29-Zentiva-made-1-5-milion-desinfectants",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-07-29-Zentiva-made-1-5-milion-desinfectants"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/2020-Zentiva-Prague-Site.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "AE14536A049F4A46950912CF05F26857-en",
    "tags": [
      "Awareness Days",
      "Impact"
    ],
    "publish_date": "2020-09-28T22:00:00Z",
    "language": "en",
    "name": "2020-09-29 World Heart Day 2020",
    "subtitle": "",
    "title": "Celebrating World Heart Day 2020",
    "content_title": "Celebrating World Heart Day 2020",
    "content_text": "Today is #worldheartday. At Zentiva, we use our heart to beat cardiovascular diseases! And we use our heart in everything we do. On this special day, let's all join the World Heart Federation to raise awareness about the importance of taking care of our hearts. Learn more on https://lnkd.in/dZu769a\n \n  \n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-09-29-World-Heart-Day-2020",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-09-29-World-Heart-Day-2020"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/2020-09-29_WHD_Bogdan.jpg?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "BD9255E26EBC44F092C7EB270CCFF2EE-en",
    "tags": [
      "Awards & Recognition",
      "Partnerships"
    ],
    "publish_date": "2020-10-05T22:00:00Z",
    "language": "en",
    "name": "2020-09-29 Zentiva Awards",
    "subtitle": "",
    "title": "Zentiva shortlisted for two 2020 GGB Awards",
    "content_title": "Zentiva shortlisted for two 2020 GGB Awards",
    "content_text": "Zentiva is honoured to be shortlisted in 2 categories for the 2020 Generics &amp; Biosimilars Bulletin Awards! We are extremely proud of our passionate people and of our strategy that places partnership at the heart of our business. Well done Team! Wish us luck and thanks to everyone supporting our exciting journey.\n\n#WinningTeam#PartnershipForSuccess#GGBawards2019\n \n  \n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-09-29-Zentiva-Awards",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-09-29-Zentiva-Awards"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2020/2020-10-06_Global_Generics_Awards.png?h=498&iar=0&w=1084"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "C4814DFCABFC4C1EBA014F0328BFC233-en",
    "tags": [
      "People & Culture"
    ],
    "publish_date": "2020-09-30T22:00:00Z",
    "language": "en",
    "name": "2020-10-1-birthday",
    "subtitle": "",
    "title": "Happy Anniversary ZENTIVA!",
    "content_title": "Happy Anniversary ZENTIVA!",
    "content_text": "THANK YOU to the whole Zentiva team for your Commitment and Passion during the past 2 years. Proud to deliver affordable, high-quality medicines to people across Europe and beyond every day. Let's keep joining forces towards a fantastic future for our company! #WeAreZentiva Click here: http://bit.ly/HBZentiva\n \n\n \n\n\n",
    "category": "Newsroom",
    "url": "/news/newsroom/2020/2020-10-1-birthday",
    "url_detail": [
      "news",
      "newsroom",
      "2020",
      "2020-10-1-birthday"
    ]
  },
  {
    "annotation": "Zentiva has become one of the receivers of the European grant within Horizon 2020, supporting exchange of young researchers between academic and industrial sectors.",
    "type": "News Article",
    "id": "B3C86FE8FB874E3886BA9336A1FDBE8E-en",
    "tags": [
      "Science",
      "R&D",
      "Innovation"
    ],
    "publish_date": "2019-08-13T22:00:00Z",
    "language": "en",
    "name": "2019-14-08-Horizon-2020",
    "subtitle": "",
    "title": "Zentiva as a member within a Horizon 2020 grant from the European Commission",
    "content_title": "Zentiva as a member within a Horizon 2020 grant from the European Commission",
    "content_text": "Zentiva as a member within a Horizon 2020 grant from the European Commission\nThanks to active participation of Prague Development Center within consortium formed by European universities interested in bridging industry and academia, Zentiva has become one of the receivers of the European grant within Horizon 2020, supporting exchange of young researchers between academic and industrial sectors.\nPharmaceutical Research Institute (PRI) from Warsaw, Poznan University of Medical Sciences (PUMS), Trinity College at the University of Dublin and University of Helsinki created an academic European core which they further bridged with several European companies, also extending academic connection to Rutgers University in New Jersey in US. The group within which Zentiva has been involved as an industrial partner, officially named Open Research Biopharmaceutical Internships Support (ORBIS), responded to the call within Horizon 2020 from the European Commission with a proposal to form an international and inter-sectoral academic and industrial network.\nSpecifically, common aim of the group is to improve drug product development pathways integrating multidisciplinary research on processes and technologies by involving academia and industry from EU (Poland, Ireland, Finland, Germany and Czech Republic), EU associated country (Ukraine) and US.\nThe complementary consortium comprises experts in computations, physical chemistry, material science, nanotechnology, pharmacy, pharmacology and bioanalysis. Within 4 years European scientists will merge their expertise in drug synthesis and dissolution, oral formulations, and bioanalytical methods with the knowledge on dermal research provided by the US partner.\nBased on areas where Zentiva aims to further deepen its scientific expertise, closest cooperation will be achieved with the University of Helsinki, Trinity College, PUMS, PRI and Rutgers.\nOur aim is to exchange researchers between us and Universities through so-called &ldquo;secondments&rdquo; which are the type of assignments resulting in few-month research spent within laboratories of the members of the consortium, exchanging knowledge and expertise based on real-life examples faced on a daily basis during drug product development.\nAs a long-term result of such approach, we believe that drug product development process will be shortened, risk of failures will be mitigated and new drug products will be made more accessible and affordable for society.\n&ldquo;Although very exciting, product development also carries high complexity, requiring continuous development of knowledge and scientific understanding, but also preparedness to fail. Translated into business language, it requires time and significant financial support which at the end reflects in the costs of the product. \nWith this program while learning more, we are also faster, and we bring the medicines to the patients sooner. In other words, we are making healthcare more affordable: a right, not a privilege.&rdquo;\nAleksandra Dumicic, Innovation Director, Zentiva.",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-14-08-Horizon-2020",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-14-08-Horizon-2020"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/European-Commission.png?h=486&iar=0&w=1440"
  },
  {
    "annotation": "Zentiva Acquires Central and Eastern European Business of Alvogen",
    "type": "News Article",
    "id": "8A91838C330A4D79B11C02C7BB9DCE71-en",
    "tags": [
      "M&A",
      "Growth",
      "Manufacturing",
      "CEO"
    ],
    "publish_date": "2019-10-24T22:00:00Z",
    "language": "en",
    "name": "2019-10-25-Alvogen-acquisition",
    "subtitle": "",
    "title": "Zentiva Acquires Central and Eastern European Business of Alvogen",
    "content_title": "Zentiva Acquires Central and Eastern European Business of Alvogen",
    "content_text": "Zentiva to further expand its geographical footprint and complement its portfolio in Generics and OTC\nPRAGUE / SOFIA, &ndash; 25 OCTOBER 2019 &ndash; Zentiva announces the signing of a definitive agreement to acquire the Central and Eastern European Business of Alvogen, for an undisclosed amount \nAlvogen CEE markets over 200 generic and over-the-counter products across multiple therapeutic areas, consisting of highly recognized brands like Lactacyd, Persen, EuBiotic and many more with leading market positions in 14 key markets across CEE including; Russia, Romania, Bulgaria, Hungary, Poland and Balkan markets.\nNick Haggar, Chief Executive Officer of Zentiva remarked &ldquo;This acquisition is a perfect fit for Zentiva and supports the execution of our strategy. Zentiva will strengthen its leadership in Central and Eastern Europe while expanding into new markets and significantly increase its specialty and OTC medicines portfolio. We look forward to welcoming more than 1,000 people from the Alvogen CEE team into our Zentiva community. Together, we will be even stronger as we continue working on our primary mission of providing high-quality and affordable medicines to people in Europe and beyond.&rdquo;\nThis transaction brings together two leading branded generics and OTC businesses in the CEE region, with complementary strengths, product portfolios, geographical footprints and cultures. The transaction is expected to close in the first quarter of 2020, subject to customary approvals.\n&ldquo;With the divestiture of the European business, we will be focusing our strategic development, growth and expansion in other areas. Through acquisitions and strong partnerships in the Asian region and continued investment in biosimilars through our sister company Alvotech, we can continue to grow and set the standards on a global platform. We thank our colleagues for their extraordinary efforts in building one of the most successful regional companies in our industry and we look forward to following the continued success of the combined business&rdquo;, said Robert Wessman, Chairman &amp; CEO of Alvogen.\nEarlier in 2019, Zentiva integrated the teams of Creo Pharma in the UK and Solacium Pharma in Romania into the Zentiva group. In September, Zentiva also announced acquisition of a manufacturing site in Ankleshwar in India. In addition to multi-million Euro investments in existing manufacturing facilities in Prague and Bucharest, Zentiva continues to maximize its competitive advantage, expanding market footprint and upgrading its manufacturing network and capabilities.\nMedia contact:\nInes Windisch\nHead of Corporate Affairs &amp; Human Resources \nTel: (+420) 601 341 444\nEmail: ines.windisch@zentiva.com\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 3,000 people and a network of production sites - including flagship sites in Prague and Bucharest &ndash; Zentiva strives to be the champion of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.\nLearn more about Zentiva on www.zentiva.com.\nAbout Alvogen\nAlvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the-counter medicines (OTC) and biosimilar products for patients around the world.  The company has commercial operations in 35 countries with 2,800 employees and operates four manufacturing and development hubs in the U.S., Romania, Korea and Taiwan. North America is Alvogen&rsquo;s single largest market and other key markets include: South Korea, Russia, Taiwan, Romania, Hungary, Ukraine, Japan and China. \nLearn more about Alvogen on www.alvogen.com.",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-10-25-Alvogen-acquisition",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-10-25-Alvogen-acquisition"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/2019_Zentiva_Alvogen.jpg?h=997&iar=0&w=1597"
  },
  {
    "annotation": "Zentiva enhances its global manufacturing footprint by signing an agreement to acquire manufacturing site in Ankleshwar, India",
    "type": "News Article",
    "id": "B92479B3D8EB40C5BE3C82D77014997B-en",
    "tags": [
      "M&A",
      "Growth",
      "Manufacturing",
      "CEO"
    ],
    "publish_date": "2019-09-10T22:00:00Z",
    "language": "en",
    "name": "2019-09-11-zentiva-acquisition-site-production-ankleshwar-inde",
    "subtitle": "",
    "title": "Zentiva enhances its global manufacturing footprint by signing an agreement to acquire manufacturing site in Ankleshwar, India",
    "content_title": "Zentiva enhances its global manufacturing footprint by signing an agreement to acquire manufacturing site in Ankleshwar, India",
    "content_text": "PRAGUE / MUMBAI / ANKLESHWAR &ndash; September 11th, 2019: Zentiva Group, a.s. announces the signing of a Business Transfer Agreement with Sanofi to acquire their manufacturing site in Ankleshwar, India. This acquisition will help ensure the continued supply of high-quality medicines to more patients by expanding the footprint and agility of Zentiva&rsquo;s manufacturing network. \n&ldquo;Expanding our network of Zentiva&rsquo;s wholly-owned manufacturing sites is a key factor in our future success, ensuring greater security of supply for people living in Europe and beyond. It enables us to innovate further to achieve operational excellence, enhance productivity and accelerate growth,&rdquo; said Nick Haggar, Chief Executive Officer of Zentiva. &ldquo;We are strongly committed to the growth and success of the Ankleshwar team and operations. The site will be the largest in our network and the team in India will play a central role in the operations of Zentiva.&rdquo;\nWith demand for high quality and affordable medicines increasing, the acquisition reaffirms Zentiva&rsquo;s commitment to stand side-by-side with pharmacists, healthcare professionals and decision makers in improving access for patients.\nEarlier in 2019, Zentiva enhanced its network with the acquisition of Solacium in Romania and Creo in the United Kingdom, as well as making multi-million Euro investments in Prague and Bucharest to maximize manufacturing capabilities.\n\n* This transaction is subject to receipt of regulatory approvals, shareholders&rsquo; approval and the completion of certain conditions as defined under the Business Transfer Agreement.\n\nAbout Ankleshwar Manufacturing Site\nEstablished in 1987, the site has a chemistry &amp; biotechnology development centre, and manufactures both intermediates and pharmaceutical formulations. A large producer of tablets, the Ankleshwar site manufactures more than 6 billion tablets annually.\n\n\nAbout Zentiva\nZentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 3,000 people and a network of production sites - including flagship sites in Prague and Bucharest &ndash; Zentiva strives to be the champions of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\n\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.\n\nMedia contact:\nInes Windisch\nHead of Corporate Affairs &amp; Human Resources \n\nZENTIVA GROUP, a.s.\nU Kabelovny 130 &ndash; 102 37 Prague 10 &ndash; Czech Republic\nCell: (+420) 601 341 444\nE-mail: ines.windisch@zentiva.com \nwww.zentiva.com",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-09-11-zentiva-acquisition-site-production-ankleshwar-inde",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-09-11-zentiva-acquisition-site-production-ankleshwar-inde"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/Zentiva_India_3.jpg?h=490&iar=0&w=1440"
  },
  {
    "annotation": "Zentiva announces completion of Solacium Pharma acquisition",
    "type": "News Article",
    "id": "A49287AE410B41C4ACBC1A65F8895422-en",
    "tags": [
      "M&A",
      "Growth"
    ],
    "publish_date": "2019-05-30T22:00:00Z",
    "language": "en",
    "name": "2019-05-31_PR_Solacium",
    "subtitle": "",
    "title": "Zentiva announces completion of Solacium Pharma acquisition",
    "content_title": "Zentiva announces completion of Solacium Pharma acquisition",
    "content_text": "PRAGUE &ndash; May 31st, 2019: Zentiva Group a.s. announces the completion of its previously declared acquisition of Romanian-based pharmaceutical company Solacium Pharma, together with its subsidiary, Be Well Pharma. The finalization of this acquisition will play a key role in the long-term growth strategy of Zentiva and will help to better support Romanian consumers&rsquo; healthcare needs.\nAbout Zentiva\nZentiva is a European producer of high quality medicines serving patients in Europe, Middle East and Africa. With a dedicated team of more than 2 900 people and our network of production sites - including our flagship sites in Prague and Bucharest - we strive to be the champions of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\n\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on. \nContact for media\nInes WINDISCH \nHead of Corporate Affairs and Human Resources \nZentiva Group \nTel.: +420 601 341 444 \nU Kabelovny 130, 102 37 Praha \nÄŒesk&aacute; republika \nInes.Windisch@zentiva.com \nwww.zentiva.com   ",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-05-31_PR_Solacium",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-05-31_PR_Solacium"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/2019-05-31_Solacium.jpg?h=490&iar=0&w=1440"
  },
  {
    "annotation": "Zentiva Group a.s. and Siyiara Enterprises have signed a Shared Purchase Agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with its subsidiary Be Well Pharma.",
    "type": "News Article",
    "id": "587435F12FCA4E71B6A1C826F7E7817C-en",
    "tags": [
      "M&A",
      "Growth",
      "CEO"
    ],
    "publish_date": "2019-03-12T23:00:00Z",
    "language": "en",
    "name": "2019-03-13-zentiva-acquired-solacium",
    "subtitle": "",
    "title": "Zentiva and Siyiara signed an agreement for the acquisition of Romanian pharma company, Solacium",
    "content_title": "Zentiva and Siyiara signed an agreement for the acquisition of Romanian pharma company, Solacium",
    "content_text": "PRAGUE &ndash; March 13th, 2019: Zentiva Group a.s. and Siyiara Enterprises have signed a Shared Purchase Agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with its subsidiary Be Well Pharma. Solacium is currently part of the Dr. Max Group and owned by Siyiara Enterprises together with Mr. Trasca Alexandru-Tony. \n\nNick Haggar, CEO of Zentiva stated: &ldquo;Zentiva is delighted to confirm the signing of its first acquisition following the carve out from Sanofi in the last quarter of 2018. Solacium complements our existing generic medicines business and grows our OTC capability and offering for patients and consumers in Romania.&rdquo;\n\n&ldquo;After Dr.Max&rsquo;s acquisition of A&amp;D Pharma Group, we have decided to primarily focus on three main pillars of our Romanian business: pharma retail, wholesale and marketing &amp; sales. Although Solacium is a fast-growing food supplement and OTC medicines producer, we believe that under the management of a specialised and successful pharmaceutical company, such as Zentiva, it can fulfil its potential and significantly boost its business beyond current levels&rdquo; said Leonardo Ferrandino, President and Group CEO of Dr.Max.\n\nThe transaction remains subject to the approval of several conditions including, but not limited to, the Romanian Competition Council.&ldquo;\nAbout Zentiva | www.zentiva.com\nZentiva is a European producer of high quality medicines serving patients in Europe, Middle East and Africa. With a dedicated team of more than 2.500 people and our network of production sites - including our flagship sites in Prague and Bucharest - we strive to be the champions of branded and generic medicines in Europe to better support people&rsquo;s daily healthcare needs.\n\nAt Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators and governments to provide the everyday solutions that we all depend on.\nAbout Solacium Pharma\nSOLACIUM PHARMA&rsquo;s vision is to become one of Romania&rsquo;s leading pharmaceutical companies, by building partnerships with healthcare professionals for the benefit of patients, consumers and employees. These partnerships are based on delivering innovative products that offer people the best choices for their health.\nMedia contact\nInes Windisch \nHead of Corporate Affairs &amp; Human Resources \nZENTIVA GROUP, a.s. \nU Kabelovny 130 &ndash; 102 37 Prague 10 &ndash; Czech Republic \nCell: (+420) 601 341 444 \nE-mail: ines.windisch@zentiva.com  \nwww.zentiva.com  \nIvo Mravinac \nPR Specialist &amp; CZ Spokesperson \nPENTA INVESTMENTS, s.r.o. \nFlorentinum, Na Florenci 2116/15, 110 00 Prague 1 &ndash; Czech Republic \nTel.: +420 225 101 109 \nCell: +420 606 656 930 \nE-mail: mravinac@pentainvestments.com \nwww.pentainvestments.com ",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-03-13-zentiva-acquired-solacium",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-03-13-zentiva-acquired-solacium"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/solacium-logo-620-348.jpg?h=348&iar=0&w=620"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "8FBBC8A9E70C47D7A9DEC27AF8DF8C36-en",
    "tags": [
      "Awards & Recognition",
      "R&D",
      "Career",
      "Partnerships"
    ],
    "publish_date": "2019-03-04T23:00:00Z",
    "language": "en",
    "name": "2019-03-05-the-park-awards",
    "subtitle": "",
    "title": "The Parc Awards Championing Rising Talent in Drug Research & Development",
    "content_title": "The Parc Awards Championing Rising Talent in Drug Research & Development",
    "content_text": "PRAGUE &ndash; March 5th, 2019: The Parc (Pharmaceutical Applied Research Center) is marking its five-year anniversary by launching The Parc Awards at a ceremony held at Zentiva Headquarters in Prague on March 5th. The Parc is a unique research platform designed to benefit future generations of scientists. \n&ldquo;We are proud to be working alongside the next generation of scientists, giving them hands-on experience of drug development in action&rdquo; commented Pavel Calta, PhD, Executive Director. &ldquo;Launching The Parc Awards, which consists of two categories, will give participating students the recognition they deserve, and we hope many of them will continue to pursue careers in drug Research &amp; Development.&rdquo;\nInitiated by Zentiva, The Parc was created in association with three academic partners: the University of Chemistry and Technology Prague; the Faculty of Science in Charles University; and is now joined by the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. This highly successful initiative has brought rising talent together with leading pharmaceutical and academic experts, all working to accelerate innovation in drug Research &amp; Development. \nThe Parc enables PhD students to gain industry work experience in solid-state chemistry, pharma technology, bio-pharmacy and clinical research. Collaborating with academic partners across Europe, The Parc also offers a mentorship program where students are supervised by top academic scientists, sharing expertise and carrying out day-to-day support. Currently, 25 PhD students are participating in this program. Since its creation, 8 students have graduated, 4 of which joined Zentiva. As for the remaining students, 2 have decided to pursue a career in academia, further expanding The Parc&acute;s science network, and 2 are currently working in other pharmaceutical companies.\n&ldquo;We are extremely grateful to Zentiva for supporting The Parc and giving our graduate students and academics the opportunity to collaborate with industry experts to address the biggest challenges in healthcare. I would like to congratulate the awardees and wish them every success in their future professional careers&rdquo; commented Prof. Ing. Franti&scaron;ek &Scaron;tÄ›p&aacute;nek, PhD.\nAbout Faculty of science of Charles University\nThe Faculty of Science was established in 1920 as the fifth faculty of Charles University. It currently has 29 departments, 3 museums and a large Botanical Garden. The faculty is academically and organizationally divided into 4 sections: biological, geographical, geological and chemical. In addition to these sections, the faculty has several specialized teaching and research centres, including interdisciplinary institutions such as the Institute for Environmental Studies. All parts of the faculty are active in both teaching and research.\nAbout Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences\nIOCB Prague is a leading internationally recognized scientific institution whose primary mission is the pursuit of basic research in chemical biology and medicinal chemistry, organic and materials chemistry, chemistry of natural substances, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. An integral part of the IOCB Prague&rsquo;s mission is the implementation of the results of basic research in practice. Emphasis on interdisciplinary research gives rise to a wide range of applications in medicine, pharmacy, and other fields.\nAbout University of Chemistry and Technology Prague\nThe University of Chemistry and Technology Prague is a natural centre of first-rate study and research in the area of chemistry in Czechia and is one of the country's largest educational and research institutions focused on technical chemistry, chemical and biochemical technologies, material and chemical engineering, food chemistry, and environmental studies.\nAbout Zentiva | www.zentiva.com\nAt Zentiva we aspire that healthcare should be a right and not a privilege. More than ever, people need better access to healthcare. Today, the everyday solutions that we all depend on truly count as a vital foundation of healthy living. Zentiva works for the people living in Europe. Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare. With more than 2,500 people across Europe and 2 production sites in Prague and Bucharest we strive to be the champions of Generics and OTC medicines to better support people&rsquo;s daily healthcare needs.\nMedia contact\n\nMounira Lemoui\nCommunication Business Partner \nZentiva Group, a.s. \nCell: +420 727 873 159 \nU Kabelovny 130, 102 37 PRAGUE \nCzech Republic \nwww.zentiva.com   ",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-03-05-the-park-awards",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-03-05-the-park-awards"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/theparc-people.png?h=821&iar=0&w=1047"
  },
  {
    "annotation": "",
    "type": "News Article",
    "id": "736BE038B7304870B064CBF621948E51-en",
    "tags": [
      "Innovation",
      "R&D",
      "Partnerships",
      "Career"
    ],
    "publish_date": "2019-02-28T23:00:00Z",
    "language": "en",
    "name": "2019-03-01-the-parc",
    "subtitle": "",
    "title": "Press Conference: Join the conversation on March 5, 2019!",
    "content_title": "Press Conference: Join the conversation on March 5, 2019!",
    "content_text": "The Parc: Championing Rising Talent in Drug Research &amp; Development\nYou are invited to attend a media event to find out more about The Parc and how it benefits future generations of scientists. \n\nWhen:                             Tuesday March 5th, 09:00 CET\nWhere:                            Zentiva Group, a.s. U Kabelovny 130 102 37 Prague 10. Czech Republic\nWeb stream link:\t http://bit.ly/2BSm1uv \n\nThe Parc is a unique research platform connecting chemistry, pharma technology, biopharmacy and clinical research.\n\nInitiated by Zentiva, The Parc was created in association with three academic partners: the University of Chemistry and Technology in Prague, the Faculty of Science in Charles University and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. This highly successful initiative provides talented science students a great opportunity to strengthen innovation power in the pharmaceutical industry.\n\nOver the course of the last five years, The Parc has brought together rising talent with leading pharmaceutical industry and academic experts, all working to accelerate innovation in drug Research &amp; Development.\n\n\nEvent program\n \nOpening\n\n    Nick Haggar, CEO Zentiva\n\nThe power of Innovation\n\n    Silvana Jirotkov&aacute;, CEO Czech Invest\n\nThe Parc\n\n    The Parc Introduction\n\nPanel discussion and Q&amp;A\n\n    Discussion with internationally renowned scientists and students involved in The Parc \n    (P. Sebek, F. Stepanek, L. Tajber, Z. Hostomsky, E. Skorepova, M. Pribyl, J. Zima)\n\nLaunch of The Parc Awards\n\n    Championing talented students and recognizing the valuable contribution of PhD scientists at the beginning of their career\n\nSite visit of Zentiva&rsquo;s Research &amp; Development center\n\n    Fueling innovation from ideation to product registration and launch\n    \n    \n\n \nJoin the conversation and gain exclusive access to key experts!\n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-03-01-the-parc",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-03-01-the-parc"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/the_parc_conference2.png?h=1526&iar=0&w=3332"
  },
  {
    "annotation": "For the 4th year in a row, Zentiva has been named as the most prestigious Employer in the Healthcare & Pharmacy sector in Czech Republic at the TOP Employers competition.",
    "type": "News Article",
    "id": "6525F265DBFA48308A221253B5DBC984-en",
    "tags": [
      "Awards & Recognition"
    ],
    "publish_date": "2019-02-05T23:00:00Z",
    "language": "en",
    "name": "2019-02-06_top-zamestnavatel",
    "subtitle": "",
    "title": "Zentiva named Top Employer for the fourth consecutive year in Czech Republic",
    "content_title": "Zentiva named Top Employer for the fourth consecutive year in Czech Republic",
    "content_text": "PRAGUE &ndash; February 6th, 2019: For the 4th year in a row, Zentiva has been named as the most prestigious Employer in the Healthcare &amp; Pharmacy sector in Czech Republic at the TOP Employers competition. The ranking of the most desirable companies and institutions are voted by an Association of Students and Graduates which takes place among students of Czech universities. It is realized in cooperation with the prestigious GFK Research Agency, Universities, Student Organizations and Corporate partners. The ranking of Healthcare &amp; Pharmacy category is based on feedback of students of the Pharmaceutical and Medical faculties of the higher education institutions. The aim of this study is to highlight the more attractive companies where young talents would like to start and develop their careers. \n&ldquo;We are very proud of this new gratification. The result of this survey acknowledge the efforts Zentiva is doing to develop talents. At Zentiva young scientists represent one of our key assets which enable us to secure our success for future generations. Energizing each other with passion and belief make Zentiva a great place to work&rdquo; says Ines Windisch, Head of Corporate Affairs and Human Resources.\n \nAbout Zentiva | www.zentiva.com\n\n\nAt Zentiva we aspire that healthcare should be a right and not a privilege. More than ever, people need better access to healthcare. \n\nToday, the everyday solutions that we all depend on truly count as a vital foundation of healthy living. Zentiva works for the people living in Europe. Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare.\n\n\nWith more than 2,500 people across Europe and 2 production sites in Prague and Bucharest we strive to be the champions of Generics and OTC medicines to better support people&rsquo;s daily healthcare needs.\n \nMedia contact\n\n\nMounira Lemoui\nCommunication Business Partner\n\nZentiva Group, a.s.\n\nCell: +420 727 873 159\n\nU Kabelovny 130, 102 37 PRAGUE\n\nCzech Republic\n\nwww.zentiva.com  \n\n\n\n \n",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-02-06_top-zamestnavatel",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-02-06_top-zamestnavatel"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/top-zamestnavatel.png?h=486&iar=0&w=1440"
  },
  {
    "annotation": "Zentiva is investing EUR 30 million to maximize its manufacturing site capabilities in Prague.",
    "type": "News Article",
    "id": "FB1200C57DD14538B3B844E92D16493B-en",
    "tags": [
      "Investment",
      "Manufacturing"
    ],
    "publish_date": "2019-01-24T23:00:00Z",
    "language": "en",
    "name": "2019-01-25_investment",
    "subtitle": "",
    "title": "Zentiva strengthens European generic footprint with Prague Manufacturing Site investment",
    "content_title": "Zentiva strengthens European generic footprint with Prague Manufacturing Site investment",
    "content_text": "PRAGUE &ndash; January 25th, 2019 &ndash; Zentiva is investing EUR 30 million to maximize its manufacturing site capabilities in Prague. The investment further strengthens Zentiva&lsquo;s manufacturing footprint and is part of a broader ambition to become the champion of generics in Europe.\n\nThomas Koene, Head of Industrial Operations: &bdquo;This investment will focus on the upgrade of our existing manufacturing capabilities, more specifically on capacity expansion. We are currently producing up to 120 million packages per year in Prague, which we distribute across Europe. After the carve out, we are accelerating investment in Prague to support our growth ambition. Our Prague manufacturing site is a major cornerstone of our company. We have already started to invest and we are committed to continue this in 2019 with a further investment of EUR 8 million&rdquo;.\n\nZentiva is at a unique and exciting crossroads in its journey. A profound transformation has been started to achieve the full business potential in a new era of independence, backed by Advent International. \n\nInes Windisch, Head of Corporate Affairs &amp; Human Resources added: &bdquo;The growth of our organization brings new opportunities for our people and positions. This great transformation will attract the best talent and retain our team to secure our success for future generations. We are currently employing more than 600 people in our Prague site, who are dedicated to producing high-quality medicines that support peoples&rsquo; daily healthcare needs.\nAbout Zentiva | www.zentiva.com\n\n\nAt Zentiva we aspire that healthcare should be a right and not a privilege. More than ever, people need better access to healthcare. \n\nToday, the everyday solutions that we all depend on truly count as a vital foundation of healthy living. Zentiva works for the people living in Europe. Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare.\n\n\nWith more than 2,500 people across Europe and 2 production sites in Prague and Bucharest we strive to be the champions of Generics and OTC medicines to better support people&rsquo;s daily healthcare needs.\nMedia contact\nMounira Lemoui\nCommunication Business Partner\n\nZentiva Group, a.s.\n\nCell: +420 727 873 159\n\nU Kabelovny 130, 102 37 PRAGUE\n\nCzech Republic\n\nwww.zentiva.com   ",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-01-25_investment",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-01-25_investment"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/zentiva-factory-new.png?h=467&iar=0&w=700"
  },
  {
    "annotation": "Zentiva is very pleased to announce the appointment of Nick Haggar to the role of Chief Executive Officer (CEO), effective as of February 11th, 2019.",
    "type": "News Article",
    "id": "2AFDBEAD72854307803EEAAF838C5173-en",
    "tags": [
      "CEO",
      "Leadership"
    ],
    "publish_date": "2019-01-14T23:00:00Z",
    "language": "en",
    "name": "2019-01-15_Nick-Haggar-CEO-Zentiva",
    "subtitle": "",
    "title": "Nick Haggar appointed CEO of Zentiva",
    "content_title": "Nick Haggar appointed CEO of Zentiva",
    "content_text": "Prague, January 15th, 2019 &ndash; Zentiva is very pleased to announce the appointment of Nick Haggar to the role of Chief Executive Officer (CEO), effective as of February 11th, 2019. Nick Haggar joins from InsudPharma where he was CEO from 2016-2019. He has been in the pharmaceutical and healthcare industry for more than 30 years and has both a strong commercial track record with leadership positions in Sandoz (Novartis), GlaxoSmithKline and Ranbaxy and technical know-how having commenced his career in technical operations at Baxter Healthcare. He was President of Medicines for Europe (former EGA) during 2014-2015. Nick Haggar will be based in Prague and will report to the Advisory Committee of Zentiva. \n\nNick Haggar commented: &ldquo;I am extremely excited to join Zentiva on its new journey. In the months ahead, we will expand our reach, increase our productivity and accelerate our growth as we help support people&rsquo;s daily healthcare needs.&rdquo;\n\n\nZentiva has been carved-out from Sanofi in October last year. The Group is now backed by Advent International, one of the world&rsquo;s largest and most experienced global private equity investors.\n\n \nAbout Zentiva\n\n\nAt Zentiva we aspire that healthcare should be a right and not a privilege. More than ever, people need better access to healthcare. Today, the everyday solutions that we all depend on truly count as a vital foundation of healthy living. Zentiva works for the people living in Europe. Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare. With more than 2,500 people across Europe and 2 production sites in Prague and Bucharest we strive to be the champions of Generics and OTC medicines to better support people&rsquo;s daily healthcare needs.\n \nContact for media\n\n\nInes WINDISCH\n\nHead of Corporate Affairs and Human Resources\n\nZentiva Group\n\nTel.: +420 601 341 444\n\nU Kabelovny 130, 102 37 Praha\n\nÄŒesk&aacute; republika\n\nInes.Windisch@zentiva.com\n\nwww.zentiva.com  \n\n\n\n \n",
    "category": "Newsroom",
    "url": "/news/newsroom/2019/2019-01-15_Nick-Haggar-CEO-Zentiva",
    "url_detail": [
      "news",
      "newsroom",
      "2019",
      "2019-01-15_Nick-Haggar-CEO-Zentiva"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2019/zentiva-flags-660-322.png?h=300&iar=0&w=653"
  },
  {
    "annotation": "Zentiva and PHOENIX joined forces this week for an inaugural Annual Partnership meeting in Prague to kick off a strategic partnership between the two healthcare companies in Europe.",
    "type": "News Article",
    "id": "729CE61083284971B5B67156EFFCA7B6-en",
    "tags": [
      "Partnerships",
      "Product Portfolio"
    ],
    "publish_date": "2018-11-22T23:00:00Z",
    "language": "en",
    "name": "2018-11-23_Zentiva_partnership-Phoenix",
    "subtitle": "",
    "title": "Zentiva and PHOENIX form strategic partnership in Europe",
    "content_title": "Zentiva and PHOENIX form strategic partnership in Europe",
    "content_text": "PRAGUE &ndash; November 23rd, 2018 &ndash; Zentiva and PHOENIX joined forces this week for an inaugural Annual Partnership meeting in Prague to kick off a strategic partnership between the two healthcare companies in Europe. \n&ldquo;At PHOENIX group we believe that Zentiva is an excellent fit for partnering at European level, thanks to their strong heritage, broad portfolio of generics and OTC medicines and presence in a large number of European markets&rdquo;, says Nemanja Jankovic, Head of Partnerships at Corporate Pharma Services &amp; Sourcing, PHOENIX group.\nThe first projects to commence under the strategic partnership are being rolled out in certain Central &amp; Eastern European (CEE) markets. &ldquo;In PHOENIX we are confident that we have found the right partner for distribution and commercial activities. We are looking forward to expanding our collaboration to benefit even more markets in the future&rdquo;, says Robert Storch, Head of Trade &amp; Revenue, Zentiva Group.\nThe companies will be working at strategic partnership level on commercial opportunities to provide better access to Zentiva products for the benefit of patients across Europe.\nAbout PHOENIX group | www.phoenixgroup.eu \n The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group&rsquo;s vision is to be the best integrated healthcare provider &ndash; wherever it is active. The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering.\nWith our European value-adding service brand &ldquo;PHOENIX All-in-One&rdquo;, we provide services for pharmaceutical companies in all 27 countries along the entire value chain, from production to point of sale generating more revenue at multiple different stages. All-in-One cuts complexity and allows our industry partners to concentrate on their core business. The service portfolio ranges from Clinical Trial Supply Services, Market Potential Insight, Market Access Services, Healthcare Logistics, Access to more than 16,000 pharmacies and to millions of patients in Europe via the pharmacy channel.\nAbout Zentiva | www.zentiva.com \nAt Zentiva we aspire that healthcare should be a right and not a privilege. More than ever, people need better access to healthcare. Today, the everyday solutions that we all depend on truly count as a vital foundation of healthy living.\nZentiva works for the people living in Europe. Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare. With more than 2,500 people across Europe and 2 production sites in Prague and Bucharest we strive to be the champions of Generics and OTC medicines to better support people&rsquo;s daily healthcare needs.\n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2018/2018-11-23_Zentiva_partnership-Phoenix",
    "url_detail": [
      "news",
      "newsroom",
      "2018",
      "2018-11-23_Zentiva_partnership-Phoenix"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2018/2018-11-23_Zentiva_partnership_Phoenix_2.jpg?h=486&iar=0&w=1440"
  },
  {
    "annotation": "Sanofi and Advent International (&ldquo;Advent&rdquo;) have finished negotiations for the acquisition of Zentiva, Sanofi&rsquo;s European generics business, by Advent and the companies have signed a Share Purchase Agreement worth &euro;1.9 billion (enterprise value).",
    "type": "News Article",
    "id": "E1FEDAC424BC424881CE854415299CD2-en",
    "tags": [
      "M&A",
      "Investors"
    ],
    "publish_date": "2018-06-27T22:00:00Z",
    "language": "en",
    "name": "sanofi-advent-finalize-negotiations",
    "subtitle": "",
    "title": "Sanofi and Advent finalize negotiations for the acquisition of Zentiva",
    "content_title": "Sanofi and Advent finalize negotiations for the acquisition of Zentiva",
    "content_text": "PARIS &ndash; June 28, 2018 - Sanofi and Advent International (&ldquo;Advent&rdquo;) have finished negotiations for the acquisition of Zentiva, Sanofi&rsquo;s European generics business, by Advent and the companies have signed a Share Purchase Agreement worth &euro;1.9 billion (enterprise value). The companies announced that they had entered into exclusive talks on April 17, 2018.\nThe signing of this Share Purchase Agreement marks a critical step on the way to the closing of the deal and the transfer of the Zentiva business to Advent, that is anticipated during the course of the fourth quarter of 2018.\nThe transaction remains subject to the approval of the competent regulatory authorities.\nAbout Zentiva\nZentiva is an agile healthcare player providing reliable access across Europe to a broad generics portfolio covering a multitude of therapeutic areas. Headquartered in Prague, Zentiva reaches over 40 million patients in 25 European countries, operating throughout a large marketplace with attractive levels of both short- and midterm growth outlook. Zentiva stands apart with the expertise and agility to tailor customer-centric solutions in the three European generics market archetypes (pharmacy, physician and tender/wholesaler). Zentiva&rsquo;s integrated value chain and pan-European commercial footprint makes it one of the largest generics players in Europe. Operating to the highest quality and safety standards, Zentiva&rsquo;s flexible manufacturing facilities in Prague and Bucharest work with partners to produce and distribute more than 350 million packs each year.\nAbout Advent International\nFounded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 330 private equity transactions in 40 countries and as of December 31, 2017, it had &euro;35 billion in assets under management. With offices on four continents, Advent has established a globally integrated team of over 190 investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; healthcare; industrial; retail, consumer and leisure; and technology, media and telecom. After more than 30 years dedicated to international investing, Advent remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.\nFor more information, visit www.adventinternational.com\nAbout Sanofi\nSanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.\nSanofi, Empowering Life\n\n \n \n \nMedia Relations Contact \nJean-Baptiste Froville\nTel. : +33 (0)1 53 77 46 46\nmr@sanofi.com\nAdvent International Media Relations Contacts \nFTI Consulting UK \nFergus Wheeler/Louisa Feltes \nTel.: +44 203 727 1000\nadventinternational@fticonsulting.com\nFTI Consulting France\nAstrid Villette \nTel.:+33 (0) 1 47 03 69 51 \nadventfrance@fticonsulting.com\nInvestor Relations Contact \nGeorge Grofik\nTel.: +33 (0)1 53 77 45 45 \nir@sanofi.com\nSanofi Forward-Looking Statements \nThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words &ldquo;expects&rdquo;, &ldquo;anticipates&rdquo;, &ldquo;believes&rdquo;, &ldquo;intends&rdquo;, &ldquo;estimates&rdquo;, &ldquo;plans&rdquo; and similar expressions. Although Sanofi&rsquo;s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the absence of guarantee that the product candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi&rsquo;s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic conditions, the impact of cost containment initiatives and subsequent changes thereto, the average number of shares outstanding as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under &ldquo;Risk Factors&rdquo; and &ldquo;Cautionary Statement Regarding Forward-Looking Statements&rdquo; in Sanofi&rsquo;s annual report on Form 20-F for the year ended December 31, 2017. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.",
    "category": "Newsroom",
    "url": "/news/newsroom/2018/sanofi-advent-finalize-negotiations",
    "url_detail": [
      "news",
      "newsroom",
      "2018",
      "sanofi-advent-finalize-negotiations"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2018/Zentiva_2018.jpg?h=486&iar=0&w=1440"
  },
  {
    "annotation": "oday marks generics manufacturer Zentivaâ€™s first day as an independent organization, following completion of the companyâ€™s previously announced divestment from Sanofi.",
    "type": "News Article",
    "id": "2B83446770374045894C8764A67DB76D-en",
    "tags": [
      "Investors",
      "CEO"
    ],
    "publish_date": "2018-09-30T22:00:00Z",
    "language": "en",
    "name": "Zentiva-independent-company",
    "subtitle": "",
    "title": "Generics manufacturer Zentiva starts operations as independent company",
    "content_title": "Generics manufacturer Zentiva starts operations as independent company",
    "content_text": "PRAGUE &ndash; October 1st, 2018 &ndash; Today marks generics manufacturer Zentiva&rsquo;s first day as an independent organization, following completion of the company&rsquo;s previously announced divestment from Sanofi. \nZentiva is headquartered in Prague, and the company &ndash; now backed by Advent International, one of the world&rsquo;s largest and most experienced global private equity investors &ndash; is entering a new era of independence and transformation.\nPatrick Aghanian, Head of Zentiva, believes that the divestment brings new opportunities for the company and its customers, resulting in a faster, more flexible and more agile business.\n&ldquo;Zentiva&rsquo;s roots reach back 530 years to the Black Eagle pharmacy, a small business on the castle side of Prague. We are very proud of our roots and heritage and we look forward to expanding and building our footprint in Generics and OTC medicines across Europe. This heritage not only strengthens our resolve to remain customer-focused, it also drives our future priorities as we strive to improve healthcare with a more personalized approach. It is our aspiration that healthcare should be a right and not a privilege, and that healthcare solutions should be accessible to as many people as possible.&rdquo;\n&ldquo;We want to build a reputation that is recognised by our partners as being synonymous with value&rdquo; he continues. &ldquo;Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare. We strive to support people&rsquo;s daily healthcare needs.&rdquo;\nPatrick adds that this latest chapter in the company&rsquo;s history is also positive news for employees: &ldquo;The intended growth of our organization brings new opportunities for our people to fulfil their potential. It also positions us well to attract the best talent and retain our team to secure our success for future generations. This is an exciting time for Zentiva and we are confident that with the support of Advent we can realize our ambition.&rdquo;\n\n\n\n\n\nAbout Zentiva\n\n\nAt Zentiva we aspire that healthcare should be a right and not a privilege. More than ever, people need better access to healthcare. Today, the everyday solutions that we all depend on truly count as a vital foundation of healthy living.\nZentiva works for the people living in Europe. Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare.\nWith more than 2,500 people across Europe and 2 production sites in Prague and Bucharest we strive to be the champions of Generics and OTC medicines to better support people&rsquo;s daily healthcare needs.\n ",
    "category": "Newsroom",
    "url": "/news/newsroom/2018/Zentiva-independent-company",
    "url_detail": [
      "news",
      "newsroom",
      "2018",
      "Zentiva-independent-company"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/news/images/2018/2018_Zentiva_HQ_perspective.jpg?h=486&iar=0&w=1440"
  },
  {
    "annotation": "",
    "type": "Media Search Page",
    "id": "8094309640FD4948B200D2262253E9D3-en",
    "tags": [],
    "publish_date": "2025-08-12T11:51:53Z",
    "language": "en",
    "name": "logo",
    "subtitle": "",
    "title": "Logo",
    "content_title": "Logo",
    "content_text": "",
    "category": null,
    "url": "/news/media-library/logo",
    "url_detail": [
      "news",
      "media-library",
      "logo"
    ]
  },
  {
    "annotation": "Zentiva.png logo, designed in line with Zentiva's branding guidelines, reflecting the company's visual identity.Â ",
    "type": "Media File",
    "id": "670C669D8C6642EEBB2C4A1052A65B35-en",
    "tags": [],
    "publish_date": "2025-08-12T11:51:21Z",
    "language": "en",
    "name": "zentivas-logo",
    "subtitle": "",
    "title": "Zentiva logo",
    "content_title": "Zentiva logo",
    "content_text": "",
    "category": "Logo",
    "url": "/news/media-library/logo/zentivas-logo",
    "url_detail": [
      "news",
      "media-library",
      "logo",
      "zentivas-logo"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/logos/zentiva.png?h=280&iar=0&w=1594",
    "file_size": "18959031"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "C0FAD5E30D1F469A818AFBED180D4A2B-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "events",
    "subtitle": "Stay informed about Zentiva's online and offline events, including in-house sessions and guest appearances at external events.",
    "title": "Events",
    "content_title": "Events",
    "content_text": "",
    "category": null,
    "url": "/news/events",
    "url_detail": [
      "news",
      "events"
    ]
  },
  {
    "annotation": "",
    "type": "Event Search",
    "id": "6571660C92BD47F5A876F10B9D7A6907-en",
    "tags": [],
    "publish_date": "2025-04-08T09:26:58Z",
    "language": "en",
    "name": "conferences",
    "subtitle": "Stay informed about Zentiva's online and offline events, including in-house sessions and guest appearances at external events.",
    "title": "Conferences",
    "content_title": "Conferences",
    "content_text": "",
    "category": null,
    "url": "/news/events/conferences",
    "url_detail": [
      "news",
      "events",
      "conferences"
    ]
  },
  {
    "annotation": "",
    "type": "Event",
    "id": "7125B1FAAC274007A4F1F35D3AD5C6C1-en",
    "tags": [
      "Exhibition",
      "Speaker",
      "Participant"
    ],
    "publish_date": "2024-04-11T00:00:00Z",
    "language": "en",
    "name": "global-community-advancing-human-health",
    "subtitle": "At the heart of Pharma CHPI is celebrating 35 years uniting pharma.",
    "title": "CPhI - A global community advancing human health",
    "content_title": "CPhI - A global community advancing human health",
    "content_text": "Speakers to be announced",
    "category": "Conferences",
    "url": "/news/events/conferences/2025/global-community-advancing-human-health",
    "url_detail": [
      "news",
      "events",
      "conferences",
      "2025",
      "global-community-advancing-human-health"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/event/CPHI-banner-event.jpg?h=1474&iar=0&w=2152",
    "date_from": "2025-10-28T09:00:00Z",
    "date_to": "2025-10-30T16:00:00Z",
    "attendance": "In person",
    "location_address_1": "Frankfurt, Germany",
    "location_address_2": "Full address for this location",
    "event_organizer": "Partnered event",
    "time_zone": "Europe/Prague"
  },
  {
    "annotation": "",
    "type": "Event Search",
    "id": "1BC9AB88FDE0408EA6A3345F110C005E-en",
    "tags": [],
    "publish_date": "2025-04-08T09:26:58Z",
    "language": "en",
    "name": "congress",
    "subtitle": "Stay informed about Zentiva's online and offline events, including in-house sessions and guest appearances at external events.",
    "title": "Congress",
    "content_title": "Congress",
    "content_text": "",
    "category": null,
    "url": "/news/events/congress",
    "url_detail": [
      "news",
      "events",
      "congress"
    ]
  },
  {
    "annotation": "",
    "type": "Event Search",
    "id": "C21F251423D742C8A940D2E378C04C0C-en",
    "tags": [],
    "publish_date": "2025-04-08T09:26:58Z",
    "language": "en",
    "name": "fair-and-exhibition",
    "subtitle": "Stay informed about Zentiva's online and offline events, including in-house sessions and guest appearances at external events.",
    "title": "Fair & Exhibition",
    "content_title": "Fair & Exhibition",
    "content_text": "",
    "category": null,
    "url": "/news/events/fair-and-exhibition",
    "url_detail": [
      "news",
      "events",
      "fair-and-exhibition"
    ]
  },
  {
    "annotation": "",
    "type": "Event Search",
    "id": "34306A56BC3C49659CFF10DC68CB3CB2-en",
    "tags": [],
    "publish_date": "2025-04-08T09:26:58Z",
    "language": "en",
    "name": "other",
    "subtitle": "Stay informed about Zentiva's online and offline events, including in-house sessions and guest appearances at external events.",
    "title": "Other",
    "content_title": "Other",
    "content_text": "",
    "category": null,
    "url": "/news/events/other",
    "url_detail": [
      "news",
      "events",
      "other"
    ]
  },
  {
    "annotation": "",
    "type": "Event Search",
    "id": "C431D44E5C0F4D53896EAF97A9F8B9B3-en",
    "tags": [],
    "publish_date": "2025-04-08T09:26:58Z",
    "language": "en",
    "name": "webinar",
    "subtitle": "Stay informed about Zentiva's online and offline events, including in-house sessions and guest appearances at external events.",
    "title": "Webinar",
    "content_title": "Webinar",
    "content_text": "",
    "category": null,
    "url": "/news/events/webinar",
    "url_detail": [
      "news",
      "events",
      "webinar"
    ]
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "DB57B38977CC412EBB9A2126AFF7ABAF-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "career",
    "subtitle": "Your talent. Our journey. One purpose.",
    "title": "Career",
    "content_title": "Career",
    "content_text": "Welcome to Zentiva, where we believe health is for everyone.For us, Zentiva is a great place to work. Our team is united by a shared purpose: to support the health and wellbeing of all generations by ensuring access to high-quality and affordable medicines. Every day, we help improve the lives of over 100 million people across Europe and beyond, contributing to a more sustainable healthcare system.We want you to enjoy what you do and grow through it. At Zentiva, we support you in discovering your strengths and unlocking your full potential. Zentiva team at a glance",
    "category": null,
    "url": "/career",
    "url_detail": [
      "career"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/careers/zen_fot_121_banner_.jpg?h=3333&iar=0&w=5000"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "586F39A551B74ADEB83D7E4011D2091D-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "careers-in-corporate-functions",
    "subtitle": "At Zentiva, our Corporate Functions connect people, strategy, and operations - driving efficiency, compliance, and growth across all areas of the business.",
    "title": "Careers in corporate functions",
    "content_title": "Careers in corporate functions",
    "content_text": "",
    "category": null,
    "url": "/career/careers-in-corporate-functions",
    "url_detail": [
      "career",
      "careers-in-corporate-functions"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/careers/zen_fot_620.jpg?h=1333&iar=0&w=2000"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "378F671AB160472EBECB97C76F21B8F5-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "benefits",
    "subtitle": "At Zentiva, we offer more than competitive pay - from health coverage and development programs to flexible work options and performance bonuses.",
    "title": "Benefits",
    "content_title": "Benefits",
    "content_text": "We want Zentiva to be a great place to work, where everyone can be their authentic self, bringing the best of their abilities to fulfil our purpose. We strive to ensure that our employees enjoy their experience from their very first day to their very last day at Zentiva.At Zentiva, we believe a great job goes beyond a paycheck. Alongside competitive salaries and performance-based bonuses, we offer a broad range of benefits designed to support your wellbeing, growth, and work-life balance. At Zentiva, benefits go beyond programs - they reflect our ongoing dialogue with our people. Every two years, our â€œHeartbeatâ€ engagement survey helps us understand how our teams feel, with an impressive 96% participation rate and 84% engagement index in 2023. We also dive deeper through focus groups, gathering feedback across roles and countries to shape our approach to sustainability, working conditions, communication, and inclusion.This open exchange is central to how we continuously improve and ensure that Zentiva remains a great place to work for everyone.",
    "category": null,
    "url": "/career/benefits",
    "url_detail": [
      "career",
      "benefits"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/careers/zen_fot_812---Edited---Edited.jpg?h=1333&iar=0&w=2000"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "DC4FF0E37EAD4B038ED47B807E9DBD46-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "contacts",
    "subtitle": "Find the right contact information to connect with Zentiva for inquiries, support, and partnerships.",
    "title": "Contacts",
    "content_title": "Contacts",
    "content_text": "",
    "category": null,
    "url": "/contacts",
    "url_detail": [
      "contacts"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/headline/contacts-headline.png?h=300&iar=0&w=600"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "FCF745ABCEEB41998EFA3F268AB3DAAC-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "information-for-our-partners-and-suppliers",
    "subtitle": "Our General Terms of Delivery define the core conditions governing every partnership and become binding upon purchase order acceptance.",
    "title": "Information for our partners and suppliers",
    "content_title": "Information for our partners and suppliers",
    "content_text": "Reporting of Fraud, Misconduct, and Suspected Serious BreachesReporting issues is a valuable contribution to the safety and wellbeing of trial participants and consumers. Thank you for following this guide.There are two responsibilities: IDENTIFY and COMMUNICATE any case of suspected fraud, misconduct, or serious breach. Such actions may be identified and informed by anyone involved: investigator, site staff, contractor, CRO, third party, sponsor staff IDENTIFYFraudAlways intentional falsification of data in proposing, designing, performing, recording, supervising, reviewing or reporting research.Examples of fraud warning signs: accrual of too many participants in a short time; data that are reported more efficiently by one investigator than other investigators; difficulty in scheduling site visits / failure to adhere to the protocol visit schedule; attempts to limit document access, reluctance to provide full and complete source documentation as per GCP requirements; doubts about the authenticity of the handwritten informed consent signature; major failure to the ALCOA principle; major and repeated drug accountability issues; creation of source data for non-existing patients or non-existing procedures; filling in the eCRF or subjectâ€™s diaries with fictitious information; violating eligibility criteria in order to boost recruitment; etc. MisconductEither intentional or unintentional failure to follow proper conduct.Examples of misconduct warning signs: generation of false data due to carelessness,  inexperience or misunderstanding, but with no intent to deceive; failure to follow the protocol; inexperienced site-staff; perceived unawareness of the Investigatorâ€™s Brochure (IB) or SmPC; too many studies at the same time at a site with the limited staff-capacity; disregard for participant safety and/or data integrity; lack of GxP knowledge in site personnel; inadequate or inaccurate record-keeping; etc. Serious breachAny deviation of the approved clinical trial protocol version or the Regulation (EU) No 536/2014 or local regulation that is likely to significantly affect safety, rights or wellbeing of clinical trial participants, and/or data reliability and robustness.Examples of serious breach warning signs: a breach of regulation and/ or  protocol that resulted in a serious adverse event (SAE); a systematic non-compliance with GCP or protocol resulting in significant impact on the integrity of the scientific value of studies; participant was dosed with the incorrect IMP from a different clinical trial; safety evaluation required by the protocol  were consistently not performed; the investigator would not allow sponsor access to the trial participantsâ€™ notes; loss of data; participants incorrectly randomised; etc. COMMUNICATEIf you are suspicious of fraud, misconduct or serious breach: inform the sponsor within 24 hours of detecting the issue by sending an email to sb@zentiva.com.The report should contain at least:data of incidentdescription of incidentsupporting evidenceThe sponsor may arrange a meeting to discuss it. Please stay available in case the sponsor has any follow-up questions.In case of a suspected serious breach, please complete the form",
    "category": null,
    "url": "/contacts/information-for-our-partners-and-suppliers",
    "url_detail": [
      "contacts",
      "information-for-our-partners-and-suppliers"
    ]
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "BEF3D9D21BC5402CB680F2B0C1E57D40-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "gdpr",
    "subtitle": "",
    "title": "GDPR",
    "content_title": "GDPR",
    "content_text": "ArchiveValidity FromToList of Zentiva entities.pdf09.07.202401.04.2025Privacy-Notice-GLOBAL-240916.pdf16.09.202431.12.2024Privacy-notice-GLOBAL-230403.pdf03.04.202315.09.2024List of Zentiva entities.pdf31.12.202308.07.2024Privacy-notice-GLOBAL-210701.pdf01.07.202102.04.2023Privacy-notice-GLOBAL-200406.pdf06.04.202030.06.2021Privacy-notice-GLOBAL-190923.pdf23.09.201905.04.2021Privacy-notice-GLOBAL-190603.pdf03.06.201922.09.2019Privacy-notice-GLOBAL-190305.pdf05.03.201902.06.2019 ArchiveHistoryValidity FromToPrivacy Notice for Whistleblowingâ€“231220.pdf20.12.2023 11.12.2024  ArchiveValidityFromToPrivacy-notice-HR-Recruitment-EN-203103.pdf31.03.202001.08.2020 ",
    "category": null,
    "url": "/gdpr",
    "url_detail": [
      "gdpr"
    ],
    "image_url": "https://edge.sitecorecloud.io/zentivagrou78d6-zentiva385a-test02ed-9fbf/media/Project/zentiva/zentiva/gdpr/GDPR.jpg?h=3333&iar=0&w=5000"
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "08FC481091A2431FBA7BD041B9EC219C-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "reporting-of-concerns",
    "subtitle": "Zentiva encourages reporting of concerns related to our compliance with applicable laws, our Code of Ethics, internal rules and ethical principles, as well as raising questions pertaining to compliance.",
    "title": "Reporting of concerns - â€œSpeak Upâ€ or â€œWhistleblowingâ€?",
    "content_title": "Reporting of concerns - â€œSpeak Upâ€ or â€œWhistleblowingâ€?",
    "content_text": "In any organization, whether private or public, big or small, breach of laws, internal rules or ethical codes may occur. This can take many forms: corruption, fraud, business malpractice or negligence. If they are not addressed, it can result in serious harm to the public interest as well as to the organizationâ€™s reputation.People who work for an organization or are in contact with it in their work-related activities are often the first to know about such occurrences and are, therefore, in a privileged position to inform those who can address the problem.â€¨We in Zentiva believe that a qualified investigation and response to any report helps the organization improve the prevention of, and ensure the proper reaction to, such activities.Thatâ€™s why Zentiva introduced the Zentiva Speak up initiative (â€œSpeak Upâ€) as a general mechanism to create a safe and confidential reporting environment. Within Speak Up, you may use any means or channel available to you (â€œSpeak Up Channelâ€) to be heard.Additionally, as a reaction to EU Whistleblower Directive, we have implemented a Whistleblowing mechanism (â€œWhistleblowingâ€). As required by the applicable local laws, we created the dedicated communication channels to be used for Whistleblowing (â€œWhistleblowing Channelâ€).The Chapter â€œReporting of Concernsâ€ in our Code of Ethics lays out the essential rules for both Whistleblowing and Speak Up mechanisms. Whistleblowing and Speak Up are both covered by detailed internal rules in each Zentiva company, and Whistleblowing, in addition, also when subject to applicable local or EU laws.If you want to raise a concern, please make sure you are using the right tool:you can always choose Speak Up, in any country, for any concern, by any channel|â€¨ORif your Zentiva entity falls within Whistleblowing scope (EU Whistleblower Directive), you can choose dedicated internal reporting channel(s) for Whistleblowing.Rest assured that there will be no retaliation in both Speak Up and Whistleblowing against good-faith reporting.â€œSpeak Upâ€ or â€œWhistleblowingâ€?If you want to raise a concern, please make sure you are using the right tool, the differences are highlighted further down. ",
    "category": null,
    "url": "/reporting-of-concerns",
    "url_detail": [
      "reporting-of-concerns"
    ]
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "E3332879CE234E6B9ECA874355E514BF-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "whistleblowers-protection",
    "subtitle": "Qualified investigation and response to reports helps us to prevent and ensure a proper reaction to unlawful activities.",
    "title": "Whistleblower Protection",
    "content_title": "Whistleblower Protection",
    "content_text": "Unlawful activities and abuse of law may occur in any organisation, whether private or public, big or small. They can take many forms: corruption, fraud, business malpractice or negligence. And if they are not addressed, it can result in serious harm to the public interest as well as to the organisationâ€™s reputation.People who work for an organisation or are in contact with it in their work-related activities are often the first to know about such occurrences and are therefore in a privileged position to inform those who can address the problem.Whistleblowers, i.e. persons who report information about wrongdoing in a work-related context, help to prevent damage and detect threat or harm to the public interest that may otherwise remain hidden.We in Zentiva believe that a qualified investigation and response to such reports helps us to prevent and ensure a proper reaction to such unlawful activities. Thatâ€™s why Zentiva introduced the Zentiva Speak Up initiative.In 2019, The European Union adopted a Directive on the protection of persons who report breaches of Union law (as of 23 October, 2019, no. 2019/1937, hereinafter the â€œDirectiveâ€). This Directive provides whistleblowers with slightly different protection than the Zentiva Speak Up initiative and whistleblowersâ€™ protection under the Directive is thus implemented separately with respect to applicable laws of the countries where Zentiva is present. Whistleblowing in individual countries Zentiva, k.s. Zentiva International a.s. If you cannot find a particular Zentiva affiliate in the list above, it means that the affiliate is outside the scope of EU whistleblowersâ€™ protection under the Directive (e.g. due to number of employees being below 50).Please note, that whistleblowersâ€™ protection is only granted when the report is made through the internal reporting channel of the respective legal entity. Therefore, please make sure you are using the right reporting channel. In case you make the report to an entity not concerned by the report we can neither investigate nor forward the report to the right entity. In that case, we will not evaluate the report. The confidentiality of your report will not be compromised and we will inform you that the report will not be investigated further.Please NOTE, that THIS IS NOT AN ACCESS TO ZENTIVA SPEAK UP initiative. If you wish to make a report outside of scope of EU Whistleblowers protection [(e.g. reports outside of the whistleblowers protection, anonymous reports in some countries, etc.)], we encourage you to use Zentiva Speak Up initiative.",
    "category": null,
    "url": "/reporting-of-concerns/whistleblowers-protection",
    "url_detail": [
      "reporting-of-concerns",
      "whistleblowers-protection"
    ]
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "BC41679BABB243D5BE09D574DAF83723-en",
    "tags": [],
    "publish_date": "2025-03-13T23:00:00Z",
    "language": "en",
    "name": "speak-up",
    "subtitle": "The courage to speak up represents the foundation for building trust internally and externally.",
    "title": "Speak Up",
    "content_title": "Speak Up",
    "content_text": "This Platform was established to report actual or suspected violations of laws, ZentivaÂ´s Code of Ethics, internal rules and ethical principles and to raise concerns and questions related to compliance; and with a further aim to take the required actions to mitigate the potential or the actual risk, to protect the company and individual employees.We in Zentiva believe that a qualified investigation and response to such reports helps us to prevent and ensure a proper reaction to such unlawful activities. Thatâ€™s why Zentiva introduced the Zentiva Speak Up initiative.In 2019, The European Union adopted a Directive on the protection of persons who report breaches of Union law (as of 23 October, 2019, no. 2019/1937, hereinafter the â€œDirectiveâ€). This Directive provides whistleblowers with slightly different protection than the Zentiva Speak Up initiative and whistleblowersâ€™ protection under the Directive is thus implemented separately with respect to applicable laws of the countries where Zentiva is present.Please note, that THIS IS NOT AN ACCESS TO ZENTIVA internal reporting channel implemented according to EU Directive.If you wish to report a breach and use an electronic form according to the Directive and its local implementation, you can find the link here.Please, keep in mind that your report within the Speak Up line WILL NOT be considered and handled as a report made within Zentiva Whistleblowers protection internal reporting system and you WILL NOT enjoy the protection under the Whistleblower protection laws.This is not an emergency service. Do not use the Platform to report events presenting an immediate threat to life, property, or the environment.The operational steps thereto related, including the investigation of the speak-up itself, are done primarily in-house, either by the Compliance Department or other relevant departments in line with the applicable legislation and internal processes.By following the link below, you will be redirected to the Platform, where the speak-up form is available. Other compliance and Speak Up line contacts+420 267 242 440compliance@zentiva.comHead of Ethical Compliance Zentiva Group, a.s.U kabelovny 529/16102 00 Prague 10, Czech Republic",
    "category": null,
    "url": "/reporting-of-concerns/speak-up",
    "url_detail": [
      "reporting-of-concerns",
      "speak-up"
    ]
  },
  {
    "annotation": "",
    "type": "Content Page",
    "id": "528B973D80F741C3A1542FF030C15FEA-en",
    "tags": [],
    "publish_date": "2025-04-15T07:36:38Z",
    "language": "en",
    "name": "whistleblower-protection-zentiva-group",
    "subtitle": "",
    "title": "Whistleblower Protection for Zentiva Group, a.s. - Czech Republic",
    "content_title": "Whistleblower Protection for Zentiva Group, a.s. - Czech Republic",
    "content_text": "See Czech version below Welcome to Zentiva Group, a.s. whistleblowers protection system under the act no. 171/2023 Coll., as amended.If you wish to make a report under the Zentiva Group, a.s. EU whistleblower protection system and the act no. 171/2023 Coll., as amended, this is the right place.Zentiva Group, a.s. has appointed a designated person for this role:Petra Rihova+420 267 242 440whistleblowing-cz@zentiva.com Reporting to Ministry of JusticeFinally, please be informed that you always have the right to make a report under the EU whistleblower protection and under the act no. 171/2023 Coll., as amended, to the Ministry of Justice. You can find the relevant information including the reporting channel here: https://oznamovatel.justice.cz/informace-pro-oznamovatele/ and here https://oznamovatel.justice.cz/chci-podat-oznameni/. CZECH / ÄŒeskyVÃ­tejte na strÃ¡nkÃ¡ch vnitÅ™nÃ­ho oznamovacÃ­ho systÃ©mu spoleÄnosti Zentiva Group, a.s. zÅ™Ã­zenÃ©ho podle zÃ¡kona ÄÃ­slo 171/2023 Sb. o ochranÄ› oznamovatelÅ¯v platnÃ©m znÄ›nÃ­.Pokud si pÅ™ejete podat oznÃ¡menÃ­ spoleÄnosti Zentiva Group, a.s., podle zÃ¡kona ÄÃ­slo 171/2023 Sb. o ochranÄ› oznamovatelÅ¯, pak je toto to sprÃ¡vnÃ© mÃ­sto.Jako pÅ™Ã­sluÅ¡nÃ¡ osoba byla spoleÄnostÃ­ Zentiva Group, a.s. urÄena:Mgr. Petra Å˜Ã­hovÃ¡+420 267 242 440whistleblowing-cz@zentiva.com OznamovacÃ­ systÃ©m Ministerstva spravedlnostiZÃ¡vÄ›rem vÃ¡s informujeme, Å¾e mÃ¡te po celou dobu prÃ¡vo podat oznÃ¡menÃ­ podle SmÄ›rnice o ochranÄ› oznamovatelÅ¯ a podle zÃ¡kona Ä. 171/2023 Sb. na Ministerstvo spravedlnosti. PÅ™Ã­sluÅ¡nÃ© informace vÄetnÄ› oznamovacÃ­ho formulÃ¡Å™e a dalÅ¡Ã­ch kontaktÅ¯ naleznete zde: https://oznamovatel.justice.cz/informace-pro-oznamovatele/ a zde https://oznamovatel.justice.cz/chci-podat-oznameni/.",
    "category": null,
    "url": "/reporting-of-concerns/whistleblower-protection-zentiva-group",
    "url_detail": [
      "reporting-of-concerns",
      "whistleblower-protection-zentiva-group"
    ]
  }
]
